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STUDIES OF B CELL DEVELOPMENT AND V(D)J RECOMBINATION 
Peter Chovanec 
Abstract 
The process of generating the vast diversity of immunoglobulin receptors and secreted antibodies 
begins with the recombination of the joining (JH), diversity (DH) and variable (VH) genes in the 
immunoglobulin heavy chain locus. The ability to produce antibodies is restricted to the B cell lineage 
and is tightly regulated, starting with the temporal separation of the recombination process, in which 
DH-JH precedes VH-DHJH recombination. Successful recombination of both heavy and light chain loci 
results in the expression of an antigen receptor on the cell surface. Subsequent selection stages 
remove non-functional and autoreactivity receptors from the final pool of antigen responding B cells 
that ultimately give rise to antibody secreting plasma cells. Understanding the complexity of the 
recombination processes and the diversity of the resulting antibody repertoire has been a major focus 
of academic and industrial research alike.  
Therapeutic monoclonal antibodies have seen many successful applications within the clinic and they 
constitute a billion-dollar industry. However, limitations therein have resulted in the emergence of 
antibody engineering approaches and the use of natural sources of alternative heavy chain only 
antibodies (HCAbs/nanobodies). The biotechnology company Crescendo Biologics has taken the highly 
desired characteristics of HCAbs a step further with the creation of a mouse platform capable of 
producing fully humanized HCAbs. The Crescendo platform presents a unique opportunity to expand 
our understanding of how mouse B cell development functions by exploiting the features of heavy 
chain only antibody production. Furthermore, the platform enables the expansion of our limited 
knowledge of the epigenetic mechanisms involved in the recombination of the human 
immunoglobulin heavy chain locus.  
Using flow cytometry, with dimensionality reduction analysis approaches, I investigated B cell 
development in the context of HCAbs. These studies revealed a previously uncharacterised 
developmentally intermediate B cell population. Due to ethical and availability limitations to studies 
of human bone marrow, the primary pre-selection human B cell repertoire has not been studied in 
detail. The isolation of several B cell developmental stages and the use of our novel DNA-based high-
throughput unbiased repertoire quantification technique, VDJ-seq, allowed me to study 
recombination of the human IGH locus sequence and observe HCAb repertoire selection within the 
mouse environment.  
The adaptation of next generation sequencing techniques to antigen receptor repertoire 
quantification has provided an unprecedented insight into repertoire diversity and the alterations it 
undergoes during infection or ageing. Our VDJ-seq assay is unique in its ability to interrogate DNA 
recombinants. To expand its capabilities, I investigated several limitations of the technique, including 
mispriming and PCR/sequencing errors, and implemented experimental and bioinformatics solutions 
to overcome them, which included the creation of a comprehensive analysis workflow. 
Finally, I have developed and applied a novel network visualisation method for genome-wide 
promoter interaction data generated by promoter capture Hi-C. The availability of high quality human 
pluripotent stem cell datasets allowed me to utilise the new techniques to further our understanding 
of the dynamics of genome organisation during early human embryonic development. This 
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During a vertebrate’s life, an enormous variety of pathogens are encountered on a daily basis ranging 
from bacteria to viruses and other parasitic organisms. The adaptive branch of the immune system 
represents one of the main defences against these invaders. It is uniquely capable of tailoring the 
immune response to the encountered pathogens and forming a memory of past encounters for a swift 
future defence. This unique ability is what allows vaccines to train our immune system to protect us 
from otherwise deadly pathogens. The adaptive ability stems from the vast diversity of 
immunoglobulins (antibodies when secreted) produced by the B cell and T cell lymphocyte lineages 
that are capable of binding to pathogen epitopes with high affinity and alerting the immune system 
of the invader’s presence. The diversity of immunoglobulins stems from the combinatorial 
recombination of three gene segments, which together create the variable exon that forms the 
epitope recognition site of immunoglobulins. Further diversification mechanisms in B cells select and 
hone low-affinity immunoglobulins into high-affinity pathogen specific ones, which are eventually 
secreted in the form of antibodies.  
The vast majority of our knowledge about the immunoglobulin recombination process comes from 
studies in mice. During my PhD, I focused on developing methods for the quantification of 
immunoglobulin repertoires and examining the recombination of a human immunoglobulin transgene 
model, with the goal of further understanding the processes that govern recombination in humans. 
The human transgene model is a unique mouse therapeutic platform capable of producing 
high-affinity heavy chain only antibodies. I begin by introducing B cell development within a mouse 
and examining the different selection checkpoints each B cell must pass through. For a mouse to 
produce heavy chain only antibodies several engineering feats had to be accomplished, the 
consequence of which I examine in terms of B cell development. I later examine the transgene and 
attempt to correlate the proximity of epigenetic factors with recombination frequency. I next describe 
the optimisation of an unbiased repertoire quantification assay developed in the lab and the 
development of a comprehensive analysis pipeline. Finally, I will delve into a side-project involving the 
development of a new visualisation method for promoter capture Hi-C and its use in examining 
changes in a model of early human embryonic development.   
1.1 Initiation of early B cell development within the bone marrow 
All blood-cell lineages originate from self-renewing hematopoietic stems cells (HSCs) that reside within 
the bone marrow. As they progress down different developmental lineages, they acquire lineage 
specific characteristics. The earliest indication of differentiation down the B cell lineage are presented 
by the transcription of terminal deoxynucleotidyl transferase (TdT), which is responsible for non-
template (N) nucleotide addition during antigen receptor recombination. The expression of TdT is 
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thought to be restricted to the B cell lineage. Collectively, the HSCs that are biased towards the 
lymphoid lineage are known as early lymphoid progenitors (ELP) (Figure 1-1) (Hardy et al., 2007). In a 
subset of ELPs, further progression down the B cell lineage into the common lymphoid progenitors 
(CLP) is accompanied by the expression and translation of the recombination-activating genes 1 and 
2 (RAG1/2). The RAG1/2 recombinases initiate DH-JH recombination of the immunoglobulin heavy 
chain (Igh), which leads to the loss of differentiation potential into non-lymphoid lineages (Igarashi et 
al., 2002). The B cell lineage specification is accompanied by the expression and repression of multiple 
transcription factors (TFs) that regulate the developmental progression. Both ELPs and CLPs still retain 
multi-lineage potential (Busslinger, 2004), and plasticity of the B cell lineage is not lost until the 
expression of the B220 and CD19 cell surface proteins in progenitor B cells (pro-B; fraction B; Figure 
1-1) (Rumfelt et al., 2006).   
 
Figure 1-1: Changes in cell-surface molecules (beige) during murine bone marrow B cell development.  
The stage-specific presence of different cluster of differentiation (CD) molecules has allowed their use as markers for 
separating B cell development into discrete stages. The changes in cell-surface markers are accompanied by changes in gene 
expression and intracellular protein translation (purple). Adapted from (Hardy et al., 2007). 
1.2 Commitment to B cell development in bone marrow 
1.2.1 VDJ recombination of the immunoglobulin heavy chain 
After diversity (DH) and joining (JH) genes undergo a lineage specific recombination event (DH-JH) that 
was initiated in CLP, the sequential recombination of the variable (VH) genes (VH-DHJH) follow in pro-B 
cells (fraction B/C) (Figure 1-2). This ordered lineage specific rearrangement of genes is known as V(D)J 
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recombination and is mediated by the RAG1/2 recombinases. RAG1/2 are responsible for the double-
stranded DNA breaks at recombination signal sequence (RSS) sites that initiate recombination 
(Oettinger et al., 1990). The RSS is a genomic sequence composed of highly conserved heptamer (7 
bp) and nonamer (9 bp) motifs that are separated by a 12 bp or a 23 bp spacer sequence (Figure 1-3 
a). In the Igh locus, the V and J genes are flanked by the 23bp spacer while the D genes are flanked by 
the 12bp spacer. Recombination only efficiently happens between 12/23 RSSs (the ‘12/23 rule’), 
ensuring the ordered recombination of J to D to V genes and preventing the recombination of J genes 
to V genes (Schatz and Swanson, 2011). Recombination can take place by either deleting the 
intervening signal joint (SJ) sequence, in the case when the RSSs are in opposite direction, or the SJ 
sequence is inverted and leads to the retention of both the coding joint (CJ) and the SJ (Figure 1-3 b). 
The RSSs in the Igh all face opposite directions that results in the deletion of the SJ sequence, whereas 
half the Igκ V genes are in the same orientation as the Jκ genes leading to recombination by inversion 
(Zachau, 1993) (Figure 1-3 b). The RSS, despite its conserved sequence, is almost never observed in its 
consensus configuration in vivo. Certain regions of the RSS are more important in recombination and 
display higher levels of conservation, such as the first three bases of the heptamer (Ramsden et al., 
1994).  
 
Figure 1-2: B cell development in the bone marrow.  
The different stages of development as defined by the Philadelphia/Basel nomenclature and also described in terms of 
phenotypic fractions (Hardy et al., 1991) are shown along with key proteins, such as BiP and the surrogate light chain (SLC) 
components (VpreB and λ5), present at each stage. BiP is a chaperone protein that retains unpaired heavy chains within the 
endoplasmic reticulum (white). Igα/Igβ are signal transducers for the pre-BCR receptor. V to DJ recombination of the Igh 
terminates after fraction B/C, while recombination of the Igl takes places in fraction D. At three developmental stages 
(checkpoints) B cells are subjected to positive or negative selection. The first and second checkpoints relate to the pre-BCR 
receptor, during which its ability to assemble (checkpoint 1) and functionally signal (checkpoint 2) proliferation and 
recombination of the Igl is assessed. B cells without a functional pre-BCR and negatively selected out. The third checkpoint 
related to the BCR and the ability of the light chain to pair with the heavy chain. B cells with non-functional or autoreactive 
BCRs are selected out, while the rest are positively selected and allowed to mature in the periphery.  
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Beside the RSSs within immunoglobulin loci, there are also millions of other regions of the genome 
capable of binding the RAG1/2 recombinases termed cryptic RSSs (cRSS) (Schatz and Ji, 2011). cRSSs 
can, in cases such as in lymphoma, lead to chromosomal translocations. The exact sequence 
composition of the RSS has been proposed to be one of the main factors that determines 
recombination efficiency. To capture the potential of an RSS sequence for recombination, a statistical 
model was devised that assigns a recombination information content (RIC) score to each potential 
RSS. The RIC score was able to distinguish cRSSs from true RSSs as well as show a correlation with 
actively recombining VH genes (Bolland et al., 2016; Cowell et al., 2002, 2003). However, other factors 
must also impact the process as observed from the different recombination frequencies of identical 
RSS sequences (Feeney et al., 2004). We have previously shown that the RSS acts more like a ‘binary 
switch’, enabling recombination of individual VH genes, but other chromatin factors influence the 
efficiency/frequency of recombination (Bolland et al., 2016).  
 
Figure 1-3: Recombination signal sequence (RSS) and RAG1/2 mediated recombination.  
(a) The RSS contains a conserved heptamer and nanomer motif separated by 12 (blue) or a 23 bp (red) spacer. The difference 
between the spacers corresponds to one helical turn on the DNA. (b) During recombination, the RSS12 and RSS23 come together 
with a heterotetramer composed of RAG1 and RAG2. RAG1/2 cleaves the DNA sequence at the RSS and performs 
recombination through either deletion or inversion of the intervening DNA. In deletional recombination the signal joint (SJ) 
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sequence is circularised and removed, whereas in inversional recombination the SJ sequence is inverted and retained between 
the coding joint (CJ) sequence. Based on (Little et al., 2015). 
Following the dsDNA cleavage by the RAG1/2 recombinases, a pair of hairpin loops form to protect 
the cleaved DNA. The hairpins are opened for repair with the Artemis:DNA-dependent protein kinase 
complex (Ma et al., 2002). If cleavage takes place at the apex of the hairpins, the result is a blunt-end. 
Alternatively, cleavage can take place several base pairs away from the apex, resulting in single-
stranded overhangs. Filling of these overhangs results in palindromic DNA sequences (P nucleotides) 
that were not present in the germline. The cuts are subsequently repaired with the cooperation of the 
RAG recombinases with the non-homologous end joining (NHEJ) repair machinery along with TdT 
(Agrawal and Schatz, 1997; Schatz and Ji, 2011). The repair process leads to nucleotide deletions, 
which are characteristic of NHEJ, and TdT mediated non-template nucleotide additions (non-germline 
(N) nucleotide addition) (Desiderio et al., 1984). The addition of N and P nucleotides at the junctions 
between the immunoglobulin genes (VH-Junction-DH-Junction-JH) further diversifies the antibody 
repertoire. The hyper-variability established through V(D)J recombination gives an antibody its 
specificity in the form of the complementarity determining region 3 (CDR3) (Tonegawa, 1983). 
Recombination is the first mechanism that drives the generation of the highly diverse antibody 
repertoire responsible for the recognition and neutralisation of pathogens.  
1.2.2 Pre-BCR expression and signalling 
The expression of the signal transducers Igα and Igβ along with the VpreB and λ5 non-covalently 
bonded proteins, which make up the surrogate light chain (SLC), happens early on in B cell 
development (Figure 1-2). After the productive recombination of the Igh, the resulting heavy chain 
(HC) polypeptide is deposited on the cell surface as a dimer along with Igα/β and the covalently 
bonded SLC, forming the pre-BCR. After numerous rounds of B cell receptor selection during 
development, only a minority of B cells from the starting pool manage to reach maturity (Allman et 
al., 1993). This selection takes place at several key developmental checkpoints.  
1.2.2.1 Surrogate light chain pairing and the pre-BCR - checkpoint 1 and 2  
The pre-BCR constitutes the first major selection checkpoint during B cell development (Figure 1-2). 
The pairing of the SLC with the HC indirectly assesses the ability of the HC to ultimately pair with the 
light chain (LC) peptide at the immature B cell stage (fraction E) and form a functional BCR receptor 
(Melchers, 1999). The expression of the pre-BCR triggers a signalling cascade that leads to proliferation 
and developmental progression. CD25, the α chain of the interleukin-2 receptor (IL-2Rα), is transiently 
upregulated on the cell surface of pre-BCR expressing B cells (Figure 1-1) along with CD2, while RAG1 
and RAG2 are down-regulated.  
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The functional relevance of CD25 upregulation on pre-B cells is unknown. Culturing B cells in the 
presence of IL-2 does not affect their proliferation or differentiation (Rolink et al., 1994), and a three 
cell surface marker analysis of bone marrow B cells in IL-2Rα knockout mice showed no differences 
from their wildtype counterparts in young mice (Willerford et al., 1995). With age, both IL-2 deficient 
and IL-2Rα knockout mice display a severe reduction of B cells in the mature compartments and 
throughout early development (Schultz et al., 2001; Willerford et al., 1995). The loss of both IL-2Rα 
positive B cells and B cells that do not yet express IL-2Rα suggests an IL-2Rα independent cause, one 
which has been suggested to involve an influx of dysregulated T cells into the bone marrow (Sadlack 
et al., 1995; Schultz et al., 2001). An abstract published from an ASH annual meeting suggest that the 
two other chains that make up the IL-2 receptor, IL-2Rβ (CD122) and IL-2Rγ (CD132), do not pair with 
IL-2Rα and do not respond to the IL-2 ligand. However, it additionally suggests that IL-2Rα is involved 
in pre-BCR signalling, revealing an unappreciated role of this receptor in B cell development once the 
data is published (Lee et al., 2015). 
Large pre-B cells (fraction C’) undergo 2-5 cell divisions (clonal expansion) during which the absence 
of the recombinase enzymes is critical (Decker et al., 1991; Hess et al., 2001). This expansion is 
essential for increasing the immunoglobulin repertoire diversity, as multiple HC clones can each have 
a differently rearranged LC. The expansion and differentiation has been shown to be independent of 
the pre-B cell environment, which suggests it can be driven by internal signalling events (Rolink et al., 
2000). The pre-BCR also signals its own expression-termination and degradation by inducing the 
expression of the lysosome-associated protein transmembrane 5 (LAPTM5). LAPTM5 was shown to 
target a large pool of pre-BCRs within the endoplasmic reticulum (ER) to the lysosome for degradation 
(Parker et al., 2005; Kawano et al., 2012). The degradation along with proliferative dilution leads to 
the observed absence of the pre-BCR in small pre-B cells (fraction D) (Figure 1-2).  
1.2.2.2 Pre-BCR signalling regulation 
SLP-65 (also known as BLNK/BASH) is the main signalling molecule downstream of the pre-BCR that 
mediates the SLC negative feedback loop, opposes the termination of heavy chain recombination and 
inhibits proliferation induced by class IA PI3K signalling (Herzog et al., 2009) (Figure 1-4) to essentially 
allow the recombination of the light chain. The pre-BCR feedback loop involves the up-regulation of 
Ikaros, Aiolos and IRF4 via SLP-65, which subsequently silence SLC genes (Ma et al., 2008; Thompson 
et al., 2007) (Figure 1-4). SLP-65 expression is crucial in controlling proliferation, developmental 
progression and B cell function, as highlighted by SLP-65 knockout mice (Jumaa et al., 1999; Hayashi 
et al., 2000). The SLC greatly increases the signal transduction of the pre-BCR via SLP-65 (Meixlsperger 
et al., 2007) and in turn silences itself through the downstream Ikaros and Aiolos transcription factors. 
The exact mechanism by which SLP-65 represses PI3K is not yet known. The phased timing of large 
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pre-B cells (fraction C’) proliferation induced by PI3K, before its repression by SLP-65, has been 
suggested to be the result of the abundance of PI3K proteins at the time of pre-BCR signalling versus 
the need for expression and translation of SLP-65 that delays its presence (Herzog et al., 2009). When 
the pre-BCR initiates signalling, it leads to the phosphorylation of SYK (autonomous receptor 
signalling), which in turn activates the PI3K pathways that results in the degradation of forkhead box 
O (FOXO) transcription factor (TF) in the absence of SLP-65. Absence of FOXO TFs leads to proliferation 
and inhibition of differentiation, whereas its presence leads to RAG1/2 expression, Igl recombination 
and B cell differentiation (Herzog et al., 2009). SLP-65 is crucial in differentiation and stopping 
proliferation, acting as a tumour suppressor. The cell cycle is controlled by cyclin-dependent kinases 
(CDKs) that are dependent on cyclins to become catalytically activated. Cyclin D3 has been shown to 
be involved in the expansion of the large pre-B cell pool (fraction D) in a receptor-mediated manner. 
The pre-BCR is required to stabilise cyclin D3 and prevent its degradation (Cooper et al., 2006). FOXO 
has been implicated in cell cycle delay through the regulation of p27 (a CDK inhibitor) expression. In 
addition, FOXO activates the expression of RAG1/2 during p27 induced cell cycle arrest (Herzog et al., 
2009). In the absence of p27, RAG2 is targeted for degradation by the cyclin A/CDK2 complex (Lee and 
Desiderio, 1999) (Figure 1-4). Through this mechanism, recombination is confined to G1 and G0 of the 





Figure 1-4: Pre-BCR signalling activation of SLP-65.  
Syk dependent phosphorylation and activation of SLP-65 leads to the repression of PI3K activity through a yet unknown 
mechanism and the activation of the FOXO1 transcription factor. In the absence of SLP-65, PI3K through AKT (protein kinase 
B or PKB) phosphorylates the FOXO transcription factors that results in their relocalisation into the cytoplasm and degradation 
by the proteasome. After the proliferative burst supplied through the pre-BCR and mediated by PI3K, SLP-65 assumes control 
and turns SLC (VpreB, λ5) expression off, leading to the downregulation of surface pre-BCR. SLP-65 also initiates IgL 
recombination through FOXO1 mediated cell cycle arrest, which involves the inhibition of cyclin D3 via Ikaros and Aiolos, and 
the upregulation of Rag1/2. Aiolos also promotes expression of the CDK inhibitor p27. CDK signal the cell that it can progress 
into the next stage of the cell cycle. The inhibition of the CDK-cyclin complexes also prevents the degradation of Rag2, which 
is normally ubiquitylated and targeted for degradation via the CDK-cyclin complexes (Herzog et al., 2009). Based on (Werner 
and Jumaa, 2015). 
1.2.2.3 The role of polyreactivity in pre-BCR function and BCR editing 
The importance of polyreactive BCR specificity for B cell development was demonstrated in a study by 
Köhler et. al. using an inducible system of the downstream target of the pre-BCR and BCR receptor, 
SLP-65 (Figure 1-4). By expressing a fusion of a polyreactive or a non-autoreactive V region with the 
µHC and inducing SLP-65 in a SLP-65-/- line, they were able measure the ability of the polyreactive 
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chimeric receptor to induce calcium flux. The non-autoreactive receptor on the other hand, was only 
able to induce efficient calcium mobilisation after stimulation with an anti-µHC antibody (Köhler et al., 
2008). The ligand-independent signalling ability of polyreactive BCRs even in the presence of the LC 
highlighted their similarity with the pre-BCR, for which the SLC has been shown to strongly enhance 
the induction of calcium flux, while the LC reduces it (Meixlsperger et al., 2007). In addition, the study 
showed that with artificial receptor editing (replacing the LC) the autonomous signalling of 
polyreactive BCRs was abolished. Overall, the study suggests that auto/polyreactivity plays a key role 
in the function of the pre-BCR and additionally facilitates the expansion of early immature B cells 
(fraction E) (Köhler et al., 2008). 
1.2.3 The BiP chaperone predominantly bind the CH1 antibody domain  
Conventional unpaired µHCs are efficiently retained within the endoplasmic reticulum (ER) through 
one of the Hsp70 chaperone family (heat shock) proteins, called BiP, that is present at high 
concentrations within the ER (Haas and Wabl, 1983; Ellgaard and Helenius, 2003). BiP binds the CH1 
domain of the heavy chain (Bole et al., 1986; Hendershot et al., 1987) and, unlike other antibody 
domains that can fold independently of each other, has been characterised in vitro as intrinsically 
disordered (Feige et al., 2009). The HCs are retained within the ER (Hendershot et al., 1987) in a 
reduced state until the constant region of the light chain releases BiP in an ATP dependent manner 
(Vanhove et al., 2001) and folds the domain into its correct conformation (Feige et al., 2009). Although 
BiP predominantly interacts with the CH1 domain, the deletion or replacement of the domain 
demonstrated that BiP continued to weakly bind the altered HC (Kaloff and Haas, 1995). Indeed, in 
some cases of heavy chain disease (HCD), where only the V region of the HC is missing, the ability to 
express the HCs on the cell surface was demonstrated (Corcos et al., 1991, 1995). It is the additional 
formation of dimers between HCs lacking the CH1 domain that leads to the release of residual BiP 
(Kaloff and Haas, 1995). A similar stabilisation of the CH1 domain in HCs from HCD patients that lack 
the V region could explain their ability to be expressed on the cell surface (Corcos, 2010). Interestingly, 
HC without the CH1 domain were shown to still bind the LC at the CH2 and CH3 domains non-covalently 
(Hendershot et al., 1987). Overall, this illustrates the importance of the CH1 domain, together with the 
SLC or the LC, as a safeguard to ensure ordered progression that is essential in normal B cell 
development. In a LC knockout and HCD models, B cell development fails past the immature B cell 
stage (fraction E) (Corcos et al., 1995; Zou et al., 2003). Interestingly, the ablation of the SLC does not 
fully block development at the pro-B (fraction BC) stage (Mundt et al., 2001a; Schuh et al., 2003; 
Shimizu et al., 2002; Su et al., 2003) despite the expectation that the HC should be sequestered in the 
ER via BiP (Shimizu et al., 2002).  
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1.2.4 The BCR and central tolerance - checkpoint 3 
The re-expression of the recombination machinery (RAG1/2) after the termination of pre-BCR 
signalling initiates VL-JL recombination of the Igκ (kappa light chain) locus in small pre-B cells (fraction 
D) (Oettinger et al., 1990) (Figure 1-2) and results in the formation of the BCR receptor. The enormous 
diversity generated by VDJ recombination inevitably results in a subset of immunoglobulins with self-
recognition. High levels of signalling through the BCR receptor leads to the activation of proliferation 
instead of differentiation at the immature B cell stage (fraction E). This seems to be a mechanism to 
allow further Igl recombination with the aim of reducing the high avidity of auto-reactive BCRs for self-
antigens (Pelanda et al., 1997; Meixlsperger et al., 2007). In such cases, the recombination machinery 
that was retained from the initial Igl recombination is used for successive rounds of Igκ editing or 
recombination of the second Igl locus, Igλ (lambda light chain). Receptor editing is one of the main 
mechanism of central tolerance, along with cell inactivation (anergy) and the last resort of clonal 
deletion (apoptosis) (Nemazee, 2006; Pelanda and Torres, 2012). In addition to the negative selection 
of high level signalling BCRs, the absence of tonic signalling from unproductive BCRs has been shown 
to trigger receptor editing and lead to a de-differentiation phenotype (Schram et al., 2008; Tze et al., 
2005). This additional trigger allows the rescue of B cells that contain a LC incapable of pairing with 
the HC. Tonic signalling would normally silence recombination and promote positive selection 
(Verkoczy et al., 2007) and its ablation ultimately results in clonal deletion (Lam et al., 1997). 
Successful surface expression of a functional BCR, composed of two HCs covalently paired with two 
LCs, terminates RAG1/2 expression and gives rise to the immature B cell (fraction E) that can migrate 
out of the BM and further mature in the periphery (Melchers, 2015).  
1.3 Chromatin states governing VDJ recombination in the Igh locus 
The expression of the RAG recombinase enzymes is only observed in specific lineages of lymphocytes 
and at precise developmental stages. An additional layer of control atop RAG expression is apparent 
from the sequential recombination of DHJH before VHDJH. The chromatin states that exert temporal 
control over recombination through chromatin accessibility will be discussed in this section, with a 
focus on the mouse Igh locus. Not much is known about the chromatin states in the human context, 
knowledge of which will be crucial in extending our understanding of how VDJ recombination is 
controlled in humans and whether it mirrors the mechanisms uncovered in mouse.  
1.3.1 Igh locus relocation and regulation during development 
The lamina network is essential to the architecture and function of the nucleus. Lamina-binding 
proteins serve as an interface between the nuclear backbone and its contents. They have been 
implicated in influencing a range of functions from transcriptional activity, epigenetic marks to 
location (Wilson and Foisner, 2010). Constitutive heterochromatin and the nuclear periphery are two 
11 
 
major classes of transcriptionally repressed sub-nuclear compartments. They are characterised by 
condensed chromatin and play an important role in chromatin accessibility and gene suppression 
(Pickersgill et al., 2006; Beisel and Paro, 2011). Previously, the importance of enhancers in locus 
relocation has been demonstrated with the β-globin locus (Ragoczy et al., 2006). The Igh locus contains 
a super-enhancer, the intronic enhancer Eµ, which was suspected to have a role in relocation (Bowen 
and Corcoran, 2008). In non-lymphocytes, the immunoglobulin loci are sequestered at the nuclear 
periphery. The dependence of chromosomal relocation, from the nuclear periphery into the inner 
nucleus, on the intronic enhancer Eµ was later shown using 4C and related techniques (Guo et al., 
2011a). 4C is a proximity ligation based assay that captures chromosome conformations in a ‘one 
versus all’ format, meaning it captures all the fragments interacting with a site of interest (Wit and 
Laat, 2012). The most distal part of the murine Igh locus (5’ J558 genes) is localised at the nuclear 
periphery, while the 3’ end protrudes into the inner nucleus (Yang et al., 2005). This 3’ DJ protrusion 
is thought to be recruited to a transcription factory, where the continuous transcription of Iµ from the 
intronic enhancer Eµ anchors it in place (Corcoran, 2010). The term transcription factory stems from 
the observation that transcription of active genes occurs in pre-formed nuclear foci with high 
concentrations of active RNA polymerase II (RNAPII) (Hozák et al., 1993; Mitchell and Fraser, 2008). 
The localisation of the Igh at a transcription factory may contribute to ordered recombination of the 
VDJ genes (Bowen and Corcoran, 2008).  
1.3.2 Allelic exclusion 
Each B cell contains a unique immunoglobulin that is selected to recognise and bind to a single antigen 
with high affinity. This one cell equals one receptor nature of B cells is achieved through a process 
called allelic exclusion, which collectively describes the events that lead to the productive 
rearrangement and expression of only a single uniquely recombined Igh and Igl allele within each B 
cell. Allelic exclusion involves the sensing of a successful recombination through multiple mechanisms, 
including DNA damage-sensing proteins, RAG2, mRNA and signalling triggered by the pre-BCR.  
Unlike DH-JH, VH-DHJH recombination is limited to only one allele despite both alleles being in 
euchromatic regions of the nucleus and accessible to the recombination machinery. The monoallelic 
restriction of VH-DHJH recombination has been attributed to the recruitment of ATM (ataxia-
telangiectasia mutated) to the site of the RAG-mediated dsDNA break, triggering signalling that leads 
to the repositioning of the second allele to pericentromeric heterochromatin (PCH) (Hewitt et al., 
2009). Additional support for the role of allele repositioning in allelic exclusion was provided by the 
same lab in a study where the absence of ATM or the C-terminus of RAG2 resulted in a higher 
frequency of biallelic breaks and the retention of both alleles in the euchromatic compartment 
(Chaumeil et al., 2013). The exact mechanism by which ATM and RAG2 perform this relocalisation is 
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unknown, but allele-specific 4C experiments in mature B cells showed both alleles present within 
similarly active compartments (Holwerda et al., 2013), suggesting the PCH relocation is only transient. 
Interestingly, in mature B cells the distal V region of both alleles appears to be recruited to a less 
transcriptionally active compartment, which has been proposed to focus the transcriptional and 
enhancer activity onto the productively recombined V promoter (Holwerda et al., 2013).  
The triggering of allelic exclusion by sensing dsDNA breaks does not explain the ability of B cells to 
recombine the second allele in cases of unproductive recombination. A study that separated the 
transcription of the recombined immunoglobulin gene from the protein production was able to show 
that a µHC transgene placed within one of the endogenous alleles and under the control of a weak 
promoter induces recombination of the second allele. In the case of a strong promoter, secondary 
recombination was inhibited (Lutz et al., 2011). The transcription of an unproductive recombination 
results in the rapid degradation of the transcript by the nonsense mediated decay pathway (Eberle et 
al., 2009). The study by Lutz et al. suggests that the stability of transcripts and therefore the abundance 
of mRNA allows cells to distinguish productive from unproductive recombination events that 
determine if further recombination is required or if allelic exclusion can get underway.  
After the relocalisation of the Igh into a transcription factory, it undergoes compaction that is 
dependent on interleukin-7 receptor (IL-7R) signalling (Kosak et al., 2002). The compaction is required 
to equalise the probability of recombination of distal VH genes, which are located up to 2.5 Mb away 
from the D region proximal VH genes. The subsequent productive recombination and formation of the 
pre-BCR triggers the degradation of RAG1/2 (Figure 1-4), until the recombination of lgl, along with a 
reduction of IL-7 signalling that reduces the accessibility of the VH region (Chowdhury and Sen, 2003). 
At the same time, both Igκ alleles undergo decompaction, mediated by the 3’ Igκ enhancer, that 
suggests a mechanism for limiting downstream recombination (Hewitt et al., 2008; Roldán et al., 
2005). The weakening of IL-7 signalling allows the activation of the Igκ intronic enhancer (iEκ) through 
the increased binding of the E2A transcription factor (Johnson et al., 2008). The dependence of Igh 
recombination on IL-7 is contrasted by its negative regulation of Igκ recombination, highlighting a 
mechanism that ensured a sequential non-overlapping recombination of the heavy and light chain loci 
during the transition between the pro- (fraction BC) to pre-B (fraction C’D) developmental stages. 
Altogether, an exquisite interplay of numerous mechanisms contributes to the process of allelic 
exclusion. 
1.3.3 Non-coding RNA transcription  
Protein coding transcription constitutes only a fraction of the entire mammalian transcriptome. The 
importance of non-coding RNAs (ncRNA) in transcriptional regulation is becoming more apparent as 
our understanding of the role of ncRNAs expands. Their multitude of functions is mirrored by their 
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diversity. Some of the main categories of ncRNAs include miRNA, siRNA and long non-coding RNAs 
(lncRNA) (Mercer et al., 2009). The Igh locus contains extensive lncRNA transcription. The Iµ 
transcripts that originate from the intronic enhancer Eµ (Lennon and Perry, 1985) are among the first 
transcribed in the Igh loci, along with the µ0 transcripts, just prior to recombination. µ0 emanates 
from the PDQ52 promoter/enhancer located upstream of the first DH gene (DQ52) (Kottmann et al., 
1994) (Figure 1-5). 
1.3.4 Antisense intergenic transcription and histone modification 
Intergenic transcription has been identified as a key component in facilitating VDJ recombination. The 
Igh locus contains both V region and D region antisense intergenic transcription (Figure 1-5) that has 
been shown to precede recombination and has been proposed to remodel the chromatin to enable 
recombination (Bolland et al., 2004, 2007). Through the activity of the RNA polymerase II complex, 
the locus is made accessible to chromatin re-modellers. The initiation of transcription in closed 
chromatin has been shown to be dependent on the RNA polymerase II (RNAPII) associated SWI/SNF 
ATP-dependent remodelling complex (Li et al., 2007; Osipovich et al., 2009). Opening of chromatin 
facilitates other changes that include loss of the repressive histone H3K9 methylation and gain of 
permissive H3K36me3, H3 and H4 acetylation marks (Subrahmanyam and Sen, 2010). Antisense 
transcription is present in discrete locations within the Igh locus and correlates with binding sites of 
regulatory factors involved in looping (Choi et al., 2013a). A model has been proposed where long 
antisense intergenic transcription shares a transcription factory with Eµ and in so doing brings the 
distal VH region in close proximity of the DJH region (Stubbington and Corcoran, 2013).  
 
Figure 1-5: Non-coding transcription of the Igh locus sequentially activated during VDJ recombination.  
Top figure depicts the germline Igh with transcripts in green and the Eµ enhancer depicted as purple oval. Bottom figure 
depicts a DHJH recombined Igh locus with transcription initiated in the VH region. Taken from (Matheson and Corcoran, 2012). 
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1.3.5 Igh regulatory elements  
The Igh has several enhancers and insulators that regulate the diverse chromatin landscape. Some of 
these include the Eµ enhancer and the PDQ52 promoter/enhancer, as mentioned above. The Eµ 
enhancer is indispensable in VDJ recombination. Besides its role in relocation and transcription factory 
tethering, its targeted deletions results in impaired DH to JH recombination (Afshar et al., 2006) and 
ablation of DH antisense transcription (Bolland et al., 2007). Unlike Eµ, the deletion of PDQ52 only 
results in modest alteration of J gene usage and has been proposed to have importance in secondary 
recombination (Nitschke et al., 2001). In addition to these two enhancers, a 3’ regulatory region (3’RR) 
composed of four DNase I hypersensitive site (hs1-4) has been implicated in the regulation of 
numerous processes. Most prominently, the 3’ RR region is involved in class switch recombination 
(CSR), promoting high transcription output of plasma cells and providing accessibility to the somatic 
hypermutation machinery. Upon deletion of the entire region all three functions of the 3’RR are 
severely compromised (Rouaud et al., 2013; Vincent-Fabert et al., 2010). In addition to the hs1-4 sites, 
there are four additional hypersensitive sites (hs5-8) downstream that are interspersed with a high 
density of CTCF (CCCTC-binding factor) and PAX5 binding sites (Birshtein, 2012). CTCF has been 
implicated in numerous roles ranging from transcriptional activation, repression, insulation to genome 
architecture (Phillips and Corces, 2009). The other regulatory region identified in the Igh locus is the 
IGCR1 insulator composed of two CTCF binding sites: HS4 and HS5. It is located in the VH-DH intergenic 
region and was shown to substantially decrease antisense transcription in the VH region (Featherstone 
et al., 2010). Chromatin conformation capture (3C; 4C; Hi-C) studies of the Igh revealed multiple 
interactions between the 3’RR and the rest of the locus (Birshtein, 2014), with a notable interaction 
being formed between the hs8 site and the IGCR1 (Medvedovic et al., 2013). In addition, the 3’RR has 
been shown to overlap the boundary of a topologically associated domain (TAD) that insulated the 
locus from downstream genes (Benner et al., 2015). The IGCR1 has been shown to inhibit proximal 
and promotes distal VH gene rearrangement. Perhaps most importantly it is responsible for 
maintaining a lineage specific and ordered recombination of DHJH followed by VH-DJH recombination 
(Guo et al., 2011b). The knockout of the hs5-7 sites, leaving hs8 behind, was shown to produce a mild 
skew in the normal choice of recombining genes (Volpi et al., 2012), suggesting that the overall 
interactions involving the 3’RR may influence VDJ recombination. 
Two regulatory regions equivalent to the mouse 3’RR were also discovered in the human IGH locus 
downstream of each constant α gene. They contain three DNaseI hypersensitive sites that are 
equivalent to the mouse hs1-4, with the exception of the mouse hs3B that seems to be absent in 
humans (Mills et al., 1997). Besides the 3’RR, the human IGH also shares the Eµ intronic enhancer with 
the mouse Igh (Hayday et al., 1984; Staudt and Lenardo, 1991). In addition, a difficult to clone region 
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between the Cδ and Cγ3 genes was shown to contain a high density of transcription factor binding 
motifs separated by repeats. A luciferase reporter assay revealed potential activating and silencing 
activity of the sequence, while an in vivo transgene revealed its activity was constrained to bone 
marrow B cells, suggesting it may represent a human specific enhancer (Mundt et al., 2001b).  
1.4 Evolution of the Igh locus 
The murine Igh locus of C57BL/6 mice is composed of 195 VH (110 functional, 85 pseudogenes), 10 DH, 
4 JH and 8 constant (CH) region genes that overall span approximately 3 Mb (Johnston et al., 2006; Ye, 
2004). Out of the 3 Mb, approximately 2.5 Mb is occupied by VH genes that can be divided into 15 
families based on their sequence homology (Mainville et al., 1996). In contrast, the human IGH locus 
only spans approximately 1.2 Mb and contains 123 VH genes (44 functional, 79 pseudogenes), 27 DH 
genes (23 functional, 4 pseudogenes), 9 JH genes (6 functional, 3 pseudogenes) and 5-11 constant 
region genes depending on haplotype (Lefranc and Lefranc, 2001; Matsuda et al., 1998). The human 
VH genes can be divided into 7 families (Kodaira et al., 1986). The Igh gene composition within different 
species arose from species-specific duplication events and subsequent divergence. Duplicated genes 
can either acquire a new function and remain in the genome or become pseudogenes as proposed in 
the birth-and-death evolution model (Ota and Nei, 1994). Comparison of sequence similarity in the 
C57BL/6 mouse strain showed that VH genes can be grouped into three distinct phylogenetic clans 
(Johnston et al., 2006). This confirmed the previous assignment of the mammalian VH families into 
three clans based on framework 1 (FR1) protein sequence homology (Kirkham et al., 1992). Despite 
the obvious size and gene number difference between human and mouse, it is remarkable that their 
VH genes can be assigned to one of the three shared clans that have survived in the genome for millions 
of years (Das et al., 2008; Ota and Nei, 1994) (Figure 1-6).  
 
Figure 1-6: Distribution of the three clans across the VH genes in human and mouse.  
In green are the DH genes. Red – clan I, blue – clan II, yellow – clan III. Adapted from (Das et al., 2008).  
1.4.1 Chromatin states driving recombination 
Numerous VJ primer pair PCR based methods have been used to study antigen receptor (AgR) 
repertoires, most recently with adaptations for next-generation sequencing (NGS) (Georgiou et al., 
2014; Weinstein et al., 2009). However, the biases present within these techniques hinder the 
quantification of the antibody repertoire diversity (Baum et al., 2012). The development of a novel 
assay termed VDJ-seq allowed us to overcome these limitations. VDJ-seq uses the fact that in every 
recombination there will always be a JH gene present and leverages this to perform a single round of 
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primer extension that extends into the DH and VH recombined sequence. The primer extension is 
performed with biotinylated primers that are captured, amplified and made into an Illumina ready 
library (Bolland et al., 2016; Chovanec et al., 2018).  
Obtaining quantitative data of DJH and VDJH recombination frequencies in mouse, allowed us to 
perform a detailed examination of the efficiency of this process. ChIP-seq datasets of multiple 
transcription factors and histone modifications along with other chromatin data, such as DNase 
hypersensitivity and non-coding RNA transcription, were used to determine the chromatin state of 
each VH gene. By integrating sites of active recombination within the Igh together with the chromatin 
state annotation from ChromHMM (Ernst and Kellis, 2012), it was possible to start unravelling the 
states of chromatin that influence recombination in the mouse Igh. The analysis resulted in a model 
that separated VH genes into three mutually exclusive chromatin states (State A: CTCF, RAD21; State 
E: PAX5, IRF4, YY1, along with various histone modifications; Background state). The model was highly 
predictive of recombination. Interestingly, the mutually exclusive A and E chromatin states correlated 
with the evolutionary history of the locus (Bolland et al., 2016). An equivalent analysis was also 
performed for the Igκ locus revealing that PU.1, not important in the Igh, acts as a binary predictor of 
recombination in the Igκ locus (Matheson et al., 2017).   
1.5 B cell maturation in the spleen 
Immature B cells produced in the BM migrate into the spleen where they either die or undergo 
maturation. Studies with transgenic mice have shown a dependence on BCR signalling for the 
transition into different mature subtypes. Specific signalling (BAFF or Notch2) pathways, including the 
BCR signal strength, seems to be the driving force behind lineage progression into the different mature 
B cell populations (FO, section 1.5.2; MZ, section 1.5.3; B1, section 1.5.4) (Hardy et al., 2007) (Figure 
1-7). 
1.5.1 T1-3 B cells 
Much like the development in the bone marrow, B cell maturation in the spleen has been shown to 
be a multistep process with a number of selection checkpoints (Allman et al., 2001; Loder et al., 1999). 
The progression from immature to mature B cells can be subdivided, based on differential expression 
of cell-surface markers, into three ‘transitional’ stages: T1, T2 and T3. They are all short-lived cells and 
still functionally incompetent as they are unable to respond to antigen stimulation, which is a 
prerequisite of mature B cells (Hardy et al., 2007).  
1.5.1.1 T3 Anergy - checkpoint 4 (peripheral tolerance) 
The immature B cells entering the spleen have been shown to undergo ligand-dependent apoptosis 
(Rolink et al., 1998) and silencing by anergy (Merrell et al., 2006). The T3 stage is characterised by 
down-regulation of IgM and was thought to have represented an intermediate stage in the generating 
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follicular B cells (Allman et al., 2001). It was later shown that the T3 stage contains functionally 
unresponsive (anergic) B cells, based on a panel of cell surface markers of anergy (CD93+, 
CD24intermediate, IgDhigh, CD23+, IgMlow) that was defined from a comparative analysis of wildtype and 
anergic transgenic mouse strains (Merrell et al., 2006). Therefore, BCRs with low affinity for 
auto-antigens passing through the tolerance checkpoint during the transition from immature to 
mature B cells are thought to be diverted into this anergic state. Continuous presence of auto-antigens 
is required to keep them in this state (Merrell et al., 2006). This represents an additional checkpoint 
in the periphery for selecting out auto-reactive BCRs, which seems to be more prominent in humans 
than in mice (Melchers, 2015). 
1.5.2 B2 Follicular (FO) B cells 
The final stage of maturation of a large population of recirculating immature B cells takes place in the 
anatomical site called the follicular region. Cells within this region are referred to as follicular B cells. 
They do not proliferate but constitute a population of long-lived B cells. Their survival is dependent 
on B cell-activating factor (BAFF) signalling more so than on BCR signalling (Figure 1-7) (Hardy et al., 
2007). FO B cells are thought to be the main mature B cells population that give rise to long lived 
memory B cells (Shlomchik and Weisel, 2012; Victora and Nussenzweig, 2012).  
1.5.2.1 Somatic hypermutation (SHM) - checkpoint 4 (peripheral tolerance) 
Antigen stimulation of FO B cells leads to proliferation and the expression of activation-induced 
cytidine deaminase (AID). AID catalyses the switching of antibody effector class (class switch 
recombination) and the honing of antibody binding avidity through SHM. The process of SHM may 
lead to auto-reactive antibodies which need to be silenced and removed from the repertoire 
(Melchers, 2015).  
1.5.3 Marginal zone (MZ) B cells 
MZ B cells are another population of mature B cells that are located in areas occupied by macrophages, 
which classically perform antigen filtering and scavenging tasks. Much like B-1 B cells (section 1.5.4), 
MZ B cells have been suggested to have a restricted repertoire (Martin and Kearney, 2002; Pillai et al., 
2005). Unlike FO B cells, MZ B cells are specialised against bacteria cell-wall constituents and senescent 
self-components (Hardy et al., 2007; Paul, 2012). The clearance of apoptotic cells and some types of 
bacteria is thought to be aided by their low level of polyreactive and autoreactive specificity (Martin 
and Kearney, 2002). Notch2 signalling is indispensable in MZ B cells as its deletion leads to MZ B cell 




Figure 1-7: The reciprocal signal dependence of different mature B cell subtypes.  
Taken from (Hardy et al., 2007). 
1.5.4 B-1 B cells 
B-1 B cells seem to be exclusively generated by the fetal liver, as demonstrated by transplant 
experiments (Hayakawa et al., 1985). They persist primarily through self-renewal, unlike FO and MZ B 
cells that are derived from BM precursors (Hayakawa et al., 1986). They produce what has been 
termed natural autoantibodies, as they are found even in mice kept in sterile conditions. Natural 
antibodies have higher specificity for self, compared to antibodies produced by B2 B cells (Hardy et 
al., 2007). Autoreactive specificity seems to be favoured during selection, allowing self-reactive BCRs 
into the mature B-1 B cell pool (Baumgarth, 2011). 
1.6 Therapeutic antibodies 
The use of monoclonal antibodies (mAbs) as therapeutics began in the 1980s and has grown into a 
multi-billion dollar industry with over 40 monoclonal products having gained clinical approval (Ecker 
et al., 2015). The pioneering hybridoma technology that allowed the isolation of mAbs from mice 
(Köhler and Milstein, 1975), along with the relative ease of mouse immunisation, resulted in extensive 
research and utilisation of rodent monoclonal antibodies as therapeutics. However, even before the 
advent of mAbs, serum therapies that used the sera from immunised non-human sources resulted in 
adverse effects termed serum sickness (Yamada, 2011). Similarly, mouse mAbs administered in 
humans resulted in an immune response that produced human anti-mouse antibodies (HAMA). The 
HAMA response also decreased the retention half-life of mAbs within the body, reducing their 
effectiveness as a therapeutic. This led to extensive efforts aimed at reducing the immunogenicity of 
mouse mAbs by, for example, replacing the mouse constant regions of a mAb with human constant 
regions (Yamada, 2011). At the same time, the development of phage display bypassed the hybridoma 
technology and allowed high-throughput screening of high affinity binders along with the creation of 
large human antibody repertoire screening libraries (Mondon et al., 2008). Phage display works by 
replacing the sequence of the phage coat protein with the sequence of a mAbs V region, which results 
in a fusion protein that preserves the infectivity of the phage while allowing the immunoglobulin to 
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be displayed on the surface, bind its target antigen and be affinity purified as a result (McCafferty et 
al., 1990; Smith, 1985).  
The next major advancement in humanising mAbs came from genome engineering approaches and 
the creation of humanised transgenic mice. The use of human immunoglobulin sequences in the 
production of therapeutic antibodies circumvents the potential immunogenic responses in patients to 
antibodies raised using other species intrinsic sequences. However, the use of human constant regions 
in transgenic mice resulted in inefficient developmental progression with substantial reduction of B 
cell numbers (Brüggemann et al., 1989; Fishwild et al., 1996; Green et al., 1994; Lonberg et al., 1994). 
This may be a result of inefficient interfacing of the human immunoglobulin transmembrane constant 
region with the murine Igα and Igβ signal transducers at the pre-BCR and BCR stages of development. 
Nucleotide comparison of the Igh transmembrane domains showed some differences between human 
and mouse (Varriale et al., 2010), supporting this idea. As a result, the next iteration of transgenic mice 
used the endogenous constant region in combination with human V, D and J genes to obtain potent 
in vivo affinity matured chimeric mAbs (Lee et al., 2014; Ma et al., 2013; Macdonald et al., 2014; 
Murphy et al., 2014; Osborn et al., 2013). The mAbs can have the murine constant region re-
engineered post hoc, providing fully humanised mAb therapeutics. 
Despite the extensive pursuit of mAb therapeutics, mAbs have several limitations. They are large in 
size, difficult to engineer and relatively expensive to manufacture. In addition, due to their multimeric 
structure they can be relatively unstable (Chames et al., 2009; Steels and Gettemans, 2018). The 
derivation of small fragments from antibodies, that can retain the binding activity of the original 
molecule, was a significant advance and gave rise to new antibody formats. The first demonstration 
of such moieties was the scFv fragment composed of only the heavy and light chain variable region 
from a mAb linked together with a flexible linker (Bird et al., 1988). Subsequently, Greg Winter’s group 
demonstrated that E. coli can produce mouse heavy chain variable domains without the light chain 
while retain their binding capacity, and named these fragments single domain antibodies (dAbs) (Ward 
et al., 1989). The next innovation came with the discovery of diabodies by the same group, improving 
on the short half-life of scFv fragments in serum and overcoming the aggregation of dAbs in solution 
(Holliger et al., 1993). Diabodies lack a long linker that results in two VH:VL domains forming a dimer 
and because of the two unique VH:VL components, diabodies can form bispecific interactions. The 
modular nature of fragment antibodies and their ease of manufacture in prokaryotic systems means 
that they can be used in a multi-array configuration with other effector proteins fusions such as 
cytokines, immunotoxins and membrane proteins to create chimeric receptors. More recently, 
naturally occurring dAbs, called heavy chain only antibodies, were first discovered in the serum of 
camels and later shown in other animals that are part of the Camelids group (camels, llama, vicugna) 
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in addition to cartilaginous fish such as nurse sharks (Flajnik and Kasahara, 2010; Hamers-Casterman 
et al., 1993). 
1.7 Heavy chain only antibodies (HCAbs/nanobodies) 
Heavy chain only antibodies (HCAbs) differ from conventional antibodies in two respects: they are 
missing the CH1 domain and they do not have a light chain (LC) (Hamers-Casterman et al., 1993) (Figure 
1-8). The heavy chain CH1 domain normally forms disulfide bonds with LC and its absence is the 
primary cause of the LCs inability to bind the camelid variable domains (VHHs). The VHH of an HCAb 
is the smallest part of an antibody (around 15kDa) that is able to strongly and specifically recognise its 
target (Figure 1-8) (Steels and Gettemans, 2018). The VHHs of camelids have been shown to have low 
propensity for aggregation and an ability to refold after high temperature denaturation (Ewert et al., 
2002; Pérez et al., 2001), providing a clear advantage over earlier dAbs. The higher solubility of the 
VHH domains has been attributed to the substitution of certain residues within the FR2 region. 
Alteration of these residues in a human variable domain (VH) leads to the same higher solubility 
observed in camelid VHH, confirming their importance (Davies and Riechmann, 1994). These residues 
are normally involved in hydrophobic interactions between VH and VL chains and their conversion into 
more hydrophilic residues allows VHHs to further resist pairing with the VL (Genst et al., 2006; Steels 
and Gettemans, 2018). The lack of a VL in HCAbs results in a lower combinatorial diversity of camelid 
VHHs. However, on average camelid VHHs have a longer CDRH3 domain with an overall higher 
conformational variation compared to conventional human and mouse antibodies (Wu et al., 1993; 
Muyldermans et al., 1994). The VHH CDRH3 domain also features an additional disulphide bond that 
is thought to stabilise the domain and allow novel loop conformations (Nguyen et al., 2000) (Figure 
1-8). The longer CDRH3 region increases the VHHs antigen interacting surface area and compensates 
for the lack of VL, which along with structural variation increases the diversity or the VHH repertoire. 
The appearance of longer CDRH3 domains is thought to be the result of selection for properly folded 




Figure 1-8: The structure of a conventional IgG antibody (left) alongside a heavy chain only antibody (right).  
One of the key differences is the lack of the CH1 domain in the HCAb. It is through this domain that the immunoglobulin light 
chain is covalently attached to the heavy chain. The left portion of each diagram shows protein annotations; the dotted lines 
represent disulphide bonds. The right portion of the diagram shows DNA sequence annotations. The VHH fragment (VH for 
human HCAb) of the HCAb is the smallest part of the antibody that is still capable of specifically binding an epitope of an 
antigen. Dashed lines represent disulphide bonds. Adapted from (Georgiou et al., 2014). 
1.7.1 Therapeutic applications of HCAbs 
HCAbs provide several key advantages that overcome the limitations of mAbs and provide additional 
functionality. The small size of HCAbs endows them with superior tissue penetrance that is especially 
critical in cancer therapy, while also allowing them to target conventionally inaccessible surfaces 
(clefts) such as the active sites of enzyme. This ability allows HCAbs to be used as inhibitors and 
disruptors of protein interactions. Much like other antibody fragment formats, HCAbs inexpensive 
manufacture, ease of engineering and higher stability have made them into attractive therapeutics, 
with multiple clinical trials currently underway. Dimeric or trimeric HCAbs created with flexible linkers 
can improve avidity or create bispecific binders that improve the HCAbs binding specificity, a desirable 
feature in therapeutic applications such as tumour targeting (Bannas et al., 2017). In addition, 
multimeric HCAb formats are able overcome their relatively short half-life in vivo, while their ability to 
retain function within the reducing environment of cells has made them a powerful research tool 
(Steels and Gettemans, 2018). Multimeric HCAb formats have an increased size (30-45 kDa) compared 
to the monovalent HCAb (15 kDa) that can reduce their penetration efficiency; however, their size is 
still much smaller than the 150 kDa of mAbs (Bannas et al., 2017).  
Early studies comparing camelid VHH domains to human VH domains have shown camelid VHHs have 
more desirable biophysical properties, such as reversible folding and the ability to resist aggregation 
after denaturation (Ewert et al., 2002), suggesting human VH would make less desirable nanobodies. 
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However, later studies have identified and selected human VH domains that had the same biophysical 
properties as camelid VHHs (Jespers et al., 2004). Within the enormous human antibody repertoire, it 
is not surprising that a subset of human VH domains would possesses camelid VHH qualities. Studies 
trying to pinpoint the consensus of this subset have found some amino acid commonalities (Christ et 
al., 2007; Dudgeon et al., 2009). However, no large-scale studies with more than a few variable region 
sequences have been conducted to determine if this subset of human VHs arises from specific VDJ 
gene usage or through downstream random diversification processes such as TdT nucleotide 
incorporation and somatic hyper-mutation (SHM). The ability to use human VDJ genes for the 
production of HCAbs is key in preventing the production of human anti-mouse antibodies (HAMA 






C57Bl/6JBabr mice (hereafter referred to as wildtype (WT)) were housed and bred at the Biological 
Support Unit (BSU) at the Babraham Institute, Cambridge. Crescendo mice (humanised HCAb 
producing transgenic mice created by Crescendo Biologics) were housed and bred at the Charles River 
laboratories facility (Manston, Kent, UK). WT mice were culled using carbon dioxide asphyxiation in 
accordance with the Humane Killing of Animals under Schedule 1 to the Animal (Scientific Procedures) 
Act 1986. Crescendo mice legs and spleens were shipped over night or on the same day in RPMI-1640 
media (cat. no. R8758; Sigma) supplemented with 5% foetal calf serum (FCS) (cat. no. F9665; Sigma). 
 
2.2 Cell lines 
Nalm6 (B cell precursor leukaemia cell line) cells were grown in RPMI-1640 (cat. no. R8758; Sigma) 
supplemented with 10% FCS (cat. no. F9665; Sigma) and Penicillin Streptomycin (cat. no. 15140-122; 
Invitrogen; 100x) at a 0.5x final concentration. For storage the Nalm6 cells were frozen down in 70% 
RPMI-1640, 20% FBS and 10% DMSO. All media was filter sterilised before use (cat. no. 431097; 
Corning). Nalm6 cells were maintained at 1-2 million/ml density, split 1:2-1:3 every 3 days and seeded 
at 1 million/ml density (minimum 0.5 million/ml).  
Yeast with 10V YAC construct were grown in synthetic complete drop out medium composed of 1.725 
g of SP supplements (cat. no. CYN0405; Formedium), 0.18 g amino acids mix (cat. no. DCS0741; 
Formedium), 200 ml water and 4 g glucose (cat. no. G/0500/53; Fisher Scientific) which was added 
after autoclaving at 121 oC for 15 minutes.  
The naïve and primed hPSC were cultured by Amanda J. Collier, under the supervision of Peter Rugg-
Gunn. All work was carried out in accordance with the UK Stem Cell Bank Steering Committee and 
Babraham Institute Health and Safety and Human Tissue Ethics Committees. 
2.3 3D DNA Fluorescent in-situ hybridization (FISH) 
3D DNA FISH was performed as previously described (Bolland et al., 2013). Briefly, 50-20 µl of cells at 
a concentration of 10 million cells/ml were placed onto poly-L-lysine coated slides (cat. no. P0425; 
Sigma) and left for 5 minutes to allow attachment. The slides were placed into 4% formaldehyde/PBS 
(PFA; cat. no. 28794.295; VWR) for 10 minutes and quenched in glycine for at least 10 minutes at 22oC. 
The following text has been redacted due to sensitivity of the material 
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After permeablisation using Saponin (cat. no. 4521; Sigma), the slides were stored in 50% glycerol at -
20 oC for at least a week before proceeding to three rounds of freeze thawing in liquid nitrogen. After 
PBS (cat. no. 70011044; Gibco) washes, the slides were placed in 0.1N HCl, rinsed and then subjected 
to another round of permeablisation using Saponin and Triton X-100 (cat. no. T9284; Sigma). Probes 
(Table 2-1) precipitated with mouse Cot-I (cat. no. 18440016; Invitrogen) and salmon sperm DNA (cat. 
no.  D7290; Sigma) were added to the cells which subsequently underwent denaturation at 78oC for 
exactly 2 minutes, followed by a 16 hr incubation at 37 oC to allow hybridisation. After SSC washes, 
cells were counterstained with DAPI followed by an additional fixation with 3.7% formaldehyde, which 
results in a cleaner signal and longer storage life. Finally, a coverslip was mounted along with a drop 
of Vectashield (cat. no. H-1000; Vector Laboratories) or ProLong Diamond antifade mounting media 
(cat. no. P36970; Invitrogen). Imaging was performed on the Olympus BX61 fluorescent microscope 
or on the Metafer/MetaCyte slide scanning system with the help of Simon Walker, Daniel Bolland, 
Jannek Hauser and Fatima Santos. In general, 13 Z-stacks were imaged and maximum intensity merged 
using ImageJ v1.48 (Schneider et al., 2012).  
Table 2-1: FISH probes used to visualise the IgH locus and the Crescendo inserted YAC transgene.  
Probe contains Species Labelling  Origin 
IgH constant region – all 
constant genes 
Mouse Alexa fluor 488 (cat. no. 
A32750; Invitrogen) 
RP24-258E20 BAC 
VD intergenic region probe 
1-7 
Mouse Alexa fluor 555 (cat. no. 
A32756; Invitrogen) 
PCR product 
(Ramadani et al., 
2010) 
VD intergenic region probe 
1-4 
Human Alexa fluor 555 PCR product (see 
Table 2-2) 
Cγ, Cε, Cα, 3’RR Mouse Alexa fluor 488 RP23-149L24 BAC 
J, Cµ, Cδ, Cγ genes  Mouse Alexa fluor 488 RP23-109B20 BAC 
IGHV1-2 – IGHV3-13 Human Alexa fluor 647 (cat. no. 
A32757; Invitrogen) 
RP11-659B19 BAC 
IGHV3-21 – IGH4-39 Human Alexa fluor 647 RP11-72N10 BAC 
Chr14 paint Mouse Green CytoCell AMP14G-S 
Chr12 paint Mouse Green CytoCell AMP12G-S 
 
2.3.1 DNA FISH probe design and generation 
DNA FISH probes for the human IGH V-D intergenic region were designed using the web engine 
boosted fluorescence in-situ hybridisation (webFISH) tool (Nedbal et al., 2012) (Table 2-1). The human 
genome assembly GRCh37 was used. Probe design was limited to a small region on chromosome 14 
with coordinates 106385388-106405563 that corresponds to the V-D intergenic region. The tool 
maximises coverage of repetitive regions such as the IgH by also considering locally repetitive regions. 
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These regions are absent from the rest of the genome, hence making them good probe targets despite 
their repetitiveness.  
The 10V YAC yeast were grown until OD 0.69 and collected with a 2975 xg spin for 2 minutes. DNA 
was extracted using the YeaStar Genomic DNA kit (cat. no. D2002; Zymo Research). The webFISH-
generated primers were used to amplify the VD intergenic regions from the extracted DNA. Gel 
extracted PCR products were inserted into the pGEM-T Easy Vector plasmid and expanded up in DH5α 
cells. The probe sequence was verified using Sanger sequencing. 
For probes made from BACs, the BAC DNA was extracted using the NucleoBond BAC 100 kit (cat. no. 
740579; Macherey-Nagel), following manufacturers protocol. 
2.3.2 Nick translation probe labelling  
Nick translation labelling of probes was performed as previously described (Bolland et al., 2013) with 
some modifications. Briefly, mixed on ice 5 µl 10x NTB (0.5 M Tris-HCl pH 7.5, 50 mM MgCl2, 0.5 mg/ml 
nuclease-free BSA fraction V), 0.1 M DTT, 4 µl d(GAC)TP mix 0.5 mM, 1µl dTTP 0.5 mM, 6 µl aminoallyl-
dUTP 0.5 mM (cat. no. R1101; Thermo Scientific), 1 µl DNA Polymerase I 10 U/µl (cat. no. M0209; 
NEB), 1µl DNase I dilution (1:25) (cat. no. 04716728001; Roche), H2O to a final volume of 50 µl. The 
mix was incubated for exactly 2 hours at 16 oC and then for 5 minutes at 75 oC to inactivate DNase I. 
DNA digestion was visualised using a 2% agarose gel. Each probe was nick translated in a separate 
reaction (1 µg each). Optimally digested DNA was pooled (4 µg), ethanol precipitated and the pellet 
was re-suspended in 4 times 1.25 µl H2O followed by quantification using the NanoDrop  
spectrophotometer (cat. no. ND-1000; Thermo Fisher Scientific).  Single-use dried pellet of amine 
reactive dye was re-suspended in 2 µl anhydrous DMSO (cat. no. 154938; Sigma). For a 10 µl reaction, 
2 µg of DNA in a 5 µl volume was heated to 95 oC for 5 minutes and placed on ice. 3 µl of NaB buffer 
(0.2 M Sodium bicarbonate pH 8.3) was added to snap cooled amine-modified DNA followed by 2 µl 
of re-suspended dye. After 1 hour incubation the QIAquick PCR purification kit (cat. no. 28104; Qiagen) 
was used to purify the probes. The probe florescent intensity was analysed on the NanoDrop 1000.  
Table 2-2: Primers obtained from webFISH and used for VD intergenic region probe generation. 
Name Forward primer Reverse primer 
U1 TGCAACGTGCCCTTGTAACACC AGAACCCACACCATATTCTTTGACTTGTGC 
U2 CCAACAGCTCACCTGCAGCC TGGCACCTCTTAAATCCCTGATCTTGC 
U3 GCTTCCCAACTCATTCTGTGAGTCCAGC GAAGAGGGACCAGGTTGGGAGGC 
U4 TCAGCCAATTTAAGGAGGTTTTCCAGTTGC TGCTCAGGACCCCAGAAGGC 
 
2.4 General molecular biology methods 
All solution and general molecular biology methods were performed as described before (Sambrook 
and Russell, 2000). 
26 
 
2.4.1 PCR agarose gel extraction 
The 1-2% agarose gel prepared with TBE and stained with 40 μg/l ethidium bromide were run 
alongside a lane containing MassRuler DNA ladder (cat. no. SM0403; Thermo Scientific) and visualised 
using the Molecular Imager Gel Doc XR System from Bio-Rad (Model: Universal Hood II). PCR products 
were excised using a UV fluorescent table and a razor. Slices were placed into a pre-weighted 1.5 ml 
Eppendorf tube. The PCR products were purified from agarose using QIAquick Gel Extraction kit (cat. 
no. 28704; Qiagen) according to manufacturer’s instructions and quantified on the NanoDrop.  
2.4.2 Cloning 
Cloning was performed using the pGEM-T Easy Vector System I from Promega. 25 ng of pGEM-T Easy 
vector was incubated with T4 DNA ligase and a ratio of less than 1 to 8 vector to PCR product for 30 
minutes at room temperature and then at 4 oC overnight or at 16 oC overnight. 30 µl of subcloning 
efficiency DH5α chemically competent E.coli (cat. no. 18265017; Invitrogen) were transformed with 
the ligated vector as per manufacturer’s instructions. The transformed E.coli were incubated at 37 oC 
for 1.5 hours in 100 µl of S.O.C media (cat. no. 15544034; Invitrogen) on a Thermomixer (cat. no. 
12799008; Eppendorf). Petri dishes containing Luria-Bertani (LB) Agar with 100 µg/ml of Ampicillin 
were prepared and used to plate out transformants. 
2.4.2.1 Screening transformants 
Single colonies were picked, after overnight incubation at 37 oC, and used for starter cultures 
composed of 3 ml LB broth with 100 µg/ml Ampicillin. Part of the pick colony was dipped into a PCR 
mix to screen for successfully transformed clones.  
2.4.3 Sanger DNA sequencing 
Sequencing of plasmids was performed by Beckman Coulter Genomics using the T4 universal 
primers. The results were visualised and analysed using ApE (A plasmid Editor -
biologylabs.utah.edu/jorgensen/wayned/ape/). 
2.4.4 Primer design 
All primers were designed using Primer-BLAST (Ye et al., 2012). For large arrays of primers, the primers 
were designed using a custom python script wrapper for Primer3 (Rozen and Skaletsky, 2000).  
2.5 Transgene localisation using a restriction enzyme-based PCR method 
The transgene amplification with adjacent genomic sequence was performed as previously described 
(Bryda and Bauer, 2010), with modifications. Genomic DNA was extracted from CD19 positive bone 
marrow B cells using the DNeasy Blood & Tissue kit (cat. no. 69506; Qiagen) following manufacturer’s 
instructions. The DNA was digested for 2 hours at 37 oC using five restriction endonucleases: BglII, 
EcoR1, PstI, SacI, XbaI. All PCR reactions were performed with Qiagen HotStarTaq DNA polymerase 
(cat.no. 203203; Qiagen) using the Q-solution (Betaine) which helps in the amplification of complex 
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templates (rich in GC) by altering the DNA melting temperatures. The first single round of PCR was 
performed using the Biometra T3 thermocycler with the 3R primer (Table 2-3) at 95 oC for 15 minutes, 
60oC for 1 minute, 72 oC for 10 minutes, and hold at 9 oC. After preparation of the Y linker (annealing 
of Y linker A and E) (Table 2-3), the PCR product was incubated for 16 hours at 16 oC with T4 DNA ligase 
(cat. no. M0202M; NEB). The second round and third round of PCR was performed using 2R and 1R 
primers (Table 2-3) and the resulting PCR products were run out on a 1 % agarose gel alongside a lane 
containing MassRuler DNA ladder (cat. no. SM0403; Thermo Scientific). The distinct band above 848bp 
obtained from XbaI digested DNA was excised and extracted. The extracted DNA was cloned using the 
pGEM-T Easy Vector System I from Promega and sequenced. 
Table 2-3: Sequences of primers and linkers used for transgene localisation.  
Primers 1R-3R were used to extend outwards into the unknown sequence adjacent to the transgene. Primers D and G were 
used in conjunction with the Y linker to extend inwards from the unknown sequence into the transgene.  
Name Forward primer Reverse primer 
3R  TGAGCGAGGAAGCGGAAGAGCGCCTG 
2R  GCACTCTCAGTACAATCTGCTC 
1R  ACACCCGCCAACACCCGCTGAC 
Primer D GCAAACGATAAATGCGAGGACGGT  
Primer G ATGCGAGGACGGTACACGGCGACC  
Y Linker A GTGCAGCCTTGGGTCGCCGTGT (3′-
Spacer-C3-CPG) 
 




2.6 Targeted locus amplification (TLA) 
TLA was performed as previously described (Vree et al., 2014). 10 million non-recombining cells from 
a bone marrow depletion using Ly6c, Ter119, Mac1, Gr1 biotinylated antibodies (see Table 2-8) were 
collected for TLA. After a spin (250 xg for 10 minutes at 22 oC), the cells were resuspended in 1ml 
PBS/10% FCS and fixed for 10 minutes at 22 oC with the addition of 37 % formaldehyde (cat. no. 
1039991000; Merck) to a final concentration of 2 %. 1 M glycine was added and tubes were placed on 
ice followed by a PBS wash (500 xg for 2 minutes at 22 oC) and the addition of 500µl lysis buffer (50 
mM Tris pH 7.5; 150 mM NaCl; 5 mM EDTA; 0.5 % NP-40; 1 % Triton X-100). Lysis was performed 5 
minutes at 22 oC followed by 5 minutes at 65 oC and 1 minute on ice. After lysis, the supernatant was 
removed (1000 xg for 2 minutes at 22 oC) and the pellet was washed in 400 µl 1x NEBuffer 4 (cat. no. 
B7004; NEB) (1000 xg for 2 minutes at 22 oC), and resuspended in a final volume of 300µl 1x NEBuffer 
4. 12 µl of 5 % SDS was added and the sample was incubated at 37 oC for 30 minutes while shaking 
(900 RPM), followed by the addition of 30 µl 20 % Trition X-100 and further incubated at 37 oC for 30 
minutes while shaking (900 RPM). 400 U of NlaIII (cat. no. R0125; NEB) were added and incubated 
overnight at 37 oC while shaking (900 RPM). Digestion efficiency was determined by running a digested 
and undigested control on a 0.6 % agarose gel. The restriction enzyme was inactivated by incubation 
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at 65 oC for 20 minutes after which 40 U of T4 DNA ligase (cat. no. 15224025; Invitrogen) were added 
and incubated with the nuclei for at least 2 hours at 22 oC. De-crosslinking was performed with 5µl 
Proteinase K (10 mg/ml; cat. no. 03115879001; Roche) overnight at 65 oC, followed by 5µl RNase A 
(10 mg/ml; cat. no. 19101; Qiagen) digestion at 37 oC for 10 minutes. A phenol/chloroform (cat. no. 
P3803; Sigma) purification was performed and the aqueous phase was ethanol precipitated with 3 M 
Sodium Acetate pH 5.2 (1/10 volume) and 100 % Ethanol (1.8x volumes) at -80oC until sample was 
completely frozen. The DNA was spun down (20,000 xg for 20 minutes at 4 oC), supernatant discarded 
and pellet washed with 70 % ethanol followed by another spin (20,000 xg for 4 minutes at 22 oC). The 
air-dried pellet was dissolved in 150 µl 10 mM Tris pH 7.5 at 37 oC. A second restriction enzyme 
digestion was carried out overnight at 37 oC with NspI (cat. no. R0602; NEB), followed by enzyme 
inactivation at 65 oC for 25 minutes. 100U of T4 DNA ligase (cat. no. M0202; NEB) was added to the 
digested DNA, to a final volume of 14 ml, and incubated overnight at 16oC. Next day, the DNA was 
ethanol precipitated with the addition of 3 M Sodium Acetate (1/10 volume), 14µl Glycogen 
(20mh/ml; R0551; Thermo Scientific), 100 % ethanol (2.25 volumes) and stored at -80oC until 
completely frozen. After a spin (3200 xg for 15 minutes at 20 oC), the supernatant was discarded and 
the pellet was washed with 70% ethanol, followed by another spin (3200xg for 15 minutes at 20oC). 
The pellet was air-dried and dissolved in 150 µl 10 mM Tris pH 7.5 at 37 oC. The TLA PCR (34 cycles, 2 
minutes each) was performed in 25 µl reactions with 100ng of DNA using anchor primers that are 
facing away from each other (Table 2-4) and the Phire polymerase (cat. no. F122S; Thermo Scientific). 
The concentration and fragment length profiles of the TLA library was determined with the 2100 
Bioanalyzer (cat. no. G2939BA; Agilent). Library quantity was determined using the KAPA Illumina 
Library Quantification Kit (cat. no. KK4824; KAPA Biosystems). The library was 150 bp pair-end 
sequenced on the Illumina MiSeq system. 
Table 2-4: TLA anchor primers used to amplify circularised DNA from within the YAC transgene arm on the J gene proximal 
side.  
 
2.6.1 Transgene analysis primers 
Long amplicon PCR was performed with either the Phire polymerase (cat. no. F122S; Thermo 
Scientific) or the Q5 high-fidelity polymerase (cat. no. M0492S; NEB). 
Table 2-5: Primes used to check the integrity of the transgene YAC arms. 
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2.6.2 TLA analysis 
For genome tracks and read count plots, the TLA reads were aligned to GRCm38 to determine the 
location of the transgene and to GRCh37 to uncover the composition of the transgene. Bowtie 2 
(Langmead and Salzberg, 2012) with --very-sensitive --score-min L,0,-1 settings was 
used for alignment. Reads that did not align the first time were in-silico digested with NlaIII and aligned 
again. BAM files were merged (Li et al., 2009) and analysed using Seqmonk v1.42.0 
(https://www.bioinformatics.babraham.ac.uk/projects/seqmonk/). GRCm38 blacklisted regions (The 




version 87 was used for IGH gene coordinates. For the GRCm38 alignment, 12kb-sized probes were 
used to visualise the data. 
 
Aligned sequences were visualised with the Integrative Genomics Viewer (IGV) (Robinson et al., 2011). 
 
2.7 Sample preparation for FISH and flow cytometry 
2.7.1 Cell isolation from bone marrow 
Bone marrow was extracted from femurs and tibias by removing the ends of bones and flushing with 
RPMI-1640 media (cat. no. R8758; Sigma) supplemented with 5 % FCS (cat. no. F9665; Sigma) and 
25 mM HEPES (cat. no. 15630056; Gibco) (bone marrow media) using a 25-gauge needle and 2 ml 
syringe.  A 10 ml stripette was used to dissociate extracted bone marrow, after which the content 
was transferred into a fresh 50 ml falcon, leaving bone fragments behind.  
2.7.2 Cell isolation from spleen and thymus 
C57BI/6JBabr spleens/thymus were extracted and stored in bone marrow media.  The spleens/thymus 
were forced through a 70 µm cell strainer (cat. no. 352350; BD) using the round bottom of a 1.5 ml 
Eppendorf tube and with regular additions of bone marrow media. 
2.7.3 Cell preparation 
Cells from bone marrow, spleen and thymus were prepared in the same manner. Cells were spun at 
336 xg 4 oC for 5 minutes and bone marrow medium was decanted. The cells were re-suspended in 
ice cold Dulbecco’s PBS (D-PBS; cat. no. D8537; Sigma) and spun at 448 xg 4 oC for 8 minute to burst 
the erythrocytes (red blood cells) by osmotic lysis. Cells were re-suspended in 10ml of MACS buffer 
(2 mM EDTA, 0.5 % FCS in PBS) and filtered through a 70 µm cell strainer (cat. no. 352350; BD) with 
the use of the round bottom of a 1.5 ml Eppendorf tube to push through any residual tissue. A sample 
of cells was taken, diluted 1:10 and counted on a haemocytometer.  
2.7.4 Depletion using magnetic cell sorting (MACS) 
Cells prepared and counted with the haemocytometer were re-suspended in MACS buffer (2 mM 
EDTA, 0.5 % FCS in PBS) at 25x106 cells/ml with biotin conjugated antibodies (see Table 2-8). After a 
30 minute incubation on ice, the cells were diluted with D-PBS, spun 336 xg at 4 oC for 5 minutes and 
re-suspended at a concentration of 107 cells per 95 µl of MACS buffer. 5 µl of streptavidin MACS beads 
(cat. no. 130-048-101; Miltenyi) was added and cells were incubated for 15 minutes at 4 oC, with 
periodic stirring. The cells were filtered through a 40 µm cell strainer (cat. no. 352340; BD) to prevent 
the LS columns (Miltenyi Biotech 103-042-401) from clogging. A single LS column was prepared at 4 oC 
The following text has been redacted due to sensitivity of the material 
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in the cold room by placing it onto the provided magnetic stand and washing it with 3 ml of MACS 
buffer. The streptavidin incubated cells were washed, spun (336 xg for 5 minutes at 4oC) and the pellet 
was disrupted with 4-10 ml MACS buffer, depending on cell count. The cell suspension was placed 
onto the LS column (1-3 mice 1 column; 4-7 mice 2 columns; 8-10 mice 3 columns; 11-13 mice 4 
columns) and the flow through was collected as the depleted fraction. Two 1 ml washes with MACS 
buffer were performed to collect any residual cells. The column was taken off the magnet and the 
undesired enriched cells were washed off with 5 ml of MACS buffer using the provided plunger (these 
were used for certain assays such as TLA, but were often discarded).  
Table 2-8: List of antibodies used for magnetic cell depletion of cells other than the desired B cells.  
This was primarily performed to reduce FACS times.  
Antigen Clone Dilution  Source Expressed on 
Ly6c ER-MP20 1:400 MCA2389B Bio-Rad  
Granulocytes; macrophage/dendritic 
cell precursors; subpopulations of B- 
and T-lymphocytes; endothelial cells 
Ter119 TER-119 1:400 13-5921-85 Ebioscience Erythroid cells 
CD3e eBio500A2 (500A2) 1:800 
13-0033-81 
Ebioscience Thymocytes; mature T cells; NKT cells 
Mac1 
(CD11b) M1/70 1:1600 
13-0112-82 
Ebioscience 
Macrophages; NK cells; granulocytes; 
activated lymphocytes; B-1 cells 
Gr1 (Ly-6G) RB6-8C5 1:1600 13-5931-81 Ebioscience  Monocytes; granulocytes; neutrophils 
 
2.8 Flow cytometry  
2.8.1 Staining 
All cells were stained at 20x106 cells/ml concentration in MACS buffer.  
2.8.1.1 Titration 
All antibodies were titrated prior to use. The optimal concentration was calculated by dividing the 
median fluorescent intensity (MFI) of the positive population by the MFI of the negative population 
(set using an unstained control) giving a signal-to-noise ratio. The concentrations with the highest 
signal to noise ratio were used (Table 2-9).  
Table 2-9: Antibodies used in flow cytometry cell surface staining of B cell subpopulations. 
Antigen Conjugate Clone Dilution Source 
B220 BV421 RA3-6B2 1:200 Biolegend UK 
B220 PerCP-Cy5.5 RA3-6B2 1:400 BD Pharmingen 
CD19 PerCP-Cy5.5 1D3 1:800 BD Pharmingen 
CD43 FITC S7 1:200 BD Pharmingen 
CD43 PE-Cy7 S7 1:1000 BD Pharmingen 
BP-1 PE BP-1 1:200 BD Pharmingen 
CD25 APC PC61.5 1:1000 eBioscience 
CD25 Biotin 7D4 1:400 BD Pharmingen 
IgM PE eB121-15F9 1:400 eBioscience 
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IgG1 PE A85-1 1:1000 BD Pharmingen 
CD24 (HSA) Biotin M1/69 1:400 BD Pharmingen 
CD24 (HSA) FITC 30F1 1:800 eBioscience 
CD24 (HSA) PE 30F1 1:1600 eBioscience 
AA4.1 APC AA4.1 1:2000 eBioscience 
CD5 PE-Cy7 53-7.3 1:1000 eBioscience 
CD21/35 Biotin 7G6 1:2000 BD Pharmingen 
CD23 BV711 B3B4 1:400 BD Pharmingen 
 
Table 2-10: Streptavidin conjugated flurochromes used as the second layer to label biotin conjugated antibodies. 
Second layer Dilution Source 
SA-BV605 1:500 BD Pharmingen 
 
Table 2-11: Live dead stains used 
Live/dead stain Dilution Source 
FVD eflour 506 1:1600 eBioscience 
FVD eflour 780 1:2000 eBioscience 
DAPI Final concentration - 300 nM Roche  
 
2.8.2 Staining panels 
2.8.2.1 Bone marrow 
An antibody panel with different fluorochromes was used to analyse the bone marrow B cell 
developmental stages (Table 2-12). The panel was an adaptation of a previously reported gating 
strategy (Hardy et al., 1991; Rumfelt et al., 2006)(Figure 2-1). This gating strategy and a reduced panel 
of five colours, with a live dead stain, were used for sorting population for downstream analysis (Table 
2-13 and Figure 2-2). 
Table 2-12: Flow cytometry bone marrow staining panel 
Antigen Fluorophore 
B220 BV421 
CD43  PE-Cy7/FITC 




Fixable viability dye eflour 506/DAPI 
CD16/32 Fc block - 
 











(Legend on next page) 




Figure 2-1: A representative gating scheme for bone marrow B cells. 
The different developmental stages are assigned for the bone marrow staining panel 2 (CTG2 depicted) as defined by the 
Hardy fractions (Hardy et al., 1991). The dot plot with fraction F, BC and C’DE cells shows the reasoning for the positioning of 
gates separating fraction D (fraction D and fraction C’ are joined as one population and only labelled fraction D here) and E, 
as well as the final fraction F (B220 high CD43- fraction F cells used in plot). The separation of CD19+ from CD19- cells was 
based on the highest density of double negative cells. 
 
 
Figure 2-2: Gating strategy used for sorting fractions BC/C’DE/intermediate EF/F. 
Sorting gates are highlighted in blue (CTG2 depicted).  





To examine potential alterations in B cell splenic populations a 7 colour panel with a live/dead stain 
(Table 2-14) was devised based on previously reported cell surface markers (Allman and Pillai, 2008) 
with the help of Manuel Diaz-Munoz. The panel allowed enumeration of T1-3, marginal zone (MZ) and 
follicular (FO) B cell subsets, along with an estimate of B-1 B cell counts (Figure 2-3). The AA4.1 positive 
staining of T1-3 cells along with the AA4.1 negative staining of MZ and FO cells resulted in a continuous 
gradient of cells. In order to separate T1-3 from MZ and FO cells an AA4.1 fluorescence minus one 
(FMO) was run alongside the full panel.  









Fixable viability dye eflour 506 







Figure 2-3: Spleen gating strategy for the enumeration of B1, T1-3, marginal zone (MZ) and follicular (FO) B cells. 




2.8.3 Flow cytometry analysis 
Flow cytometry compensation and gating was performed in FlowJ0 10.4. Additional analysis was 
performed in the R software environment. The FCS files were run through FlowAI v1.2.4 (Monaco et 
al., 2016) to filter out events affected by technical variation such as abrupt flow rate fluctuations. 
Subsequently, lymphocytes, singlets and live cells were gated in FlowJo and exported as new FCS files. 
All data was logicle transformed using the flowCore package (Ellis B et al., 2017), and additionally 
scaled for FlowSOM analysis. The data was dimensionality reduced for visualisation either using 
FlowSOM (Gassen et al., 2015) or tSNE (Maaten and Hinton, 2008). FlowSOM uses self-organising 
maps (SOMs) for dimensionality reduction, allowing it to scale to large numbers of cells. Each cell was 
assigned to a SOM with a 10x10 grid, which means similar cells are grouped into 100 separate clusters. 
The clusters were visualised on a minimal spanning tree (MST). For tSNE analysis, the data was 
downsampled to 10,000 events. Analysis was run multiple times to ensure reproducibility of the 
results.  
2.9 Immunostaining of paraffin embedded spleen sections 
Paraffin embedding and spleen sectioning was performed with the instruction of Elena Fineberg and 
Salah Azzi.  
Whole spleens were fixed for 24 hours in 4 % formaldehyde/PBS at 4 oC, followed by tissue 
dehydration (PBS wash, 30 % ethanol for 30 minutes, 50 % ethanol for 30 minutes, 70 % ethanol for 
30 minutes, 100 % ethanol for 30 minutes, 100% ethanol overnight 4 oC; ethanol was diluted with 
PBS). The dehydrated spleens were embedded in paraffin and left to set overnight. Before sectioning, 
the blocks were incubated overnight on ice at 4 oC. 0.5 µm sections were cut using a Leica paraffin 
microtome and mounted onto Superfrost Plus slides (cat. no. 631-0108; VWR). The slides were placed 
into Histo-Clear II (cat. no. 101412-882; VWR) bath twice for 10 minutes. This removes all the wax 
from the sections, allowing the spleens sections to be rehydrated (100 % ethanol for 10 minutes, 100 
% ethanol for 5 minutes, 70 % ethanol for 5 minutes, 50 % ethanol for 5 minutes, 30 % ethanol for 5 
minutes, PBS for 5 minutes or overnight at 4oC; ethanol was diluted with PBS). Epitope retrieval was 
performed using Sodium citrate buffer (10 mM Sodium citrate, 0.05 % Tween 20, pH 6.0 adjusted with 
1 N HCl) boiled for 20-30 minutes in a microwave (800 W; 1 minutes preheat followed by 10 seconds 
on 50 seconds off for 20-30 minutes). 
The epitope retrieved spleen sections were washed in PBS for 5 minutes, followed by 0.5 % Triton 
X-100 in PBS 10 minutes incubation at 22 oC. Another 5-minute PBS was performed before 100 µl of 
blocking solution (1 % BSA in PBS) was applied and incubated for 30 minutes in a humidified chamber 
at 22 oC. The secondary rabbit anti-mouse IgG was diluted 1:100 in blocking solution and 100 µl was 
applied to each slide. The slides were incubated in a dark humidified chamber for 30-45 minutes, 
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followed by two 5 minutes washes in 0.1 % Tween 20/PBS and a 5 minutes PBS wash. Sections were 
counterstained with DAPI/2xSSC for 2 minutes and washed in PBS for 10 minutes. A 3.7 % 
formaldehyde fixation for 5 minutes was carried with a subsequent 155 mM glycine quench for at 
least 10 minutes. After a PBS 5 minute rinse, the slides were dried around the spleen section and a 
coverslip with Vectashield (cat. no. H-1000; Vector Laboratories) was mounted. Imaging was 
performed on the Olympus BX61 fluorescent microscope. 
2.10 VDJ-seq 
VDJ-seq of FACS sorted fractions was performed as previously described (Chovanec et al., 2018). 
Between 1.1-5 µg of DNA was purified using the DNeasy Blood & Tissue Kit (cat. no. 69504, Qiagen). 
DNA was sonicated to a 500bp average fragment size using the Covaris E220 ultrasonicator (peak 
incident power (W): 105; duty factor: 5 %; cycles per burst: 200; treatment time (s): 80; temperature 
(oC): 7; and water level: 6). After end repair and A-tailing the adaptors with a 6 N/12 N UMI were 
ligated to the DNA fragments using T4 DNA ligase (cat. no. M0202M; NEB). After purification with 1x 
AMPure XP beads, primer extension was performed using Vent (exo-) (cat. no. M0257; NEB), human 
biotinylated J gene primers and a single extension cycle. The primer extension products were captured 
using the MyOne streptavidin T1 Dynabeads (cat. no. 65601; Invitrogen) (5µl of beads for every 1µg 
DNA) overnight at 22oC while rotating. The beads with the bound primer extension product were 
washed twice with B&W buffer (10 mM Tris-HCl pH 7.5; 1 mM EDTA; 2 M NaCl; 0.05% Tween 20), once 
with EB buffer (10 mM Tris pH 8) and resuspended in 10.5 µl for every 1 µg DNA. The DNA (not 
exceeding 1 µg per 25 µl reaction) was amplified off the beads using the short Illumina adaptors (see 
Table 2-17) with the Q5 high-fidelity polymerase (cat. no. M0492S; NEB). All reactions were pooled, 
and the supernatant was collected on a magnetic rack, followed by a 1x AMPure XP bead purification. 
A second round of PCR amplification was performed with the P5-7 flow cell primers (see Table 2-18) 
to create the final library, followed by a double 1x AMPure XP bead purification to remove primer 
dimers created during PCR. The concentration and fragment length profiles of the VDJ-seq libraries 
were determined with the 2100 Bioanalyzer (cat. no. G2939BA; Agilent). Library quantity was 
determined using the KAPA Illumina Library Quantification Kit (cat. no. KK4824; KAPA Biosystems). 







Table 2-15: Adapter sequences 
Name Sequence (5'-3') 
Adapter 1  
P7 adapter F1 ACACTCTTTCCCTACACGACGCTCTTCCGATCTNNNNNNGACTCG*T 
P7 short adapter R1-block [phos]CGAGTCNNNNNNAGATCGGAAGAG*C[spcC3] 
Adapter 2  
P7 adapter F2 ACACTCTTTCCCTACACGACGCTCTTCCGATCTNNNNNNCTGCTCC*T 
P7 short adapter R2-block [phos]GGAGCAGNNNNNNAGATCGGAAGAG*C[spcC3] 
* Phosphorothioate bond; short R adapter should be phosphorylated at 5’ end and have a carbon-3 
spacer incorporated at the 3’ end to prevent it being used to prime in later reactions. 
Table 2-16: Biotinylated J-specific oligos. 
Primer Sequence (5’-3’) 
Mouse JH1 Rev Bio [biotin]AGCCAGCTTACCTGAGGAGAC 
Mouse JH2 Rev Bio [biotin]GAGAGGTTGTAAGGACTCACCTG 
Mouse JH3 Rev Bio [biotin]AGTTAGGACTCACCTGCAGAGAC 
Mouse JH4 Rev Bio [biotin]AGGCCATTCTTACCTGAGGAG 
  
Human JH1 Rev Bio [biotin]CCAGACAGCAGACTCACCTG 
Human JH2 Rev Bio [biotin]TGCAGTGGGACTCACCTG 
Human JH3 Rev Bio [biotin]AGAAGGAAAGCCATCTTACCTG 
Human JH4 Rev Bio [biotin]CAGGAGAGAGGTTGTGAGGACT 
Human JH5 Rev Bio [biotin]AGGGGGTGGTGAGGACTC 
Human JH6 Rev Bio [biotin]CCATTCTTACCTGAGGAGACG 
 
Table 2-17: Sets of J-specific reverse primers.  
The primers map 10 bp for mouse and 15 bp for human downstream of the J junction to allow for nucleotide additions, 
modifications and deletions at the junction occurring during V(D)J recombination. 
Primer Sequence (5’-3’) 
P7 short ACACTCTTTCCCTACACGACGCTC*T 
  
Mouse JH1 P5 
short 
GTGACTGGAGTTCAGACGTGTGCTCTTCCGATCTCCCTGTGCCCCAGACATCGA*A 
Mouse JH2 P5 
short 
GTGACTGGAGTTCAGACGTGTGCTCTTCCGATCTAGTGGTGCCTTGGCCCCAGTA*G 
Mouse JH3 P5 
short 
GTGACTGGAGTTCAGACGTGTGCTCTTCCGATCTACCAGAGTCCCTTGGCCCCAGTA*A 





Human JH1 P5 
short 
GTGACTGGAGTTCAGACGTGTGCTCTTCCGATCTGGTGCCCTGGCCCCAGT*G 





Human JH3 P5 
short 
GTGACTGGAGTTCAGACGTGTGCTCTTCCGATCTACCATTGTCCCTTGGCCCCA*G 
Human JH4 P5 
short 
GTGACTGGAGTTCAGACGTGTGCTCTTCCGATCTGACCAGGGTYCCYTGGCCC*C 
Human JH5 P5 
short 
GTGACTGGAGTTCAGACGTGTGCTCTTCCGATCTCAGGGTTCCYTGGCCCCAG*G 




Human JH6 P5 
short 2 
GTGACTGGAGTTCAGACGTGTGCTCTTCCGATCTTKSCCCCAGACGTCCATACCG*T 
The primers have part of the Illumina P5 sequence at the 5′ end (P5 short), along with the J-specific 
sequence at the 3′ end (in bold). A single forward primer (P7 short) annealing to the P7 sequence in 
the ligated adapter is used at the other end. Asterisks (*) represent phosphorothioate bonds. Code 
for degenerate primers: B=G+T+C; D=G+A+T; H=A+T+C; S=G+C; V=A+C+G; W=A+T; K=G+T; M=A+C; 
N=A+C+G+T; Y=C+T; and R=A+G. 
Table 2-18: Flow cell index primers.  
Index shown in bold. 
Primer Sequence (5'-3') 
P7 flow cell AATGATACGGCGACCACCGAGATCTACACTCTTTCCCTACACGAC 
P5-I5 flow cell index 1 CAAGCAGAAGACGGCATACGAGATCGTGATGTGACTGGAGTTCAGACGTGT 
P5-I5 flow cell index 2 CAAGCAGAAGACGGCATACGAGATACATCGGTGACTGGAGTTCAGACGTGT 
P5-I5 flow cell index 3 CAAGCAGAAGACGGCATACGAGATGCCTAAGTGACTGGAGTTCAGACGTGT 
P5-I5 flow cell index 4 CAAGCAGAAGACGGCATACGAGATTGGTCAGTGACTGGAGTTCAGACGTGT 
P5-I5 flow cell index 5 CAAGCAGAAGACGGCATACGAGATCACTGTGTGACTGGAGTTCAGACGTGT 
P5-I5 flow cell index 6 CAAGCAGAAGACGGCATACGAGATATTGGCGTGACTGGAGTTCAGACGTGT 
P5-I5 flow cell index 7 CAAGCAGAAGACGGCATACGAGATGATCTGGTGACTGGAGTTCAGACGTGT 
P5-I5 flow cell index 8 CAAGCAGAAGACGGCATACGAGATTCAAGTGTGACTGGAGTTCAGACGTGT 
P5-I5 flow cell index 9 CAAGCAGAAGACGGCATACGAGATCTGATCGTGACTGGAGTTCAGACGTGT 
P5-I5 flow cell index 10 CAAGCAGAAGACGGCATACGAGATAAGCTAGTGACTGGAGTTCAGACGTGT 
P5-I5 flow cell index 11 CAAGCAGAAGACGGCATACGAGATGTAGCCGTGACTGGAGTTCAGACGTGT 
P5-I5 flow cell index 12 CAAGCAGAAGACGGCATACGAGATTACAAGGTGACTGGAGTTCAGACGTGT 
P5-I5 flow cell index 13 CAAGCAGAAGACGGCATACGAGATTTGACTGTGACTGGAGTTCAGACGTGT 
P5-I5 flow cell index 14 CAAGCAGAAGACGGCATACGAGATGGAACTGTGACTGGAGTTCAGACGTGT 
P5-I5 flow cell index 15 CAAGCAGAAGACGGCATACGAGATTGACATGTGACTGGAGTTCAGACGTGT 
P5-I5 flow cell index 16 CAAGCAGAAGACGGCATACGAGATGGACGGGTGACTGGAGTTCAGACGTGT 
P5-I5 flow cell index 17 CAAGCAGAAGACGGCATACGAGATCTCTACGTGACTGGAGTTCAGACGTGT 
P5-I5 flow cell index 18 CAAGCAGAAGACGGCATACGAGATGCGGACGTGACTGGAGTTCAGACGTGT 
P5-I5 flow cell index 19 CAAGCAGAAGACGGCATACGAGATTTTCACGTGACTGGAGTTCAGACGTGT 




2.10.1 VDJ-seq analysis 
VDJ-seq was analysed using the BabrahamLinkON pipeline (Chovanec et al., 2018) described in more 
detail in section 4. For CTG2 mice, the 6bp UMI adaptor was used along with 8bp from the V region to 
deduplicate all sequences.  
. 
Genes with identical reference sequences were merged (IGHD5-18*01, IGHD5-5^01; IGHD4-11*01, 
IGHD4-4*01; IGHV1-69*01, IGHV1-69D*01; IGHV3-23*01, IGHV3-23D*01; IGHV3-30*04, IGHV3-30-
3*03; IGHV3-30*02, IGHV3-30-5*02; IGHV3-30*18, IGHV3-30-5*01; IGHV3-29*01, IGHV3-30-42*01). 
Only the first called gene was taken from IgBlast calls that contained multiple V, D, or J gene calls. 
Sequences with a V gene score of 100 or higher and a J score above 35 were used for analysis. Expected 
frequency was calculated using the first  (excluding IGHV7-4-1, IGHV4-30-2 and IGHV3-30-3, 
which were not in the GCRh37 reference annotation) that should be within the transgene. Multiple 
testing correction for the binomial test was performed using the Benjamini & Hochberg method (FDR).  
VDJ-seq data generated by Louise Matheson (CTG1 and Human VDJ-seq) were processed as previously 
described (Bolland et al., 2016; Matheson et al., 2017) by Felix Krueger. Quantification was performed 
in Seqmonk v1.42.0 (https://www.bioinformatics.babraham.ac.uk/projects/seqmonk/). 
Throughout my thesis, I will be using the IMGT definitions of productive and unproductive to describe 
rearranged genes and reserve functional, pseudogene and ORF (Open Reading Frame) to describe the 
germline sequence (Lefranc, 1998). This is an important distinction as functional genes can have both 
productive and unproductive rearrangements based on the N and P nucleotide addition and nibbling, 
resulting from non-homologous end joining (NHEJ) at the junctions. Unproductive rearrangements 
contain a premature stop codon and/or an out-of-frame junction and they do not translate into 
functional protein. Additionally they may not contain the highly conserved amino acids, such as 
cysteine (C) at position 23 and tryptophan (W) at position 41 that mark the CDR3 boundaries (Lefranc, 
2014). 
2.11 CTCF peak proximity to RSS analysis 
ENCODE generated ChIP-seq data for the lymphoblastoid cell line GM12878 was used to determine 
transcription factor proximity to the V gene recombination signal sequence (RSS) (The ENCODE Project 
Consortium, 2012). Each of the V genes was assigned to one of three main clans based on IMGT 
nomenclature: clan I comprises of IGHV1, IGHV5 and IGHV7 subgroups; clan II comprises of IGHV2, 
IGHV4, IGHV6 and IGHV(II) subgroups; clan III comprises of IGHV3 and IGHV(III) subgroups (Lefranc, 
2000). V genes not assigned to any of the three clans were labelled as ‘Other’. 
The following text has been redacted due to sensitivity of the material 
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2.12 Primed hPSC H9 NK2 
H9 NK2 cells were obtained from Austin Smith at the WT-MRC Cambridge Stem Cell Institute with 
permission from WiCell (Takashima et al., 2014). These cells contain a doxycycline inducible NANOG 
and KLF2 construct for resetting to a naïve state of pluripotency. The cells were maintained under 
feeder free conditions on Vitronectin (cat. no. A14700; Thermo Fisher Scientific) coated plates (5µg/ml 
in PBS and coated for at least an hour at 22oC or overnight at 4oC) in TeSR-E8 (cat. no. 05990; StemCell 
Technologies) culture medium which was changed daily. The cells were typically passaged at a 1:10 – 
1:15 split ratio every 6 days. To passage the cell, the culture medium was aspired and residual media 
was gently washed away PBS. Cells were incubated for 5 minutes at 22oC with Gentle Cell Dissociation 
Reagent (GCDR) (cat. no. 07174; StemCell Technologies), followed by aspiration of GCDR and addition 
of TeSR-E8. The cells were manually dissociated from the culture vessel using a 5ml stripette, collected 
and passaged to freshly coated Vitronectin vessels. 
2.13 Naïve hPSC H9 NK2 
H9 NK2 naïve cells were derived from H9 NK2 primed hPSCs after NANOG and KLF2 transgene 
induction and cultured in t2iL+PKCi media. Fully reset naïve hPSCs were obtained from Austin Smith 
at the WT-MRC Cambridge Stem Cell Institute with permission from WiCell (Takashima et al., 2014). 
The N2B27 basal medium for t2iL+PKCi media was prepared as follows: 1:1 mixture of DMEM/F12 
(cat. no. 21331020; Thermo Fisher Scientific) and Neurobasal (cat. no. 21103049; Thermo Fisher 
Scientific); 0.5x N2 supplement (cat. no. 17502048; Thermo Fisher Scientific); 0.5x B27 supplement 
(cat. no. 17504044; Thermo Fisher Scientific); 2mM L-Glutamine (cat. no. 25030024; Thermo Fisher 
Scientific); 50U/ml Penicillin-Streptomycin (cat. no. 15140122; Thermo Fisher Scientific); 0.1mM β-
mercaptoethanol (cat. no. 31350010; Thermo Fisher Scientific). The complete t2iL+PKCi media was 
prepared from the N2B27 basal medium with the addition of the following components (used within 
2 days of addition): 1µM PD0325901 (WT-MRC Cambridge Stem Cell Institute); 1µM CHIR99021 (WT-
MRC Cambridge Stem Cell Institute); 2µM Gö6983 (cat. no. 2285; Tocris); 20ng/ml human LIF (WT-
MRC Cambridge Stem Cell Institute). The cells were maintained under feeder free conditions on 
Matrigel growth factor reduced basement membrane matrix (cat. no. 354230; Corning) coated plates 
(diluted 1:100 in DMEM/F12 and coated for at least an hour at 22oC or at 4oC overnight) with the 
t2iL+PKCi media changed daily. The cells were typically passaged every 3-4 days at a 1:4-1:5 split ratio. 
To passage the cells, the culture media was aspired followed by a 3-5 minute incubation with Accutase 
(cat. no. A1110501; Thermo Fisher Scientific) at 37oC. Cells were collected and the Accutase was 
diluted at least 1:1 with DMEM/F12 before a 3 minute 300xg, followed by resuspension in complete 
medium and passaging onto freshly coated Matrigel vessels.  
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2.14 Promoter capture Hi-C and Hi-C 
Promoter capture Hi-C and Hi-C was performed by Stefan Schoenfelder as previously described 
(Mifsud et al., 2015; Schoenfelder et al., 2015). Approximately 80x106 cells (naïve and primed hPSC) 
were used to ensure libraries with high enough complexity would be obtained. 
2.14.1 Hi-C 
Cells were fixed in 2% formaldehyde (cat. no. AGR1026, Agar Scientific) for 10 min and quenched with 
ice-cold glycine (cat. no. 410225; Sigma) at a final concentration of 125mM. Cells were washed with 
50ml PBS pH 7.4 (cat. no. 0010001; Gibco) using a 400xg 10 min 4oC spin, followed by another spin. 
The cell pellet was snap frozen in liquid nitrogen and stored at -80oC.  
After thawing the cell pellet, the cells were resuspended in 50ml ice-cold lysis buffer (10mM Tris pH 
8; 10mM NaCl; 0.2% Igepal CA-630; protease inhibitor cocktail (cat. no. 04693159001; Roche) and 
incubated for 30 minutes on ice. The nuclei were pelleted at 650xg for 5 minutes 4oC and washed with 
1.25x NEBuffer 2 (cat. no. B7002; NEB). After the wash, the nuclei were resuspended in 1.25x NEBuffer 
2 (7x106 cells per Eppendorf), 0.3% final concentration SDS (cat. no. V6551, 10% stock; Promega) and 
incubated at 37oC for 1 hour with agitation (950 rpm). Triton X-100 (cat. no. T8787; Sigma) was added 
to the nuclei to a final concentration of 1.7% and further incubated for 1hr at 37oC with agitation (950 
rpm). The HindIII restriction enzyme (cat. no. R0104; NEB) was added at a concentration of 1500 units 
per 7x106 cells and digestion was carried out overnight at 37oC with agitation (950 rpm). The restriction 
enzyme ends were filled in with Klenow (cat. no. M0210; NEB) for 75 minutes at 37oC using biotin-14-
dATP (cat. no. 19524-016; Invitrogen), dCTP, dGTP, dTTP (cat. no. 10297018; Invitrogen) all at a final 
concentration of 30µM. This was followed by ligation with 50 units of T4 DNA ligase (cat. no. 15224-
025; Invitrogen) for 4 hours at 16oC in a 5.5ml volume of ligation buffer (50mM Tris-HCl pH 7.5; 10mM 
MgCl2; 1mM ATP; 10mM DTT; 100µg/ml BSA; 0.9% Triton X-100) per 7x106 cells. Subsequently the 
crosslink was reversed by overnight incubation at 65oC with the addition of 65µl of 10mg/ml per 7 
million cells Proteinase K (cat. no. 03115879001; Roche), followed by an additional 65µl Proteinase K 
incubation for 2 hours at 65oC. An RNase treatment was performed using 15µl of 10mg/ml RNase A 
(cat. no. 10109169001; Roche) per 7x106 cells at 37oC for 1 hour. Two phenol/chloroform (P3803; 
Sigma) extractions were performed followed by DNA precipitation using 3M Sodium Acetate pH 5.2 
(1/10 volume) and 100% Ethanol (2.5x volumes) overnight at -20oC. The DNA was spun down at 3200xg 
for 30 minutes 4oC and resuspended in 400µl TLE (10mM Tris-HCl pH 8; 0.1mM EDTA) and transferred 
to a new 1.5ml Eppendorf tube. Another phenol/chloroform extraction and DNA precipitation was 
performed with the DNA pellets being washed three times in 70% ethanol and quantified using the 
Quant-iT Pico Green kit (cat. no. P7589; Invitrogen).  
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To prevent the pull-down of non-ligated products the biotin from fragment ends was removed using 
the T4 DNA polymerase (cat. no. M0203; NEB) with 40µg of the Hi-C library DNA incubated for 4 hours 
at 20oC, followed by phenol/chloroform extraction and DNA precipitation overnight. The precipitated 
DNA was sonicated to a size peak of around 400bp using the Covaris E220 sonicator with the following 
settings: duty factor - 10%; peak incident power - 140W; cycles per burst - 200; time - 55 seconds. End 
repair was performed using T4 DNA polymerase (cat. no. M0203; NEB), T4 polynucleotide kinase (cat. 
no. M0201; NEB), Klenow (cat. no. M0210; NEB) in the presence of dNTPs in ligation buffer (cat. no. 
B0202; NEB) and incubated for 30 minutes at 22oC. DNA was purified using the QIAquick PCR 
purification kit (cat. no. 28104; Qiagen). A-tailing was performed with Klenow exo- (cat. no. M0212; 
NEB) and dATP incubated for 30 minutes at 37oC, followed by heat inactivation of the enzyme at 65oC 
for 20 minutes. A double-sided Agencourt AMPure XP bead (cat. no. A63881;  Beckman Coulter) 
fragment size selection was performed. First, a 0.6x concentration of AMPure XP beads was used to 
remove large fragments. The supernatant was transferred to a new Eppendorf tube and the beads 
stuck to the magnetic separator (cat. no. 12321D; DynaMag-2 magnet; Invitrogen) were discarded. 
Additional AMPure XP beads were added to the supernatant to make up a 0.9x concentration of beads 
to DNA volume. After two washes with freshly prepared 70% ethanol, the DNA was eluted with 100µl 
of TLE (10mM Tris-HCl pH 8.0; 0.1mM EDTA). MyOne Streptavidin C1 Dynabeads (cat. no. 65001; 
Invitrogen) were used to isolate biotinylated ligation products in a binding buffer (5mM Tris pH 8, 
0.5mM EDTA, 1 M NaCl) for 30 minutes at 22oC. While on the DynaMag-2 magnet, the C1 Dynabeads 
were washed twice with binding buffer and once with ligation buffer (cat. no. B0202; NEB). Illumina 
PE adapters were ligated onto Hi-C ligation products that were still bound to the streptavidin C1 beads 
using T4 DNA ligase (cat. no. M0202; NEB) with ligation buffer for 2 hours at 22oC slowly rotating. The 
streptavidin C1 beads were washed twice with wash buffer (5mM Tris, 0.5 mM EDTA, 1 M NaCl, 0.05% 
Tween20) and once with binding buffer and finally resuspended in a final volume of 90µl NEBuffer 2. 
Hi-C DNA was amplified off the streptavidin C1 beads with 7 PCR cycles using the Illumina PE PCR 1.0 
and 2.0 primers, followed by 0.9x AMPure XP beads purification. The concentration and fragment 
length profiles of the Hi-C libraries were determined with the 2100 Bioanalyzer (cat. no. G2939BA; 
Agilent) and libraries were pair-end sequenced on the Illumina HiSeq 2500 system.  
2.14.2 Promoter Capture Hi-C (PCHi-C) 
The capture of promoter containing HindIII fragments was carried out using the SureSelect XT Target 
enrichment (cat. no. 5190-4806, 5190-4831; Agilent Technologies) according to manufacturer’s 
instructions as previously described (Schoenfelder et al., 2015). 37,608 biotinylated 120-mer custom 
RNA baits were designed by Simon Andrews as previously described (Mifsud et al., 2015), targeting 
the ends of 22,076 HindIII fragments overlapping Ensembl v75 (GRCh37) annotated promoters of 
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protein-coding, noncoding, antisense, snRNA miRNA and snoRNA transcripts. The targeting sequence 
needed to have a GC content ranging between 25% and 65%, containing no more than 2 consecutive 
Ns and be no more than 330bp from the restriction fragment ends. 500ng of the Hi-C library was used 
for the promoter capture, resuspended in 3.6µl H2O along with Agilent Technologies hybridization 
blockers 1, 2 and a custom hybridization blocker (cat. no. 931108; Agilent Technologies). The Hi-C 
library DNA was denatured at 95oC for 5 minutes and allowed to hybridise in the presence of a 
hybridisation buffer with the RNA capture bait system at 65oC for 24 hours. 60µl of MyOne 
Streptavidin T1 Dynabeads (cat. no. 65601, Invitrogen) were washed three times in 200µl binding 
buffer, followed by incubation with the Hi-C DNA/RNA capture bait mixture in 200µl of binding buffer 
for 30min at 22oC. Streptavidin bound DNA was isolated using a magnetic separator (cat. no. 12321D; 
DynaMag-2 magnet; Invitrogen) followed by washes, 15 minutes in 500µl wash buffer I followed by 3 
washes in 500µl wash buffer II at 65oC for 10 minutes. A final 300µl wash with NEBuffer 2 was 
performed and the beads were resuspended in a final volume of 30µl NEBuffer 2. A post-capture 4 
cycle PCR was performed with Illumina PE PCR 1.0 and PE PCR 2.0 primers followed by a Agencourt 
AMPure XP bead (cat. no. A63881; Beckman Coulter) clean-up step. The concentration and fragment 
length profiles of the Hi-C libraries were determined with the 2100 Bioanalyzer (cat. no. G2939BA; 
Agilent) and libraries were pair-end sequenced on the Illumina HiSeq 2500 system. 
2.15 ChIP-seq 
ChIP-seq experiments were performed with Amanda J. Collier.  
All buffers were pre-chilled to 4oC with cOmplete EDTA-free protease inhibitor (cat. no. 04693159001, 
Roche) freshly added. 15 million cells per ChIP were Accutase (cat. no. A1110501; Thermo Fisher 
Scientific) treated and collection in a 50ml conical tube, followed by a 300xg 5 minute spin at 4oC. 
Pellet was resuspended in PBS. Cells were double cross-linked with freshly prepared DSG (cat. no. 
80424-50MG-F; Sigma) for 45 minutes at 22oC and subsequently with 1% methanol-free formaldehyde 
(cat. no. AGR1026, Agar Scientific) at a cell density of 108 cell in 45 ml media for 12.5 minutes at 22oC. 
Fixation was stopped with the addition of glycine at a final concentration of 125mM and incubated for 
5min at 22oC. After two PBS washes, cells were resuspended in Wash buffer 1 (10mM Hepes pH 7.5; 
10mM EDTA; 0.5mM EGTA; 0.75% Triton X-100) and incubated for 10 min at 4oC. After spinning at 
3200xg for 5 minutes 4oC, nuclei were resuspended in 10ml Wash buffer 2 (10mM Hepes pH 7.5; 
200mM NaCl; 1mM EDTA; 0.5mM EGTA) and incubated for 10 minutes at 4oC. Another 3200xg 5 
minute at 4oC spin was performed followed by resuspension in 1ml of freshly made Lysis/sonication 
buffer (150mM NaCl; 25mM Tris pH 7.5; 5mM EDTA; 0.1% Triton X-100; 1% SDS; freshly dissolved 0.5% 
Sodium deoxycholate) per 12 million cells. Lysis was performed on ice for 30 minutes, followed by 
sonication 15 seconds on, 30 seconds off (Microson ultrasonic cell disruptor XL Misonix; output setting 
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4; 10-11 W) for 20 cycles. Optimal fragment size of 200-500bp is desired. Fragmented chromatin was 
spun down at 10000xg for 15min at 4oC and supernatant was transferred to a new tube and diluted 
1:10 with ChIP dilution buffer (150 mM NaCl; 25mM Tris pH 7.5; 5mM EDTA; 1% Triton X-100; 0.1% 
SDS; 0.5% Sodium deoxycholate). 500µl was taken for the input and the remaining diluted supernatant 
was incubated with 5µg of antibody (see Table 2-19) overnight at 4oC. Magnetic protein A (120µl per 
IP) or protein G (180µl per IP) Dynabeads (cat. no. 10002D, 10004D; Invitrogen) were washed with 
Wash buffer A (50mM Tris pH 8; 150mM NaCl; 0.1% SDS; 0.5% Sodium deoxycholate; 1% NP40; 1mM 
EDTA) and blocked for 1 hour at 4oC with yeast tRNA (cat. no. AM7119; Invitrogen) and BSA (cat. no. 
B9000s; NEB). The pre-blocked beads were added to the antibody bound chromatin and incubated for 
7-8 hours at 4oC. Subsequently the magnetic beads with the bound antibody chromatin complex were 
rinsed 1x with Wash buffer A, washed 2x with Wash buffer A, washed 1x with Wash buffer B (50mM 
Tris pH 8.0; 500mM NaCl; 0.1% SDS; 0.5% Sodium deoxycholate; 1% NP40; 1mM EDTA), washed 1x 
with Wash buffer C (50mM Tris pH 8; 250mM LiCl; 0.5% Sodium deoxycholate; 1% Igepal CA-630; 1mM 
EDTA) and rinsed with 1x TE buffer (10mM Tris pH 8; 1mM EDTA). Chromatin was eluted off the beads 
with 450µl of Elution buffer (1% SDS; 0.1M NaHCO3 in H2O). Additionally, 11µl Proteinase K (20mg/ml) 
and 5µl RNase A (10mg/ml) were added (including the input) and incubate at 37oC for 2 hours, 
followed by an overnight 65oC incubation to reverse the crosslink. DNA was purified using AMPure XP 
beads (cat. no. A63881; Beckman Coulter) and eluted in 40µl H2O. DNA was quantified using the Qubit 
fluorometer (cat. no. Q33216; Invitrogen) dsDNA HS assay kit (cat. no. Q32851; Invitrogen). Libraries 
were prepared using the NEBNext Ultra II DNA library prep kit for Illumina (cat. no. E7645S; NEB) using 
the manufacturers protocol. 
Table 2-19: List of antibodies used for ChIP-seq 
Reactivity Catalogue number 
H3K4me1 ab8895; Abcam 







2.16 Data processing and analysis 
Table 2-20: Summary of datasets generated in lab and datasets used from publications, including MACS2 peak calling 
settings, number of significant peaks called, and effective genome size used with deeptools. 


















28017 40 2,701,495,761 2.70x109 1.00x10-7 (Ji et al., 2016) 
H3K27ac 34116 40 2,701,495,761 2.70x109 1.00x10-9 (Ji et al., 2016) 
H3K27me3 224 40 2,701,495,761 2.70x109 1.00x10-9 (Theunissen et al., 
2014) 
H3K4me1 32998 75 2,747,877,777 2.70x109 1.00x10-7 In lab 
H3K4me3 21986 40 2,701,495,761 2.70x109 1.00x10-9 (Theunissen et al., 
2014) 
H3K9me3 6239 100 2,805,636,331 2.70x109 1.00x10-9 (Theunissen et al., 
2016) 
OCT4 6481 40 2,701,495,761 2.70x109 1.00x10-9 (Ji et al., 2016) 
CTCF Primed 
hPSC 
16223 40 2,701,495,761 2.70x109 1.00x10-7 (Ji et al., 2016) 
H3K27ac 19748 40 2,701,495,761 2.70x109 1.00x10-9 (Ji et al., 2016) 
H3K27me3 5200 40 2,701,495,761 2.70x109 1.00x10-9 (Theunissen et al., 
2014) 
H3K4me1 34857 36 2,701,495,761 2.70x109 1.00x10-7 (Rada-Iglesias et al., 
2011) 
H3K4me3 20832 40 2,701,495,761 2.70x109 1.00x10-9 (Theunissen et al., 
2014) 
H3K9me3 8219 100 2,805,636,331 2.70x109 1.00x10-9 (Theunissen et al., 
2016) 
OCT4 7108 40 2,701,495,761 2.70x109 1.00x10-9 (Ji et al., 2016) 
 
2.16.1 Mapping and processing Hi-C and PCHi-C data - HiCUP 
Hi-C data and PCHi-C data was mapped and artefacts were filtered out using HiCUP version 0.5.8-0.5.9 
(Wingett et al., 2015) with the GCRh38 human genome build. HiCUP was run by Steven Wingett. The 
Hi-C protocol enriches for library fragments that contain two DNA fragments separated by a biotin 
incorporated restriction site. In order to align these chimeric reads (di-tags), HiCUP truncates reads at 
the restriction enzyme cut site, producing a contiguous genomic sequence, which should each map to 
a single restriction fragment. In addition, HiCUP performed filtering of experimental artefacts and 
uninformative di-tags. These may be a result of adjacent restriction fragments re-ligating, or ligation 
of a restriction fragment to itself resulting in circularisation. Furthermore, inefficient biotin removal 
from non-ligated DNA fragments results in “dangling ends”, while inefficient streptavidin pull-down 
results in a high proportion of DNA sequences without an overlapping restriction cut site, termed 
“internal fragments”. HiCUP reports can be found in appendix.  
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2.16.2 Calling significant promoter interactions - CHiCAGO 
Interaction significance was called using CHiCAGO version 0.2.4 (Cairns et al., 2016). CHiCAGO utilises 
a convolution of a negative binomial distribution and a Poisson distribution to create a background 
model. The model incorporates interactions arising from Brownian motion as a function of genomic 
distance along with random ‘technical’ noise arising from assay and sequencing artefacts. The 
assumption is that these two sources of background are independent and therefore can be combined 
into a Delaporte distribution.  
Because of the high correlation of the two biological replicates, it was decided to merge them as part 
of the CHiCAGO pipeline. An interaction was considered significant if it had a score of 5 or more, based 
on previous empirical observations, which aimed to strike a balance between the saturation of 
regulatory features over promoter interacting regions vs random controls and the number of total 
interactions retained, which decreases with increased score threshold (Freire-Pritchett et al., 2017). 
For promoter regulatory region interaction analysis, an interaction with a score lower than 5 was 
retained if an equivalent significant interaction was present in the other cell type. For simplicity all 
network visualisation was done only with interaction score of 5 or more; however, network with a 
score of 3 or more were also constructed to validate cell specific interaction observations. 
2.16.3 Chromatin state analysis 
Chromatin state analysis was performed using ChromHMM (Ernst and Kellis, 2012, 2017) (hidden 
Markov model). Trim Galore quality trimmed and Bowtie2 (Langmead and Salzberg, 2012) aligned 
(GCRh38) BAM files were binarised using the BinarizeBam command with default 200bp bin 
settings. Both naïve and primed cell types were stacked to provide a single-genome annotation with 
the inclusion of ChIP-seq input samples as an additional feature. Model learning was performed on a 
range of states with 16 being chosen as the final number (Figure 2-4). These were further reduced into 
7 states which were more biologically relevent (Active – H3K27ac, H3K4me3, H3K4me1; Polycomb 
repressed – H3K27me3; Bivalent – H3K27me3, H3K4me3, H3K4me1; Heterochromatin repressed – 
H3K9me3; Mixed - H3K27me3, H3K4me3, H3K4me1, H3K9me3; Background – low emission 





Figure 2-4: ChromHMM emission probability of 16 states for 5 histone modifications and their respective input sample.  
The 16 states were additionally reduced to 7 states based on the combination of histone modifications within each state: 
Active – H3K27ac, H3K4me3, H3K4me1; Polycomb – H3K27me3; Bivalent – H3K27me3, H3K4me3, H3K4me1; 
Heterochromatin – H3K9me3; Mixed - H3K27me3, H3K4me3, H3K4me1, H3K9me3; Background – low emission probability 
levels in all samples.  
To assign a state to each HindIII fragment, the overlap of the 7 states with each restriction fragment 
was determined and reduced to a single final state based on the following rules: any single state 
superseded the background state; the bivalent state superseded the polycomb state; a mixture of 
multiple states was labelled as unclassified.  
2.16.4 RNA-seq analysis 
Trim Galore (https://www.bioinformatics.babraham.ac.uk/projects/trim_galore) quality trimmed and 
Hisat2 (Kim et al., 2015) aligned (GCRh38) BAM files (see Table 2-21) were loaded into Seqmonk 
(http://www.bioinformatics.babraham.ac.uk/projects/seqmonk) along with Ensembl gene 
annotation release 85. Raw counts were exported for DESeq2 (Love et al., 2014) differential gene 
expression analysis, along with log2(FPKM) normalised values. 
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Table 2-21: RNA-seq dataset used.  
Sample Accession Publication 
Naïve H9 reset ERR590398; ERR590400; 
ERR590399 
(Takashima et al., 2014) 
Primed H9 ERR590408; ERR590410; 
ERR590401 
(Takashima et al., 2014) 
 
2.16.5 ChIP-seq analysis 
Peak calling on Trim Galore (https://www.bioinformatics.babraham.ac.uk/projects/trim_galore) 
quality trimmed and Bowtie2 (Langmead and Salzberg, 2012) aligned (GCRh38) BAM files was 
performed with MACS2 (Zhang et al., 2008). The settings used and number of peaks called is detailed 
in Table 2-20.  
2.16.6 Genome browser tracks 
Normalised bigwig files for genome browser visualisation were produced using Deeptools (Ramírez et 
al., 2016). For ChIP-seq samples the BAM files were normalised with the reads per genomic content 
(RPGC) method, ignoring chrY and chrMT. This essentially divides the number of reads per bin with a 
scaling factor (inverse of the sequencing depth of the sample) for 1x average coverage.  The effective 
genome size used for each sample is listed in Table 2-20. A 10bp bin size with a 200bp read extension 
was chosen with a bigwig file output. Finally, the inputs were subtracted from the sample. For RNA-
seq tracks, the BAM files were normalised using the DESeq2 scaling factor (Naïve - 0.34576529; Primed 
- 1.873937595), with a default bin size of 50bp. As the RNA-seq was directional, separate files were 
produced for each strand. Tracks were visualised using the WashU Epigenome Browser v46.1 (Zhou et 
al., 2011, 2013, 2015). 
2.16.7 Hi-C analysis and the definition of A/B compartments and TADs.  
The Hi-C analysis was performed by Csilla Varnai using HOMER v4.7 (http://homer.salk.edu/homer/) 
(Heinz et al., 2010). Interaction matrices were binned at 25kb and 250kb resolutions and corrected 
using the iterative correction algorithm (Imakaev et al., 2012). A correlation matrix was constructed 
from normalised data at 250kb resolution and principle component analysis was performed to call A/B 
compartments(Lieberman-Aiden et al., 2009). The assignment to A or B compartment was based on 
the overlap with H3K4me3 ChIP-seq peaks (see Table 2-20). TADs were called using directionality 
indices (Dixon et al., 2012) of interactions 1Mb upstream and downstream from the centre of a 25kb 
sliding window with a 5kb step interval. The directionality indices were smoothed by calculating a 
running average over a 25kb window and pairs of local maxima and minima with a standard score 
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difference (TAD ΔZ score) above 2 constituted a TAD call. Finally, the TAD ends were extended 
outwards to the bins with no directionality bias. 
2.16.8 Promoter capture Hi-C (PCHiC) analysis 
Analysis of significantly called PCHiC interactions was performed using custom scripts in R and Python. 
Interactions networks were constructed using the R igraph v1.2.1 package (Csardi and Nepusz, 2006). 
Community detection was performed using the multi-level optimisation algorithm (Blondel et al., 
2008) implemented within igraph. For a subnetwork to be split into individual communities a 
modularity score of 0.7 or more was required. Network visualisation was performed within Gephi 
v0.9.2 (Bastian et al., 2009) using the ForceAtlas2 layout algorithm (Jacomy et al., 2014). The 
multi-dimensional scaling (MDS) layout within Gephi, developed by Wouter Spekkink 
(http://www.wouterspekkink.org), was used to obtain distance representative layouts of individual 
subnetworks. Genome tracks were visualised with either the KaryoploteR v1.6.3 R package (Gel et al., 
2017) or using the WashU Epigenome Browser version 46.1 (Zhou et al., 2011, 2013, 2015). Circular 





3 B cell development and epigenetic mechanisms underpinning 
recombination in a human immunoglobulin transgene model 
3.1 Background 
Numerous studies have sought to uncover the complex roles of the Igh and Igl (immunoglobulin light 
chain) in B cell development. The Igl recombines and is expressed at the small pre-B developmental 
stage (fraction D), which is followed by the formation of the BCR through the pairing of the light chain 
(LC) and the heavy chain (HC) proteins. By functionally inactivating both endogenous immunoglobulin 
Igl loci (Igλ and Igκ; Igl-/-) in the mouse, B cell development is arrested at the pre-B developmental 
stage, unable to progress without the BCR (Zou et al., 1995, 2003). The reciprocal experiments were 
also performed in the Igh locus, where the targeted deletion of the constant region genes functionally 
inactivated the locus. By only targeting the heavy chain constant domain genes (CH), developmentally 
important genes interspersed in the intergenic regions of the Igh, such as Adam6, remained 
functionally intact (Featherstone et al., 2010; Han et al., 2009). The inactivation of the Igh resulted in 
a developmental block at the pre-B-I cell stage (fraction BC), where the absence of the HC prevented 
the formation of the pre-BCR that is required for developmental progression (Ren et al., 2004). A later 
study, also from Marianne Brüggemann’s lab, demonstrated that in Igl-/- mice the high selection 
pressures of B cells without a LC can result in the spontaneous production of HCAbs, resulting from 
random mutation within the CH1 domain (Brüggemann et al., 2010; Zou et al., 2007). Additional studies 
performed using camel (dromedary) HCAb recombined sequence have shown that HCAbs can be 
successfully produced in mice and are capable of driving mouse B cell development (Zou et al., 2005). 
The ability of VHHs and mouse variable fragments to drive B cell development expands our ability to 
utilise HCAbs for potential therapeutic applications. Additionally, by utilising humanised mice, the 
longer and broader distribution of amino acids within the human CDRH3s could potentially increase 
the intrinsic ability of HCAbs to recognise conventionally inaccessible epitopes (Lee et al., 2014; 
Muyldermans, 2013), in addition to circumventing the production of HAMAs.  
3.1.1 Crescendo Biologics and the Crescendo Mouse 
The biopharmaceutical company Crescendo Biologics was created to harness the therapeutic potential 
of fully human heavy chain only fragments. Their successful creation of the Crescendo mouse platform 
gave them the ability to harness the mouse in vivo antibody maturation process and obtain high 
affinity human HCAbs, termed Humabody VH, against desired antigens with exceptional biophysical 
characteristics. Currently, Crescendo Biologics is pursuing the development of multi-functional 
Humabody therapeutics in oncology, utilising Humabody VH to selectively activate tumour-targeted T 
cell engagers within the tumour microenvironment, which would avoid the toxicity of current chimeric 
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3.1.2 Predicted B cell development in CTG mice 
From our current knowledge of the CTG2 mouse, it is possible to draw parallels with other models of 
B cell development.  Without the CH1 domain, it is reasonable to postulate that the surrogate light 
chain (SLC) would be unable to bind the HC in CTG2 mice in the same capacity as in WT. The SLC pairing 
with the HC and the formation of the pre-BCR constitutes an important B cell developmental 
checkpoint. As a result, the SLC knockout models are a valuable resource for our understanding of B 
cell development in CTG2 mice. 
3.1.2.1 SLC knockout models display an alteration in B cell development 
The invariant SLC is encoded by the VpreB1/2 and λ5 genes and shares structural homology to the LC. 
In SLC triple knockout (SLC-/-; VpreB1-/-, VpreB2-/-, λ5-/-) mice, the observation that the pairing of two 
HCs results in allelic exclusion, while non-pairing results in recombination of the second allele, 
indicates that pre-BCR signalling is at least partially intact (Shimizu et al., 2002). Studies with truncated 
HCs revealed that the SLC is not essential for pre-BCR signalling and function (Shaffer and Schlissel, 
1997). The transmembrane signal transduction proteins Igα and Igβ have to be intact for 
developmental progression. So, while a defective HC leads to developmental arrest at the pro-B stage 
(fraction BC), a defective SLC results in decreased proliferation, but allows B cells to progress to the 
pre-B stage (fraction C’) and beyond (Shaffer and Schlissel, 1997; Shimizu et al., 2002). The SLC-/- has 
also been shown to impact on the total number of B cells in the spleen (Shimizu et al., 2002). In pre-B 
cells, most heavy-chains associated with the SLC are found in the ER, whereas most HCs associated 
with the LC at the immature stage of development are found on the plasma membrane. A study using 
localisation sequences attached to the HCs to redirect them into the trans-Golgi network (TGN), 
demonstrated that the pre-BCR is capable of signalling and inducing pre-BCR dependent events from 
other cellular compartments other than the plasma membrane (Guloglu and Roman, 2006). The ability 
to signal from other compartments is supported by previous studies that demonstrated the ligand-
independent (autonomous) signalling capability of the pre-BCR, which has been proposed to result 
from the interaction of multiple pre-BCR receptors through their charged domains on the SLCs (Köhler 
et al., 2008; Ohnishi and Melchers, 2003; Winkler and Mårtensson, 2018). 
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Independently of the HC, crosslinking of Igβ has been implicated in transducing signals that trigger 
developmental progression from the pro-B stage (fraction BC) (Nagata et al., 1997). Igα/Igβ has been 
shown to have independent, but critical functions in B cell developmental progression (Papavasiliou 
et al., 1995; Reichlin et al., 2001). The HC in the absence of the SLC/LC relocates from the ER to the 
plasma membrane together with Igα (Su et al., 2003). Additionally, truncated HCs in LC-/- mice are 
deposited on the cell surface together with Igβ (Zou et al., 2008). Interestingly, a mouse strain whose 
B cell development was reliant on IgG1 instead of IgM showed a decreased dependence on Igα for 
maintenance (Waisman et al., 2007). The levels of IgM in serum of SLC-/- mice were not significantly 
affected, although they seemed to have slightly reduced immune response to antigens (Shimizu et al., 
2002). 
3.1.2.2 B cell development with a IgG-BCR and the importance of secreted IgM (sIgM) 
The importance of the IgM class is highlighted by its presence in all vertebrates (Flajnik, 2002). The µ 
and δ are the only heavy chains lacking a cytoplasmic tail and as a result are thought to be more reliant 
on the Igα/β (CD79) transmembrane proteins. Igα/β associate with the pre-BCR/BCR and transduce 
signals through their cytoplasmic ITAM modules (Geisberger et al., 2003). Igα/β have been shown to 
associate with all classes of immunoglobulins. They are required for the surface expression of IgM, 
IgA, but not IgG2b. In IgG-BCR mouse models, the use of the γ constant region (forming IgG) instead 
of µ (forming IgM) was shown to impact B cell development (Waisman et al., 2007). A reduction in the 
transitional B cells and an increase in MZ B cells was observed in the spleen. In addition, there was a 
higher number of fraction A-C B cells with severely diminished numbers of fraction D and extending 
to fraction E B cells, suggesting a developmental block at the pre-BCR stage of development (Waisman 
et al., 2007). The IgG-BCR mouse models also demonstrated the dispensability of Igα for IgG-BCRs but 
not that of Igβ. The truncation of both Igα/β fully blocked B cell development from the pro-B (fraction 
B) stage of development (Song et al., 2016; Waisman et al., 2007),  
It is known that IgG has a more profound response to antigen stimulation compared to IgM based on 
its ability to induce higher clonal expansion and production of antibodies that results from its unique 
signalling (Martin and Goodnow, 2002). The difference between IgM and IgG signalling was shown to 
be due to the inhibitory action of CD22 on IgM and IgD BCRs. The IgG BCR is able to circumvent this 
inhibition through its unique cytoplasmic tail that prevents phosphorylation and therefore activation 
of CD22 (Wakabayashi et al., 2002). This suggests that the use of an IgG in early B cell development 
and the altered B cell development observed in mouse models could be a consequence of the unique 
signalling of the IgG receptor. 




The importance of IgM in B cell development extends beyond its signalling capacity as a BCR. Natural 
IgMs or secreted (sIgM) (produced even under sterile conditions) are polyreactive and have been 
described to recognise self-antigens (Ferry et al., 2007). They are produced in the bone marrow and 
the spleen at high levels by CD5- plasma cells and B-1 cells, which typically reside in the peritoneal 
cavity (Choi et al., 2012; Reynolds et al., 2015; Savage and Baumgarth, 2015). Besides their protective 
roles during infection, they have also been implicated in cellular debris clearance and the reduction of 
autoantigen levels (Ehrenstein and Notley, 2010). The deletion of the secretory sequence in exon 4 of 
the Cµ gene that ablates sIgM (Ehrenstein et al., 1998) has also been shown to impact normal B cell 
development.  
The impact is most noticeable on the peripheral B cell populations, such as in the spleen, where a 
significant increase in MZ B cell and a significant decrease in FO B cells was observed (Baker and 
Ehrenstein, 2002; Nguyen et al., 2015; Tsiantoulas et al., 2017). One suggested mechanism for this 
change is the increased BCR signalling due to the failed clearance of antigens by the sIgM, which would 
direct B cells towards the MZ cell fate (Tsiantoulas et al., 2017). However, contradictory studies done 
in BCR transgene mice, and Btk or Aiolos knockout mice, suggest weaker BCR signalling directs cell 
fate towards MZ B cells and stronger towards FO B cells instead (Casola et al., 2004; Pillai and Cariappa, 
2009; Pillai et al., 2004). Yet, even within these studies one BCR transgene model specific for a low-
dose self-antigen resulted in a contrary development of B cells into the MZ fate (Wen et al., 2005). In 
addition, the observed increase in B-1 B cell population upon sIgM ablation suggest that MZ and B-1 
cells respond to comparable levels of BCR signalling (Boes et al., 1998), which for B-1 cells has been 
shown to be strong rather than weak BCR signalling (Berland and Wortis, 2002). Another contrary 
result, attributed to a previously unidentified anergic population, was again generated in a later study 
which showed a decrease in the peritoneum B-1 B cell population, while maintaining normal number 
in the spleen (Nguyen et al., 2015). Reconciling these findings will be important in elucidating the exact 
mechanism driving cell fate of peripheral B cells. One possibility could be that the self-recognition and 
foreign antigen recognition give rise to different levels of BCR signal response that could potentially 
be quantified by monitoring the levels of calcium flux post BCR stimulation.  
Beyond peripheral B cells, the impact of ablating sIgM extends all the way back to the bone marrow. 
An increase in fraction A/B with a decrease in fractions D/E/F was observed in the bone marrow of 
sIgM-/- mice (Nguyen et al., 2015). In addition, an increase in the generation of autoantibodies was 
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observed (Boes et al., 2000; Ehrenstein et al., 2000) and attributed to the breakdown of central 
tolerance in the absence of sIgM-/-, which resulted in an altered B cell antibody repertoire (Nguyen et 
al., 2015). Interestingly, the breakdown of the central tolerance checkpoint at fraction E, which results 
in higher autoantibodies in the periphery, did not result in an increased number of fraction E B cells. 
This suggests that rather than more autoreactive BCRs bypassing central tolerance, it is possible that 
foreign antigen BCRs are negatively selected out due to the lack of proper stimulatory signalling from 
the sIgM. The receptor for the Fc portion of IgM (FcµR), restricted to B cells in mice and lymphocytes 
(B, T and natural killer (NK) cells) in humans (Kubagawa et al., 2017), is the most obvious target of 
sIgM. A knockout of FcµR shared a similar phenotype with the sIgM-/- models, displaying a decreased 
number of fraction D/E B cells and an increase in peritoneum B-1 B cells (Choi et al., 2013b). 
Additionally, the FcµR was shown to co-localise with the intercellular IgM and control tonic signalling 
through the internalisation of surface BCRs of the immature B cell subset (fraction E) (Nguyen et al., 
2017). These studies demonstrate an interplay between FcµR and the IgM either in the secreted or 
membrane bound form. Yet, there have been four different FcµR-/- mouse models generated by 
independent labs that each display very different phenotypes, most likely from the different exon 
combinations targeted in each study (Nguyen et al., 2017; Wang et al., 2016). One certain 
commonality to all knockouts is the production of autoantibodies that suggest an alteration in BCR 
signalling that bypasses central tolerance, but are insufficient to cause pathology associated with 
autoimmune diseases (Wang et al., 2016).  
3.1.2.3 The pre-BCR checkpoint and autoreactive antibodies 
The pre-BCR is present on the cell surface of fraction BC B cells at low levels. The HCs innate ability to 
moderately aggregate, forming multimeric complexes capable of signalling is enhanced by SLC 
mediated aggregation (Meixlsperger et al., 2007). The non-Ig tail of λ5 has been demonstrated to play 
a vital role in pre-BCR signalling and surface levels (Ohnishi and Melchers, 2003), despite having 
functional allelic exclusion in λ5-/- and SLC-/- mice (Boekel et al., 1998; Shimizu et al., 2002). In the 
absence of the SLC, lower levels of signalling may be compensated by HCs with a higher propensity for 
self-recognition and aggregation. Interestingly, positively charged arginine residues, characteristic of 
anti-DNA anti-nuclear antibodies (ANAs)(Radic et al., 1993), are found in the λ5-tail (von Boehmer and 
Melchers, 2010). The frequency of ANAs is increased in the absence of the SLC, with CDRH3 basic 
residues unusually originating from DH gene segments. Despite an increase in ANAs, no pathology was 




observed in the SLC-/- mouse. An alternative route to the generation of ANAs is via somatic 
hypermutation (SHM). This was demonstrated when a SHM sequence was reversed to its original 
germline amino acid (aa) configuration and resulted in the abolishment of auto-reactivity (Keenan et 
al., 2008; Schroeder et al., 2012). 
A skew towards MZ B cells in the numbers of splenic B cells was also observed in the SLC-/- mice, 
resulting from a decrease in FO B cell numbers rather than an increase in MZ B cells (Keenan et al., 
2008; Ren et al., 2015). A number of studies have suggested the idea that BCR signalling strength drives 
lineage progression into peripheral B cell subpopulations (Casola et al., 2004; Heltemes and Manser, 
2002; Pillai and Cariappa, 2009; Pillai et al., 2004; Tsiantoulas et al., 2017; Wen et al., 2005). In one 
such study, high levels of BCRs on the cell surface during normal development have been linked to 
negative selection, resulting from increased signalling that is characteristic of auto-reactive BCRs. 
However, modest levels of surface BCRs, obtained from alterations in transgene copy numbers, 
resulted in higher B cell numbers in the MZ-like cells (Heltemes and Manser, 2002). Additionally, a link 
between a subset of the VH gene repertoire, auto-reactivity and the B-1 B cells has been made 
(Carmack et al., 1990; Lam and Rajewsky, 1999). For example, B cells with self-reactive specificity for 
phosphatidylcholine (PtC) have been shown to segregate into the B-1 subset, while B cells that do not 
recognise PtC, segregate into the B-2 subset (Mercolino et al., 1989; Arnold et al., 1994). B-1 B cells 
share many similarities with MZ B cells such as a bias towards a self-recognizing BCR repertoire (Paul, 
2012). 
Interestingly, the polyreactive chimeric receptors (pre-BCR like) from the Köhler et. al. study were also 
expressed at much lower levels on the cell surface compared to the non-autoreactive receptors 
(mature BCR like) (Köhler et al., 2008). A similar observation was made in SLC-/- mice, where lower 
levels of surface IgM were present on immature B cells compared to WT (Ren et al., 2015). The lower 
levels may result from higher abundance of polyreactive BCRs that passed through the pre-BCR 
negative selection. By depleting MZ B cells and monitoring autoantibody production, it was suggested 
that IgG ANAs are primarily produced by CD21-23- B cells (B-1 like cells (Keenan et al., 2008)), whereas 
anti-dsDNA IgMs were produced by MZ B cells (Ren et al., 2015). The same group also reported that 
autoreactivate B cells in SLC-/- are also increased in FO B cells (Grimsholm et al., 2015).  
SLC plays a major role in the repertoire selection at the pre-BCR checkpoint, namely the VH domains 
that are unable to pair with the SLC and display autoreactivity are selected out (VH81X, VHQ52 and 
nearly half of the VHJ558 domains). In λ5-/- mice, this negative selection is non-functional (Boekel et 
al., 1997). As a result, these V genes were observed in peripheral B cells, namely FO B cells (Grimsholm 
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et al., 2015). Interestingly, despite the breakdown of central tolerance in the bone marrow, peripheral 
tolerance was still intact and B cells entering the memory B cell and plasma cell pools did not contain 
V genes defective in pairing. Whether this is also true in B cell development reliant on IgG1 instead of 
IgM is unknown (Waisman et al., 2007). 
3.1.2.4 Negative selection of auto-reactive µHC in humans - signalling without the SLC  
Based on a study done in a single patient with a particular λ5 mutation, HCs deposited on the plasma 
membrane in human B cells are unable to signal activation and developmental progression. Instead 
they undergo apoptosis (Minegishi et al., 1998). This opens up the possibility that the germline HCs of 
humans do not have the same level of autoreactivity as those in mice and ANAs are rather derived 
from SHM (Schroeder et al., 2012). The strength of the pre-BCR signalling is the determinant for 
negative selection (Conley and Burrows, 2010). The possibility that the mutation resulting in λ5 
deficiency causes a rare phenotype unlike the one studied in mice cannot be ruled out. An analysis of 
human HC transcripts revealed that about 9% will produce proteins that can be expressed on the cell 
surface without the SLC; however, their characteristically autoreactive CDRH3 lead to B cell apoptosis 
(Minegishi and Conley, 2001). Whether the signalling mechanism and thresholds function differently 
in humans is debatable. 
3.1.3  
 




3.1.4 Russell body formation 
Russell bodies (RBs) are distended cisternae of the endoplasmic reticulum (ER) filled with 
immunoglobulin aggregates. Plasma cells with RB formation and a defect in immunoglobulin secretion 
are called Mott cells (Alanen et al., 1985).  
Transfecting a truncated heavy chain plasmid construct (lacking CH1 domain) into a healthy myeloma 
cell line, which produces and secretes λ light chain, results in the formation of RBs. In a cell line that 
does not produce λ light chains, no substantial RBs were detected. The presence of RB does not seem 
to affect cell division (Valetti et al., 1991). Later work showed that RB formation can occur both in the 
presence and absence of the immunoglobulin light chain. When overexpressing the truncated heavy 
chain, the ER-associated degradation (ERAD) is overwhelmed and leads to RB formation (Mattioli et 
al., 2006). RB structures formed in the presence of the light chain (rough RB) differ from ones formed 
in their absence (smooth RB). They differ not only by the presence of ribosomes on the surface, but 
also by the structure of the aggregates within RBs (Mattioli et al., 2006). The ability of the LC to bind 
an HC lacking the CH1 domain has been demonstrated numerous times in the past (Hendershot et al., 
1987; Valetti et al., 1991). With Ac38 staining it was shown that despite the ablation of the CH1 domain, 
the light chain still interacted with the heavy chain via the V domain. This leads to aggregation through 
the CL that would normally interact with the CH1 domain (Mattioli et al., 2006). RB formation resulting 
from LC dimer formation (Kaloff and Haas, 1995; Leitzgen et al., 1997; Mattioli et al., 2006) is 
somewhat counterintuitive as usually the light chain has a BCR anti-aggregation role that prevents 
strong autonomous signalling (Meixlsperger et al., 2007). LCs are important not only in development, 
but also in facilitating the correct folding of HCs (Lee et al., 1999). In LC-/- mice, the aggregation of full-
length HCs in the ER leads to HC toxicity and cell death (Feige et al., 2009; Corcos et al., 2010).  
HCs without the CH1 domain are secreted in cell lines (Hendershot et al., 1987), in vivo models 
(Geraldes et al., 2007; Zou et al., 2007) and in Camelids that naturally produce HCAbs. Secretion of 
HCs was not observed in cell line models for RB (Valetti et al., 1991) which suggests certain types of 
HCs have a higher tendency to aggregate (Hasegawa et al., 2014). Alternatively, perhaps analogous to 
 




a subset of light chains and the requirements of HCs to escape BiP, they fail to assemble and form 
dimers that are a prerequisite for secretion (Kaloff and Haas, 1995; Leitzgen et al., 1997). A study of 
functional IgGs and their propensity to form RB suggests the variable domains of the HC and LC, 
encoding physiochemical properties, govern the severity of RB formation. They observed that RB-
forming IgGs deteriorated cell health and viability, which speculatively suggest HCs prone to RB 
formation are under negative selection in natural sources of HCAbs where RB formation has not been 
reported (Stoops et al., 2012). The formation of RB seems to be an additional quality control 
checkpoint before the release of immunoglobulins. By storing aggregation prone immunoglobulins 
within the ER the plasma cells prevent potentially harmful accumulation of extracellular 
immunoglobulins (Hasegawa et al., 2014). 
3.1.5 Hypothesis 
 











3.2 Reduced fraction D and appearance of an intermediate fraction E F population in 
CTG mouse bone marrow 
I started the project by performing a comprehensive characterisation of the different B cell 
developmental fractions (Hardy et al., 1991) (Figure 1-2) in CTG2 mice with the aim of comparing them 
to the WT counterpart (Figure 1-1). I initially used a well-established sorting panel that was used for a 
number of past projects within the lab (Bolland et al., 2016; Koohy et al., 2018). The panel used the 
CD25 marker to identify fraction C’ and D. However, the detection of the CD25 marker proved 
challenging in CTG2 mice and led me to develop a panel with alternative markers that included CD24 
and AA4.1 (CD93).  
Examination of the numbers of total cell extracted from the bone marrow of CTG2 and WT mice 
revealed very little difference. On average 128 million cells were extracted from CTG2 mice (n=8) and 
115 million cells from WT (n=5). The only noticeable difference was the higher standard deviation of 
47 million in CTG2 cell counts compared to 9 million in WT. I extended this analysis to the total counts 
of the B220+ population from flow cytometry data in the bone marrow, which proved to be equivalent 
between CTG2 and WT (Figure 3-3 a). In spleen, the overall B220+ counts are lower in CTG2 mice than 
WT; however, they do not reach statistical significance and comparing the weight of WT and CTG2 
spleens also reveals no differences (Figure 3-3 b). This suggest that the B cell compartment is intact in 
CTG2 mice.  
 
Figure 3-3: CTG2 mice show no differences in total number of B220 cells or size of spleen compared to WT mice. 
(a) Quantification of total B220 positive cells over live lymphocytes in the bone marrow and in the spleen of WT (n=3) and 
CTG2 (n=5) mice. P-values were calculated with an unpaired two-sample Mann-Whitney/Wilcoxon rank sum test with 




Examination of flow cytometry plots with the B220 and CD19 B cell markers revealed differences in 
the profile of the B220 high and low population between the CTG2 and WT mice (Figure 3-4). The B220 
low population appears to be reduced in CTG2 mice, while the B220 high population displays a much 
broader spread of intensity values along the CD19 axis. These initial observations suggest there are 
differences in B cell developmental subsets as would be expected from published knockout models 
(Brüggemann et al., 2006; Nguyen et al., 2015; Shimizu et al., 2002; Waisman et al., 2007). In addition, 
the B220 high population in CTG2 seems to maintain lower intensity values compared to WT. 
 
Figure 3-4: Differences in B cell bone marrow composition between WT and CTG2 mice.  
B220 vs CD19 pseudo-coloured dot plots show an altered profile of the B220 low population in CTG2 mice compared to WT. 
CTG2 B220 high B cells have a greater spread along the CD19 axis compared to the B220 high CD19 high WT population 
(n>10). In addition, a less distinct population of B220 positive CD19 negative B cells is seen in CTG2 mice.  
 
Due to the high dimensionality of flow cytometry data (6 parameters measured) and the possible 
unknown alterations in B cell developmental progression, I decided to use analysis approaches 
popularised and developed by the mass cytometry field, such as SPADE (Bendall et al., 2011; Qiu et 
al., 2011) and tSNE (Maaten and Hinton, 2008). Classic analysis allows two parameter comparisons 
such as those shown in Figure 3-4, meaning if a flow cytometry panel contains 6 parameters, 15 
individual pairwise comparison plots would be required to have an overview of the data. The gated 
populations would require additional plots, making such analysis intractable for an unbiased 
examination of the data. I chose to use FlowSOM, which utilises self-organising maps (SOMs) to group 
cells into a predefined number of clusters based on their cell surface marker expression similarity. The 
final SOM is visualised as a minimal spanning tree (MST), allowing for example parameter and cluster 
composition overlays. The final visualisation is equivalent to plots produced with SPADE, with the 
distinct advantage of being much less computationally taxing and allowing the use of all captured 
events in the analysis. 
From conventional pairwise pseudo-coloured dot plots it was clear that there were certain 
populations present in CTG2 mice which do not perfectly fall into the predefined B cell developmental 
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fractions. One such population is the intermediate population between fraction E and F (Figure 3-5 a). 
By plotting CD24 vs AA4.1 it is possible to view the transition from fraction BC all the way to fraction 
F. One striking difference between WT and CTG2 mice is the size of the AA4.1+ and CD24 high 
population that correspond to fractions C’ D and E. WT mice have a much larger fraction D and E 
population compared to CTG2 mice. The individual FlowSOM MSTs for WT and CTG2 capture the 
developmental progression along with the noted differences (Figure 3-5 b). The decreased proportion 
of fraction D and E cells is clearly shown, while an increase in fraction BC in CTG2 mice seems to be 
present. A dominant feature in CTG2 mice is the intermediate EF (intEF) population expansion, 
highlighted by the CD24 AA4.1 dot plots (Figure 3-5 a). More interestingly, a large portion of ungated 
cells is revealed not only clustering together with intermediate EF cells, but also forming a prominent 
feature upstream of intEF cells (Figure 3-5 b). This population, not captured by my manual gating 
strategy, very nicely illustrated the power of a global unbiased visualisation of flow cytometry data.  
The manual gating of WT cells accounts for a large proportion of all the B220 positive cells within the 
FlowSOM analysis. However, in CTG2 mice there are large populations of ungated cells. In order to 
uncover what these may be, I overlaid the expression intensity of each measured cell surface marker 
onto the MST (Figure 3-6). One important aspect to note when interpreting the expression overlay 
plots is the range of values. Because the cells used for the analysis were all B220 positive, the low 
expression values for this marker does not mean that B220 is not expressed, as opposed to the other 
markers. Examining the intermediate EF clusters, which have not been fully captured by my manual 
gates, shows that while they have downregulated AA4.1 as expected for fraction F cells, their CD24 
levels remain high, which is characteristic of fraction E. With the assumption that an IgG BCR mirrors 
the phenotypes produced by an IgM BCR, it is interesting that only a subset of these cells are 
expressing surface IgG that constitute my manually gated fraction E population. This suggests that the 
intermediate population contains cells that have failed to produce a functional cell surface expressed 
BCR. Normally such cells would undergo apoptosis after multiple failed attempts at V gene 
replacement, but instead the cells accumulate. The next set of cell clusters upstream of the 
intermediate EF gated population has not been captured by my gating strategy (Figure 3-5 b). These 
cells have downregulated AA4.1 and CD24, but their IgG expression remains low. This suggests that 
even though the cells now resemble fraction F more closely, they still do not have a functional cell 





Figure 3-5: Flow cytometry analysis of B cell developmental fractions in WT and CTG2 mice reveals an intermediate 
population.  
(a) CD24 vs AA4.1 pseudo-coloured dot plots highlighting an intermediate population between fractions E and F (intEF) in 
CTG2 mice. CD24 vs AA4.1 captures fractions BC, D, E and F on a single plot allowing a simple comparison between WT and 
CTG2. (b) Separate FlowSOM minimal spanning trees of WT and CTG2 flow cytometry data with manually gated fractions 
overlaid over the nodes. Each node represents a cluster of cells, with each pie chart giving the proportions of manually gated 
cells within that cluster. The size of the node is proportional to the cell numbers present within each cluster. Each MST was 






Figure 3-6: Marker expression of B cell fractions in CTG2 mice allows characterisation of intermediate populations. 
CTG2 mouse FlowSOM minimal spanning tree from Figure 3-5, overlaid with the expression level of 6 cell surface markers. 
The scale of low and high expression is different for each marker. For example, the B220 marker is expressed in all cells, 
despite the range of low and high expression, because all cells used in the analysis were pre-gated for B220+ cells. 
The number of cells in fraction A, D and intermediate EF are statistically different between WT and 
CTG2 (p-value 0.037, 0.037 and 0.037 respectively, Mann-Whitney/Wilcoxon rank sum test; Figure 3-8 
a). The intermediate EF population and, especially, fraction BC have a higher coefficient of variation in 
CTG2 mice compared to WT, even though the difference in fraction BC is not statistically significant 
between the two mice. The TKO mice have been shown to have a developmental block at the stage 
where a pre-BCR is required for further progression (Figure 3-7) (fraction BC to fraction C’D) and would 
be also expected to have a block at the later BCR stage (fraction D to fraction E) if a recombined heavy 
chain rescue was performed. The transgene in CTG2 mice successfully restored developmental 
progression (Figure 3-7). The dependence of successful development on the pre-BCR and BCR 
highlights their importance. As a result, fraction BC and fraction E are the two stages where I would 
expect to see a difference in CTG2 mice due to the heavy chain only nature of their pre-BCR and BCR. 
The deletion of the CH1 domain circumvents the retention of the heavy chain in the endoplasmic 
69 
 
reticulum via the BiP chaperones protein, allowing cells to progress (Zou et al., 2007). However, the 
deletion may also impair the ability of the surrogate light chain to bind to the heavy chain to form a 
functional pre-BCR, reducing developmental progression. The high variation in CTG2 fraction BC B cell 
numbers and their relatively higher proportions compared to WT supports this notion; however, the 
major impact can be seen downstream in fraction D. Ultimately, the additional knockout of the SLC 
genes would be desired to further our understanding of the role the SLC plays in heavy chain only pre-
BCR development.  
 
Figure 3-7: Flow analysis of TKO mice show B cell development does not move past fraction BC.  
All B220+ cells in the TKO mouse are CD43+ and partly BP1+. No immunoglobulin (Fc) cell surface staining in TKO mouse shows 
B cells do not progress into the immature stage of development. Together this data points to a developmental block in the 
TKO mice at the fraction B/C - C’, a stage that is reliant on the cell surface expression of the pre-BCR for developmental 
progression. The TKO block is successfully overcome in the CTG mouse and mirrors WT development. Figure adapted from 




Figure 3-8: Quantification of the B cell fractions in WT (n=3) and CTG2 (n=5) mice.  
(a) Proportions of B cell subsets over total live lymphocytes plotted for each fraction. Unpaired two-sample Wilcoxon rank 
sum test with continuity correction used to determine significance of difference between WT and CTG2 fractions. The 
coefficient of variation is shown for fraction BC and intermediate EF. (b) The line plots allow tracking of changes in B cell 
numbers between the developmental fraction for each sample, highlighting that the decrease in fraction D numbers is still 




During the fraction D stage of development, large pre-B cells undergo approximately 6 rounds of cell 
division. This clonal expansion increases the pool of cells that subsequently undergo Igl recombination, 
increasing the overall repertoire diversity. The low number of fraction D cells suggests that this 
expansion does not take place, perhaps due to an impairment in pre-BCR signalling. Nevertheless, as 
the Igl is knocked out in CTG mice, the expansion is not required for repertoire diversification and by 
fraction F the B cell proportions are equivalent to WT levels (Figure 3-8 a). Tracking the fraction 
number in each sample reveals that high fraction BC levels in CTG2 mice also predicts high 
intermediate EF numbers (Figure 3-8 b). Interestingly, the B cell number in CTG2 mice still decrease as 
they transition from fraction D to E, as is the case in WT. This suggests that despite not undergoing Igl 
productive recombination and HC pairing selection, the CTG2 B cells still face survival pressures. 
Because the pre-BCR and the BCR in CTG mice should be the same heavy chain at both developmental 
fractions, the additional selection observed suggests that they require fine-tuned levels of tonic 
signalling to pass through both selection checkpoints.  
Altogether, the analysis of the bone marrow developmental fraction reveals an expected decrease in 
fraction D B cells (Zou et al., 2007), while the overall and final fraction F numbers were in line with WT 
mice. With the use of unbiased analysis, an unexpected intermediate population between fraction E 
and F was discovered, which together with increased B cell numbers in fraction BC of CTG2 mice 
suggests that only certain selected heavy chain only pre-BCRs and BCRs go on to form the mature B 
cell pool. 
3.3 Increased marginal zone B cells and reduced follicular B cells observed in CTG 
mouse spleen with reduced transitional 1 and 2 populations 
I next wanted to examine whether the splenic B cell populations showed any deviations from the WT 
norm. The first noticeable difference with the CD19 B220 staining was a tail B220low population 
emerging from the B-2 B cells (Figure 3-9 a top panel). In WT, this population would be considered to 
consist of B-1a and B-1b cells. To determine if these cells correspond to B-1 B cells in CTG2 mice I 
quantified the CD19+B220-CD23-Ig+ cells. In CTG2, not all of the cells correspond to B-1 cells, suggesting 
that the lower B220 expression is a B-2 characteristic of B cells arriving from the bone marrow as noted 
above (Figure 3-4). Quantifying the proportion of B-1 cells over total lymphocytes did not reveal a 
significant difference between WT and CTG2 mice (Figure 3-9 b), although the dispersion of CTG2 B-1 
counts was much greater than for WT (CV 0.58 CTG2 vs 0.18 WT). This suggests that some CTG2 mice 
do have an enlarged B-1 cell population. More apparent are the differences in the marginal zone (MZ) 
and the follicular B cell (FO) populations (Figure 3-9 a middle panel). CTG2 mice have a significantly 
higher MZ population and a lower FO B cell population (Figure 3-10 a). In addition, the transitional B 
cell populations T1 and T2 are significantly reduced in CTG2 mice (Figure 3-9 a bottom panel and Figure 
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3-10 b). The reduced levels of the T1-2 B cells suggests a reduced number of B cells are exiting the 
bone marrow. This notion could be supported by the large intermediate EF and fraction F Ig- 
populations detected in the bone marrow (Figure 3-5 b), which point to a block in B cell development 
and a decreased migration into the spleen compartment.  
 
Figure 3-9: Analysis of WT and CTG2 spleen B cell populations.  
(a) Top panel shows CD19 vs B220 demarcating B1 from B2 cells. The middle panel shows CD23 vs CD21/CD35 separating 
follicular (FO) B cells from marginal zone (MZ) B cells. Bottom panel shows CD23 vs Ig, highlighting the transitional 1-3 B cell 
populations. (b) Proportion of B1 cells over live lymphocytes in WT and CTG2 spleens. The coefficient of variation (CV) is 







Figure 3-10: Quantification of spleen B cell population in WT (n=3) and CTG2 (n=5) mice.  
P-values were calculated with an unpaired two-sample Wilcoxon rank sum test with continuity correction. (a) FO MZ 
populations. (b) T1-3 populations.  
Altogether, these results show that the proportions of spleen B cell subsets are altered in CTG2 mice 
compared to WT, as expected from studies of SLC-/-, sIgM-/- and models of IgG only isotype B cell 
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3.5 Targeted locus amplification reveals location of transgene incorporation and 
sequence composition 
The Crescendo mouse was made by microinjection of the YAC transgene into mouse oocytes. This 
means the transgene integration into the genome is random and may disrupt endogenous genes and 
regulatory elements. To determine if any gene disruptions may have contributed to the phenotype 
observed by flow cytometry, I decided to determine the location of the transgene.  
My initial attempts using techniques that relied on restriction enzyme digestion followed by PCR 
amplification of the transgene flanking regions were unsuccessful and prompted me to utilise a new 
technique reliant on proximity ligation, developed in Wouter de Laat’s group, called targeted locus 
amplification (TLA) (Vree et al., 2014) (Figure 3-13). 
 
Figure 3-13: Difference in read coverage obtained from TLA compared to 4C.  
Adapted from (Vree et al., 2014). 
TLA works on the principles of chromosome conformation capture (3C) techniques, namely 4C. The 
chromatin within each nucleus of a cell is digested using a restriction enzyme, followed by ligation. 
The result is the fragments that are close together in physical space, not linear genomic space, are 
ligated into DNA circles of co-localised restriction fragments. These large DNA circles are further 
fragmented with a secondary, less frequent cutter, and PCR amplified with a pair of outward facing 
anchor primers. This amplification enriches for the sequences of interest. Unlike in 4C, where only the 
DNA around the restriction cut sites is sequenced and analysed, in TLA the full restriction fragment is 
amplified and sequenced (Figure 3-13). This process reveals sequences adjacent to the anchor, much 
like the flanking region PCR amplification methods described above, but with greater distance and 
coverage. In order to be able to amplify the flanking regions of the transgene, I have previously used 
a pair of primers spanning the transgene YAC arms and the adjoining human/mouse sequence to verify 
the integrity of the transgene ends (data not shown). Because of the confirmed presence of this region 
of the transgene, I designed the TLA anchor primers within the Hyg HIS arm joint (Figure 3-2). This 




(legend on next page)
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Figure 3-14: TLA reads aligned to the GRCm38 genome.  
(a) Genome view of deduplicated TLA reads. Chromosome 14 contains a broad distribution of reads centring on the 
highlighted region (black box). (b) Chromosome view of highlighted region showing the possible location of the transgene 
insertion. The highest peak is over a gene poor region surrounded by snoRNA genes.  
Much like in 4C, it is expected that the increase in genomic distance from a viewpoint results in a decay 
of contact probability, or in the case of TLA a decay in read coverage. Using this principle, we can use 
TLA reads mapped to the mouse genome to ascertain a possible location of the transgene insertion. 
As part of the analysis, a set of blacklisted regions produced by the ENCODE project corresponding to 
regions with artificially high levels of signal were empirically removed from further analysis (The 
ENCODE Project Consortium, 2012). The relatively high coverage observed on chromosome 14 
suggests that the transgene is located here (Figure 3-14 a - black box highlight). A zoom in on this 
region reveals a peak of reads centring within a gene poor region and surrounded by snoRNA genes 
(Figure 3-14 b).  
Thus, the TLA revealed that the transgene integration into a gene poor site prevented the disruption 
of any functionally relevant genes. In addition, the functional recombination and antibody production 
observed in CTG2 mice means the heterochromatin that is usually associated with gene poor regions, 
such as the proposed integration site, did not spread and impact the activity of the transgene (Wang 
et al., 2014).  
3.5.1 3D DNA FISH with chromosome paints confirms TLA location of transgene 
3.5.1.1 Human V-D intergenic region DNA FISH probe design 
The likely inability of the HCAbs to pair with the SLC may impose additional constraints on the 
productive recombination events that will lead to signalling and developmental progression. To test 
this, I investigated the allele recombination frequency in CTG2 B cells to determine if the frequency of 
productive first round recombination was similar to WT, or if the second allele was required to 
recombine at a higher frequency. Alteration in the expected number of double allele recombiners 
could provide a possible explanation for the higher number of fraction BC B cells observed in CTG2 
mice, as these cells would need to spend more time at this developmental stage in order allow their 
second allele to recombine. To accomplish this, I needed to design and manufacture probes for the 
human VD intergenic region, similar to the mouse VD1-7 probes described previously (Ramadani et 
al., 2010). The human VD intergenic region is considerably smaller than mouse and in order to 
maximise the size of the probes, I chose to use the DNA FISH probe design tool webFISH (Nedbal et 
al., 2012). WebFISH also considers repeats that are unique to the designated region for probe design, 
giving it an advantage over a manual approach with RepeatMasker. WebFISH returned four probes for 





Figure 3-15: Graphical output from webFISH showing the four designed probes. 
Four probes were generated for the human V-D intergenic region, shown as purple boxes. The non-unique regions are 
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3.5.2 Transgene sequencing allows correction of the reference sequence 
The transgene reference sequence, to a large extent, is based on the mouse reference genome 
sequence onto which the end-sequences of BACs, used in the construction of the transgene YAC, were 
mapped. Because the human genome reference was built from a mixture of individuals and the human 
sequences within the BAC will naturally contain polymorphisms, it is expected that the transgene 
reference will contain single nucleotide polymorphisms (SNPs).  
By aligning TLA reads to the transgene reference, single nucleotide mismatches composed of a single 
letter consensus can be observed throughout the transgene. In some instances, the TLA reads also 
highlight several nucleotides missing from the reference (Figure 3-19). More interestingly, there are 
also regions of low coverage, which can be filled using local alignment (Figure 3-20). Taking such 
mismatches into consideration for future work can prove invaluable with, for example, CRISPR-Cas9 
editing of the integrated transgene, since even a single mismatch in the guide RNA targeted sequence 




Figure 3-19: Expected SNPs in TLA data.  
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Figure 3-20: TLA reveals regions differing from the reference sequence. 
End-to-end alignment of TLA reads to the transgene reference sequence produces regions of low coverage. Using local 
alignment, the TLA reads are trimmed/masked which allows parts of the reads (local) to be aligned. The bases that were 
not aligned to the reference are shown over the gap. The consensus formed by these locally aligned reads provides a way of 
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3.6 CTG2 mice primarily utilise distal V genes and have a reduced proportion of 
productive recombination in fraction BC that recovers in fraction C’DE  
I have previously quantified recombination in CTG2 B cells merging fraction BC and C’DE together 
(Figure 3-25). I now wanted to examine the recombination of the two developmental stages 
independently. The random incorporation of nucleotides during the joining of the VDJ gene segments 
can result in out-of-frame rearrangements with a theoretical 2 in 3 chance due to the triple nature of 
codons. From previous experimental data, we know that the proportion of productive to unproductive 
rearrangements in mouse fraction BC is around 1/3 and goes up to 2/3 in fraction D (Bolland et al., 
2016; Ehlich et al., 1994). The same proportions are observed in our mouse WT VDJ-seq data. 
Interestingly, the proportions of productive to unproductive of the human IGH transgene in CTG2 
mouse at fraction BC are considerably lower compared to mouse WT Igh (11% CTG2, 31% WT) (Figure 
3-28). By fraction D, the proportion of productive sequences recovers, reaching almost WT levels (54% 
CTG2, 65% WT). 
 
Figure 3-28: Productive recombination in CTG2 fraction BC is lower than expected, but recovers in fraction C’DE. 
CTG2 mouse with human transgene recombination on the left (mean of BC n=3, C’DE n=2) and WT mouse on the right (mean 




Figure 3-29: Proportion of DJ:VDJ recombination is lower than expected in CTG2 fraction BC, but is re-established in fraction 
C’DE.  
Mean proportions of CTG2 mice are plotted on the left (BC n=3, C’DE n=2) with WT on the right (BC n=2, D n=2). The ratio is 
consistent between biological replicates (CTG2 BC VDJ - 0.55, 0.50, 0.52; BC DJ - 0.45, 0.50, 0.48; CDE VDJ – 0.70, 0.70; CDE 
DJ – 0.30, 0.30; WT BC VDJ – 0.44, 0.42; BC DJ – 0.56, 0.58; D VDJ – 0.76, 0.73; D DJ – 0.24, 0.27) . Sam Rees generated the 
WT datasets. 
The high proportion of unproductive recombination events at fraction BC in CTG2 mice suggests that 
a large proportion of B cells will be required to recombine their second allele. To test this hypothesis 
I examined the proportion of VDJ to DJ recombination events in both fraction BC and C’DE. The 
proportion of VDJ to DJ recombination events in fraction BC has been previously shown to be around 
66% DJ to 34% VDJ (Bolland et al., 2016). If more B cells need to recombine their second allele, the 
proportion of detected DJ recombination events should be lower. In WT fraction BC, only 57% of reads 
were identified as DJ, suggesting that perhaps some of these cells may be from a later fraction. 
Nonetheless, CTG2 fraction BC cells displayed a lower than expected proportion of DJ reads at 48% 
(Figure 3-29). A prerequisite for B cells that progress into fraction D is a productive recombination that 
can be translated into a protein pre-BCR. Therefore, it can be expected that all B cells in fraction D will 
have one productively recombined VDJ allele with a possible combination of a DJ or an unproductive 
VDJ on the other allele. This leads to the ratio of 75% VDJ to 25% DJ that I observed in WT fraction D 
(Figure 3-29) and that also very closely matches the first reported proportion in transformed mature 
B cells, where 40% of cells were shown to have recombined both alleles (70:30 VDJ:DJ) (Alt et al., 
1984). The proportion in CTG2 fraction C’DE is very close to the WT, confirming the ability of the HCAb 
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receptors to support progression from the pro-B (fraction BC) to the pre-B (fraction C’D) stage of B cell 
development, despite generating fewer productive recombination events in pro-B cells.  
Table 3-1: Proportion of VDJ and DJ calls in VDJ-seq data.  
Proportions were rounded to two decimal places. 
VDJ calls DJ calls Fraction Sample type VDJ:DJ 
0.67 0.21 D WT 0.76 0.24 
0.69 0.25 D WT 0.73 0.27 
0.38 0.49 BC WT 0.44 0.56 
0.36 0.49 BC WT 0.42 0.58 
0.16 0.13 BC CTG2 0.55 0.45 
0.20 0.20 BC CTG2 0.50 0.50 
0.18 0.16 BC CTG2 0.52 0.48 
0.25 0.11 CDE CTG2 0.70 0.30 
0.26 0.11 CDE CTG2 0.70 0.30 
 
I additionally wanted to ascertain that recombination between the transgene and the endogenous 
mouse Igh, which still had all VDJ genes, was not taking place. I first checked if merging the human 
and mouse IMGT reference would allow me to distinguish between the two species. The Levenshtein 
distance between human and mouse VDJ genes was great enough that it should be possible to get 
high quality calls for species chimeric recombination (Figure 3-30). I did not find any such reads, 




Figure 3-30: Heatmap of the Levenshtein distances between human and mouse VDJ genes of the IGH.  
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3.6.1 CTG2 mice do not show signs of autoreactive antibodies 
Previous studies suggest that autoreactive BCRs tend to have longer CDRH3 regions compared to non-
autoreactive BCRs and that B cells bearing these BCRs tend to be selected against in humans, favouring 
shorter CDRH3 in the periphery (Kaplinsky et al., 2014; Larimore et al., 2012; Wardemann et al., 2003). 
To further explore the possibility of autoreactive receptors being present within the HCAb repertoire, 
I examined the length and amino acid (aa) composition of the CDRH3. The CDRH3 median length in 
CTG2 mice matches previously reported human productive CDRH3 lengths (14 aa) (Zemlin et al., 2003). 
Surprisingly, the more recent repertoire sequencing study of large pre-B cells from human bone 
marrow (shown above in Figure 3-32) showed the average length of CDRH3 to be 2 aa longer at 16 aa 
(Martin et al., 2016) (Figure 3-33) (the difference is present despite the exclusion of the C and W 
conserved residues from both datasets). The length distributions of productive and unproductive 
recombination were almost identical in CTG2 mice and the mean CDRH3 size of productive 
recombination, on which selection would act, was only marginally higher in fraction C’DE compared 
to fraction BC (Table 3-2). In mouse early stages of development a selection towards longer CDRH3 
was observed in the VH7183 family (Ivanov et al., 2005), which supports the preferential selection of 
marginally longer CDRH3 in CTG2 B cell fraction C’DE (Table 3-2). In contrast, analysis of human 
repertoires, with the use of unproductive recombination as a proxy for pro-B cells (fraction BC), 
showed a preferential selection of shorter CDRH3 sequences (Larimore et al., 2012). This suggests that 





Figure 3-33: CDRH3 size distribution of productive recombination events.  
Dashed lines indicate the median of the distributions. Human large pre-B cell data were obtained from PRJNA39946 study 






Table 3-2: Mean length of CDRH3 in productive and unproductive recombination sequences. 
Productive Unproductive 
Cell type Mean CDRH3 length Cell type Mean CDRH3 length 
Human large pre-B  16.54 Human large pre-B  16.43 
CTG2 BC  14.09 CTG BC  14.01 
CTG2 C'DE 14.26 CTG C'DE  13.95 
Mouse WT BC  12.03 Mouse WT BC  12.55 
Mouse WT D  12.32 Mouse WT D  12.41 
 
Previous studies have shown that autoreactive antibodies have a preferential usage of positively 
charged amino acids, namely the frequent appearance of arginine (Barbas et al., 1995; Köhler et al., 
2008). I next checked whether HCAbs in CTG2 show preferential amino acids usage. As noted in 
previous comparisons of human and mouse antibody sequences, tyrosine (Y) is preferentially utilised 
in mice and somewhat more frequently in CTG2 mice compared to human (Figure 3-34 left and middle) 
(Zemlin et al., 2003). More importantly, arginine (R) is less prevalent in CTG2 then in WT, while 
histidine (H) and lysine (K) are more frequent in CTG2 CDRH3. These residues are only marginally 
different from the human large pre-B CDRH3, suggesting that the differences observed are due to 
species sequence differences rather than selection (Figure 3-34 right). Other residues such as cysteine 
(C), isoleucine (I), threonine (T), valine (V), proline (P), methionine (M) and glutamic acid (E) that have 
been shown to be significantly higher in humans compared to mice are also elevated in CTG2 
compared to WT (Zemlin et al., 2003).  
Altogether, these results suggest that the HCAb repertoire is not preferentially selected for 
autoreactive antibodies. The deleted CH1 domain in CTG2 BCRs that alters the proliferative boost at 
the pre-BCR developmental stage, seems to still enable sufficient signal transduction to sustain 
differentiation into mature B cells without the reported self-specificity of the WT pre-BCR (Köhler et 




Figure 3-34: Comparison of amino acid usage between CTG2 mice and mouse/Human.  
Positively charged amino acids (aa) are highlighted in red and a dashed line. Frequency of each aa was normalised to the 
total aa count for each sample. Human large pre-B cell data were obtained from PRJNA39946 study (Martin et al., 2016). 
3.6.2 The CTCF binding site proximal to V gene RSSs are found at recombination active genes 
in both CTG2 mice and humans 
We have previously shown that the recombination information content (RIC) scores that describe the 
potential of an RSS to recombine, act more like a binary switch, while other chromatin factors 
influence the recombination frequency of individual V genes (Bolland et al., 2016). To examine 
whether RSS RIC scores can explain the recombination frequency of individual human IGH V genes, I 
compared the V gene recombination frequency of large pre-B cells against their respective RIC scores. 
Because pre-B stage B cells have already undergone selection, I have only used unproductive events 
whose frequency should not have been impacted by selection, as they are only passenger events at 
this point (Kaplinsky et al., 2014; Larimore et al., 2012). The analysis reveals that much like in mouse, 
the recombination frequency is not fully explained by the individual V gene RIC scores. Most V genes 
have a high RIC score above -30, meaning their RSS sequence is close to the consensus, and there is 
no clear correlation between RIC score and V gene recombination frequency, either at the highly 
recombining or poorly recombining end of the spectrum. This prompted me to examine the chromatin 




Figure 3-35: The recombination rate of individual V genes is not fully explained by RSS RIC scores.  
RIC score is of the 23-spacer RSSs in humans. RSS scores were obtained from the Recombination Signal Sequence Site 
(https://www.itb.cnr.it/rss/). The recombination frequency of individual V genes were obtained from human bone marrow 
large pre-B cells (Martin et al., 2016). 
There are no available ChIP-seq datasets for human pro-B (fraction BC) bone marrow cells. However, 
CTCF tends to have a highly conserved set of binding sites between different tissues (Holwerda and 
de Laat, 2013). Because of this conservation, the available CTCF binding sites from a human 
lymphoblastoid cell line are likely to reflect the sites in pro-B cells and can act as a proxy dataset. As a 
result, I focused my analysis on CTCF. Much like for the mouse Igh locus, CTCF binding proximal to 
human IGH V gene RSSs is enriched in evolutionary conserved clans II and III (Figure 3-36 top). This 
suggested that the chromatin states uncovered for the mouse Igh may be conserved across species 
and also influence recombination in humans (Bolland et al., 2016). The overlapping binding of 
cohesion (RAD21) with CTCF (Holwerda and de Laat, 2013) also prompted me to analyse the RAD21 
ChIP-seq dataset and examine if the same pattern of clan segregation observed with CTCF held true 
for RAD21. Indeed, clan II and clan III V gene RSSs displayed a more proximal binding pattern compared 
to clan I genes, although to a lesser degree than CTCF (Figure 3-37). Interestingly, the highest density 
of functional V genes is at the same distance as clan II and III V genes (approximately 28-1; 255 bp), 
suggesting that there might be a relationship between CTCF and recombining V genes (Figure 3-36). 
To examine the relationship of CTCF distance and functional V genes, I first plotted the frequency of 
unproductive recombination in large pre-B cells against CTCF distance. The clan II and clan III genes 
that mostly centred around 28 from the RSS turned out to be the dominant recombining V genes 
102 
 
(Figure 3-38 a), suggesting CTCF proximity is an evolutionary conserved feature of these V genes. The 
V genes used in the human CTCF analysis were limited to the V genes present within the CTG2 
transgene. This was to allow a comparison with the human transgene within CTG2 mice, which 
provides a unique opportunity to extend the relationship between CTCF and V gene recombination 
frequency to other more transient chromatin factors such as PAX5 and EBF1. To ensure that CTG2 
mice are a good model for other chromatin marks, I first wanted to validate that the RSS CTCF 
proximity within CTG2 mice still maintains the relationship with recombining V genes observed in 
humans, despite the differences in recombination frequency observed between the transgene and 
human pre-B cell unproductive events (Figure 3-32). Indeed, clan II and clan III V genes within the 
transgene that were recombining at a frequency above expected displayed the same relationship with 
proximal CTCF sites as the human recombination frequency data (Figure 3-38 b). 
Altogether, the pattern of CTCF suggests that the chromatin signatures matching active recombination 
within the human IGH are also present within the transgene. This makes it likely that the same Igh 
chromatin signatures uncovered within mouse pro-B cells are also implicated in the recombination of 
the human IGH. 
Table 3-3: CTG2 mouse phenotype summary table. 
Bone marrow B cell 
development 
Spleen B cell development V(D)J recombination 
↑ varia on in frac on BC B 
cell counts 
↓ transi onal B cells ↓ propor on of produc ve to 
unproductive fraction BC 
↓ frac on D B cells ↓ follicular B cells ⃝ fraction C'DE productive to 
unproductive 
↑ intermediate fraction EF 
B cells 
↑ marginal zone B cells ↓ propor on of DJ to VDJ 
recombination fraction BC 
⃝ fraction F B cell counts ↑ granularity and IgG 
cytoplasmic and vesicle 
staining 
⃝ fraction C'DE DJ to VDJ 
 
⃝ B220/live B cells  
 
 
⃝ weight of spleens 
 
   
↑ Increased   ↓ Decreased   ⃝ Same as WT 
 





(Legend on next page) 
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Figure 3-36: Clan II and Clan III human V genes RSSs have proximal CTCF ChIP-seq peaks compared to Clan I.  
(Top) Each V gene is assigned to one of three clans. If a V gene is not a member of any of three clans it is assigned to the ‘Other’ category. Y-axis marginal density plots highlight the distribution 
of distances for each clan. (Bottom) Each V gene is categorised as functional or non-functional based on the presence of stop-codons or defects in the regulatory elements of the germline 
sequence. More details about the generation of the figure are within the methods section. 
 
Figure 3-37: RAD21 ChIP-seq peaks display the same pattern of proximity to clan II and clan III V gene RSSs as CTCF. 
Each V gene is assigned to one of three clans. If a V gene is not a member of any of three clans it is assigned to the ‘Other’ category. Y-axis marginal density plots highlight the distribution of 






Figure 3-38: Distance of CTCF peaks from V gene RSSs is conserved for recombining V genes.  
Horizontal dashed line indicated the expected frequency based on an even distribution of reads between recombining V genes. 
Top density plot shows distribution of CTCF distances for V genes above the expected threshold. Bottom density plot shows 
the CTCF distance distribution for all genes. CTCF data are from the GM12878 cell line. (a) Unproductive recombination 
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The use of dimensionality reduction techniques allowed the unbiased analysis of flow cytometry data 
and characterisation of B cell development in an HCAb human transgene model. Accumulation of B 
cells was observed at two points during bone marrow B cell development. Fraction BC showed a higher 
number of B cells, while fraction D was severely diminished compared to WT. The expression of the 
pre-BCR at fraction BC represents a major developmental checkpoint. Previous studies with SLC-/- mice 
and pre-BCRs restricted to the cytoplasm showed that these alterations resulted in a leaky pre-BCR 
phenotype and allowed developmental progression with diminished B cell numbers (Conley and 
Burrows, 2010; Ren et al., 2015; Shimizu et al., 2002). A possible cause of the developmental block 
and accumulation of B cells was revealed by repertoire analysis of fraction BC B cells. The repertoire 
analysis revealed a larger proportion of unproductive recombination than expected at this stage of 
development. This suggests more cells had to undergo recombination of the second allele. Indeed, 
the lower proportion of DJ reads in fraction BC supports this notion. Previous studies have shown that 
B cells with both unproductively recombined alleles accumulate in fraction C (Ehlich et al., 1994). The 
accumulation of B cells in CTG2 mice at fraction BC could be explained by a higher number of cells 
failing to recombine either of the two alleles.  
Curiously, the cause of the increased unproductive recombination is not known and had not been 
previously documented in any autoreactive, SLC-/-, LC-/- or HC only models (von Boehmer and 
Melchers, 2010; Ren et al., 2015; Shimizu et al., 2002; Zou et al., 2005, 2007). Interestingly, it has been 
suggested that the recombination machinery of mice works less efficiently on human VDJ genes, based 
on xenomouse models (mice with fully human antibodies) (Longo et al., 2017). Studies of SLC-/- mice 
also revealed a two-fold increase in pro/pre-B-I (fraction BC) cells, suggesting that the increase in CTG2 
mice may simply be the result of the inability of two HCs to dimerise and escape the ER (Kaloff and 
Haas, 1995; Shimizu et al., 2002). It would be interesting to perform repertoire analysis on SLC-/- mice 
to find out if a similar skew in productive to unproductive recombination was present.  
By fraction D, the ratio of productive to unproductive more closely resembles the expected WT ratio. 
However, the count of fraction D B cells is severely diminished compared to WT, as would be expected 
from the SLC-/- and sIgM-/- studies (Nguyen e al., 2015; Shimizu et al., 2002). Switching out the pre-BCR 
with an autoreactive antibody allowed developmental progression as well as proliferation, 
demonstrating the importance of autoreactivity at this stage of development (Köhler et al., 2008). The 
lower fraction D numbers suggests the paired HCs of CTG2 mice are able to signal developmental 
progression, but not proliferation. Repertoire data from fraction C’DE CTG2 B cells did not reveal any 
inclination towards autoreactivity, supporting the notion that the signalling initiated by the HCs is 
different or insufficient to induce proliferation.  
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The lack of proliferation during the autonomous receptor-signalling phase of the HCAb pre-BCR is 
reminiscent of the premature silencing of PI3K by SLP-65 (Figure 1-4). It is conceivable that the 
temporal separation of PI3K activity and the delay in SLP-65 function, suggested to allow proliferation 
in normal development (Herzog et al., 2009), is no longer present with a HCAb pre-BCR. Because the 
pre-BCR and BCR are conceivably identical at both stages of development (fraction BC and E), it is 
plausible that the signalling of the HCAb pre-BCR is indistinguishable from the BCR signalling and B 
cells are rushed through the intervening developmental stages. Analysis of the phosphorylation status 
of key signalling molecules downstream of the pre-BCR could reveal if the conventional pathways are 
utilised in the case of an HCAb pre-BCR (Figure 1-4). 
The second accumulation of B cells was observed between the fraction E and fraction F stages of B cell 
development in the bone marrow. The majority of these intermediate cells did not express detectable 
levels of surface BCR, suggesting these cells constitute bone marrow resident B cells rather than 
peripheral migrants (Pelanda and Torres, 2012). B cells that fail to express the HC receptor on the cell 
surface can get through the pre-BCR checkpoint (Guloglu and Roman, 2006), but most likely fail to 
pass through BCR checkpoint based on the ubiquitous BCR expression on peripheral B cells. The 
signalling exhibited by the HC at the pre-BCR checkpoint is most likely carried over to the BCR 
checkpoint, whereby some form of tonic signalling maintains B cells and allows accumulation instead 
of deletion. The possibility of an autoreactive BCR triggering secondary recombination or V gene 
replacement that might keep a B cells in a prolonged loop due to the lack of a LC is unlikely. This is 
because cells undergoing these processes have been shown to acquire a de-differentiation phenotype 
and resemble earlier fraction B cells rather than an intermediate of more mature B cells (Schram et 
al., 2008; Tze et al., 2005). However, B cells with the intermediate E F phenotype, but lacking IgG 
surface expression could be explained by rapid endocytosis of the IgG BCR that has engaged with 
(auto)antigen (Knight et al., 1997; Song et al., 2016). The levels of autoantigens would be expected to 
be much higher in sIgM-/- mice due to the importance of IgM in cellular debris clearance (Ehrenstein 
and Notley, 2010), and might trigger, to a lesser extent, the BCR without the typical positively charged 
amino acid residues. Subsequently the immature B cells that have internalised their BCR are prevented 
from exiting the bone marrow niche and instead accumulate between immature and mature B cells. 
Repertoire or RNA sequencing of these intermediate B cells may shed more light onto their origin. In 
summary, the alterations in B cell number within the bone marrow developmental fractions is most 
likely a combination of impaired SLC binding, lack of secreted IgM and the signalling of an IgG-BCR that 
does not have a light chain.  
The CTG2 mouse also displayed altered proportions of peripheral B cell in the spleen. Similar to sIgM-/- 
(Baker and Ehrenstein, 2002; Nguyen et al., 2015; Tsiantoulas et al., 2017), CTG2 mice displayed a 
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significant increase in MZ and a decrease in FO B cells. The same observations were also made in mice 
engineered to only express the IgG isoform throughout development (Waisman et al., 2007), but 
because these mice would have lacked a sIgM, the role of IgG-BCR in directing development of 
peripheral B cells is not conclusive. It would be interesting to transfer serum sIgM into IgG-BCR mice 
to examine if the two mechanisms can be untangled (Nguyen et al., 2015). In addition, SLC-/- mice also 
displayed a skew in the number of MZ to FO B cells, caused by a severe reduction in the number of FO 
B cells (Keenan et al., 2008; Ren et al., 2015). The B-lymphopenia observed in these SLC-/- studies does 
not seem to apply to CTG2 mice, where the size of the spleen as well as total B220+ B cells was not 
significantly different from WT. It is thought that the escape of autoreactive BCRs from central and 
peripheral tolerance may be the cause of decreased FO and increased MZ B cells. However, CTG2 
repertoire sequencing did not reveal a skew towards autoreactivity, suggesting that the negative 
selection that resulted in B-lymphopenia in SLC-/- was not in effect in CTG2 mice. Sequencing the 
repertoire of CTG2 MZ and FO B cells could reveal the additional role of peripheral tolerance and 
answer if autoreactive BCRs are observed in the periphery. Experiments monitoring the levels of Ca+ 
flux induced by the CTG2 HC receptors would be ideal to dissect signalling strength that biases 
development into MZ B cell subset. It is tempting to speculate that the lower fluorescence intensity of 
IgG observed in CTG2 mice compared to IgM in WT is an indication of the Ig surface levels and hence 
a proxy for signalling strength. However, the use of different antibodies with potentially different 
titrations prevents a fair comparison. In summary, the alteration of bone marrow B cell development 
and the selection of immature B cells with particular levels of BCR signalling plays an important role in 
guiding development into the different peripheral B cell subsets.  
 















4 Building an analysis package for the unbiased quantification of 
recombination and optimising the VDJ-seq method 
4.1 Background 
The advent of next generation sequencing (NGS) has led to the adaptation and development of 
techniques for the high-throughput interrogation of antigen receptor (AgR) repertoires. The ability to 
sample thousands to millions of recombined sequences is enabling the examination of repertoire 
features, such as alteration of the repertoire during immune response (Hou et al., 2016a) or ageing 
(Martin et al., 2015), and answering fundamental questions about the regulation of recombination 
(Bolland et al., 2016). Understanding the factors regulating recombination at the chromatin level first 
requires an unbiased readout of V gene usage at the DNA level. For this purpose, we developed a DNA-
based NGS technique, VDJ-seq, that quantitatively captures the products of recombination (Bolland 
et al., 2016; Chovanec et al., 2018; Matheson et al., 2017). The technique exploits the fact that each 
recombination contains one of a limited number of J genes, which can be captured after sonication 
with a single round of primer extension using a biotinylated J-specific oligo. The simple capture design 
of VDJ-seq overcomes the need for pairs of primers specific for V and J genes, which produce inherent 
biases (Baum et al., 2012), and enables it to be easily extended to any antigen receptor locus in any 
species with just a set of nested J gene primers.  
One of the challenges in repertoire quantification is distinguishing true diversity from erroneous 
diversity created by PCR and sequencing errors. Each V(D)J-recombination event results in a unique 
sequence through combinatorial joining of the V(D)J gene segments, along with exonuclease nibbling 
and P- and N-nucleotide additions at the junctions between V-D and D-J genes. Additional diversity of 
sequences is produced by point mutations introduced by somatic hypermutation (SHM) during affinity 
maturation. Because of all these natural diversification mechanisms, a single nucleotide error could 
be incorrectly interpreted as a novel clone. The negative impact of PCR and Illumina sequencing errors 
has been extensively examined in RNA based repertoire quantification and methodologies to 
overcome them using unique molecular identifiers (UMIs) have been implemented (Bolotin et al., 
2012, 2013; Shugay et al., 2014). UMIs usually consist of randomly generated sequences with high 
diversity, generally 8-12 bp in length, that are used to uniquely barcode individual DNA or RNA 
molecules (Fu et al., 2011; Greiff et al., 2015; Kivioja et al., 2012). Because of diversity overestimation 
through sequence errors, the importance of UMI use for AgR repertoire analysis has been highlighted 
in many recent studies. However, such approaches have been lacking for DNA-based repertoire 
quantification. To my knowledge VDJ-seq is the first DNA-based repertoire sequencing method to take 
advantage of UMIs (Wardemann and Busse, 2017).  
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VDJ-seq can quantitatively capture both productive and unproductive VDJ, DJ and even abnormal 
recombination events. This makes it a valuable tool for the study of the primary output of V(D)J 
recombination and repertoire selection in wildtype and knockout models. Most assays developed for 
profiling AgR repertoires utilise RNA instead of DNA and therefore are only able to capture productive 
and not yet degraded unproductive VDJ recombination. The higher abundance of RNA of the same 
recombination event within a single cell results in RNA-based assays having better sensitivity. The 
widespread use of RNA has also resulted in the creation of dedicated analysis tools that take 
advantage of the multi-copy nature of RNA to correct early PCR errors in addition to the more 
frequently observed PCR and sequencing errors (Chaudhary and Wesemann, 2018; Shugay et al., 
2014). However, DNA-based approaches also have additional advantages over RNA. The RNA output 
from a recombination event varies by orders of magnitude between cells. The different activation 
states of a cell, differences in mRNA stability along with V gene promoter strength, which stems from 
the evolutionary V gene family of origin, all contribute to the varying levels of RNA (Bolland et al., 
2016; Choi et al., 2013a; Love et al., 2000; Wardemann and Busse, 2017). As a result, a single 
contaminating antibody secreting B cell or a strong promoter can easily skew or mask the actual 
repertoire. It is for this reason that most of the RNA-based repertoire analyses are confined to groups 
of identical CDR3 and VJ gene sequences (clonotypes). In contrast, each productive recombination 
event is present at only a single DNA copy within a cell, allowing VDJ-seq to provide a true picture of 
clone numbers within the captured repertoire. 
Despite the many advantages of VDJ-seq (Bolland et al., 2016; Chovanec et al., 2018; Matheson et al., 
2017), there are several limitations that are worth noting. First, as with all DNA-based repertoire 
sequencing methods, the linear distance between the VDJs and the constant region exons prohibits 
their amplification and sequencing and therefore prevent the assignment of isotype to the captured 
VDJ recombination events. Second, the capture of target sequences using J oligos means that all 
unrecombined germline J DNA fragments will also be pulled-out and sequenced. Thus, a large portion 
of the library will contain uninformative reads. The initial VDJ-seq method included a depletion step 
where a second primer extension step, with biotin oligos positioned in the intronic regions between J 
genes, was used to remove germline DNA fragments. Despite this depletion step the final libraries still 
contained a large number of germline reads (Bolland et al., 2016; Matheson et al., 2017). 
Nevertheless, the germline reads proved essential for the implementation of mispriming correction in 
the analysis pipeline (see section 4.4) and together with VDJ and DJ recombination they provide a 
complete status of recombination within a population of cells (see section 4.3), which is important in 
studies focusing on impaired recombination. Third, a limitation of all bulk-population AgR-seq 
methods is the inability to capture the pairing information of TCRα-TCRβ, TCRγ-TCRδ and of the Igh 
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heavy-light chains. To address this shortfall, single-cell methods have been developed that either 
merge the mRNA transcripts from the two loci using overlap extension PCR (DeKosky et al., 2013; 
McDaniel et al., 2016) or generate cDNA with template switch oligos in droplets containing cell 
barcodes, which allow the two chains to be linked in-silico (10x Genomics). Although single-cell 
methods are likely to be the future of repertoire profiling, the current implementations still require 
specialised equipment, high capital investment and substantial consumables costs that prohibit their 
widespread use (Dunn-Walters et al., 2018). A final limitation of VDJ-seq stems from its use of 
sonication to derive a set of fragments that is below the 1 kb limit of efficient cluster formation of 
Illumina sequencers. An optimal size of 500 bp was chosen for the Igh, while 400 bp was enough for 
the Igκ due to its smaller recombinant size. The size allows the 300 bp paired-end chemistry to 
sequence the full length of fragments. However, the random nature of sonication results in the 
majority of captured VDJ sequences to not contain a full-length V gene sequence. This does not pose 
a problem for obtaining a complete CDR3 and assembling clonotypes, but it can limit the 
characterisation of somatic hypermutation within the CDR1 and CDR2 regions of the V gene. Despite 
these limitations, VDJ-seq is a powerful new tool for examining antigen receptor repertoires, 
harnessing the advantages that come with using gDNA as the starting material.  
4.2 Aims 
The current VDJ-seq protocol is limited to large quantities of material, preventing the analysis of rare 
populations of B cells. Existing repertoire sequencing protocols have highlighted the prevalence of PCR 
and sequencing errors that can cause artificial inflation of a repertoire’s diversity and have 
demonstrated the importance of UMIs in tackling this challenge. In addition, UMIs provide a simple 
molecule counting method through which true biological duplicates can be distinguished from PCR 
duplicates. The lack of a UMI or the presence of an insufficiently diverse UMI have limited the 
quantitative power of VDJ-seq.   
Additionally, the current analysis pipeline does not address the issues of PCR and sequencing errors 
and mispriming observed between all the J gene primers. The removal of PCR duplicates is the only 
current use of UMI sequences, which underutilises their additional ability to discriminate chimeric and 
artefactual reads from true recombination events and obtain a high-quality consensus sequence.  
 To address the current limitations of VDJ-seq and the analysis pipeline I sought to: 
1. Optimise VDJ-seq for low input samples with a sufficiently diverse UMI and establish 
required levels of over-sequencing that would enable error correction. 
2. Construct a comprehensive analysis pipeline that enables error correction, artefact 
sequence removal and accurate quantification of clonal sequences.  
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4.3 The optimisation of VDJ-seq 
The initial VDJ-seq was established using large amount of starting DNA (5-10µg) that meant it was 
limited to samples from which high numbers of B cells could be enriched. The ability of VDJ-seq to 
accurately quantify clone numbers makes it ideally suited for studies of clonal expansion, immune 
dysfunction and a host of other potential clinical applications (Georgiou et al., 2014). But to profile the 
limited quantities of material usually obtained from clinically relevant samples, I first needed to 
establish an optimised VDJ-seq protocol that produces reproducible results from low starting material. 
I took a systematic approach to optimise each step of the protocol were possible (Figure 4-1).  
The first change to the protocol was the use of the New England Biolabs (NEB) end-repair, A-tailing 
and ligation mix that allows all three reactions to be performed sequentially within a single tube 
(Figure 4-1). This removed two clean-up steps during which it is common to lose around 10-20 % of 
material. The purification after adaptor ligation was switched from QIAquick PCR purification columns 
to AMPure XP beads as the magnetic beads were able to remove higher amounts of unligated 
adaptors. To test the impact of different polymerases on the final VDJ-seq library I performed 
experiments with three polymerase combinations using the same starting material. One of the 
combinations involved switching the primer extension polymerase Vent (exo-) for the Q5 high-fidelity 
polymerase. The capture efficiency, quantified as the number of final VDJ reads divided by a 
theoretical total based on the starting material, was lower when the Q5 polymerase was used for both 
primer extension and the two rounds of PCR (Q5/Q5 1 µg) compared to the combination with Vent 
(exo-) (Vent/Q5 1 µg) (Figure 4-2 a). Despite the lower capture efficiency, the Q5 polymerase did 
produce reads with fewer errors (Figure 4-2 b). But, as these can be corrected using the UMI groups, 
it is better to have high capture efficiency by sticking with the Vent (exo-) polymerase for primer 
extension and using the Q5 for the two round PCR (Figure 4-2 a). With increasing starting material, 
the capture efficiency also seems to improve, reaching around 10% for 10 µg (data not shown). To 
further limit the loss of material I removed the steps used for depleting unrecombined fragments using 
the primer extension of the germline J gene regions with biotinylated primers. I reasoned that based 
on the efficiency of the primer extension capture and the dominance of germline reads in libraries 
prepared with a depletion step, only a small portion of germline sequences are being effectively 
removed, while the additional steps result in loss of material that could be detrimental to low material 
samples. The retention of germline reads also allows the analysis of the complete recombination 
status of a population of cells without the skew of germline depletion. Finally, a 12 N UMI adaptor was 
introduced to replace the previous 6 N adaptor, which I found out contained insufficient diversity for 
it to be solely used for grouping and deduplicating reads. Overall, these optimisations of the VDJ-seq 
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protocol allowed library generation from as little as 500 ng starting material, which is approximately 
equivalent to 100,000 cells. 
 
 
Figure 4-1: Optimised VDJ-seq assay for low starting material.  
For low starting material samples, the end repair, A-tailing and adaptor ligation are performed in a single tube to reduce 
material loss. A new longer (12 N) UMI is used. The depletion of germline reads performed previously (Bolland et al., 2016; 
Matheson et al., 2017) has been removed, as the additional steps lead to material loss which outweighs the gain in final 
library purity. In addition, the number of PCR cycles along with the required sequencing depth have been optimised to produce 






Figure 4-2: The choice of polymerases impacts capture efficiency and the amount of errors within reads.  
(a) With increasing starting material, the capture efficiency of VDJ-seq sequences also increases. The capture efficiency was 
calculated as the amount of final VDJ products captured over the total theoretical sequences expected base on the starting 
material. The use of the Vent (exo-) polymerase for primer extension along with the Q5 high-fidelity polymerase (Vent/Q5) 
produced a 1% higher capture efficiency compared to the Vent (exo-) and Pwo polymerase combination (Vent/Pwo). The use 
of the Q5 polymerase for primer extension is less efficient than Vent (exo-) as illustrated by the almost 2% decrease in capture 
efficiency when the Q5 polymerase is use for both primer extension and the subsequent PCRs (Q5/Q5). (b) The number of 
mismatches between sequences of a UMI group and the consensus sequence of that group can be used as an estimate of the 
errors generated during the library preparation process. The combination of the Q5 polymerase for both primer extension 
and PCR results in the lowest number of errors within reads, while the Vent (exo-) and Pwo polymerase combination produces 
the most within read errors.  
To establish the versatility of VDJ-seq for different amounts of starting DNA, I generated libraries from 
500 ng, 1 µg, 2.5 µg and 5 µg. From previously made VDJ-seq libraries, we roughly knew the required 
amount of amplification needed to generate an optimal library concentration (=> 2 nM) from samples 
in range of 1 µg - 10 µg. To ensure the level of sequencing was enough to allow the correction of PCR 
and sequencing errors, I first examined the duplication level within the four libraries (Figure 4-3 a). 
The duplicate distribution for each library showed a clear peak at around 10-15 reads per UMI group, 
with just the left most tail falling off the plot. This reassured me that the majority of UMI groups 
contained enough reads. I next extrapolated the level of additional unique UMIs expected to be 
observed with more sequencing depth using species accumulation curves from the preseqR package 
(Deng et al., 2015) (Figure 4-3 b). The extrapolation (Figure 4-3 b - dashed line) demonstrated that the 
current sequencing depth (Figure 4-3 b - solid line) already surpassed the inflection point of the 
accumulation curve and therefore shows that only marginal gains in new UMIs would be obtained 




Figure 4-3: A range of starting materials demonstrate the versatility of VDJ-seq.  
(a) Levels of duplicates present in VDJ-seq libraries made from different amounts of starting material. UMI groups with high 
number of sequences are desired, as they allow the high confidence correction of PCR and sequencing errors. The read counts 
shown are after removing sequences that diverged from the consensus sequence (good-to-total ratio filter). The vertical 
dashed line shows the reads that will be filtered by the low UMI read count cutoff (UMI group with two or fewer reads will be 
removed). (b) To examine the levels of over-sequenceing present within the different starting material libraries, the preseqR 
(Deng et al., 2015) package was used to estimate the number of additional unique UMIs that would be observed with more 
sequencing (dashed line), based on the observed UMIs (solid line). (c) Number of final VDJ sequences in spleen B cells obtained 
from different quantities of starting material. The number of VDJ sequences will vary depending on the population of B cell 
sequenced. 
The expected ratio for spleen B cells of 2:1 productive to unproductive recombination events is 
obtained from all four libraries, with the 500 ng starting material library still capturing nearly 10,000 
118 
 
VDJ recombination events (Figure 4-3 c). The ratio, along with the high reproducibility of V gene usage 
between high and low amounts of starting material (5 µg vs 500 ng; r2 = 0.989), suggests that low DNA 
concentrations do not introduce noticeable biases into the final VDJ-seq library (Figure 4-4 a). I did not 
make any libraries with less than 500 ng starting material, as I reasoned that for 20000 cells (100ng), 
based on a 7% capture efficiency, one would expect to capture 1400 VDJ sequences, 933 productive, which 
given the large dynamics range of recombination frequencies observed within a diverse repertoire (200 
fold for mouse Igh) would result in dropouts, making V gene usage statistics possible only for highly 
recombining V genes. However, there is nothing in the VDJ-seq protocol that would prevent starting 
from lower amounts (100 ng) with an increased number of PCR cycles, ultimately making it possible 
to analyse rare populations such as plasma cells. 
The relatively low capture efficiency of VDJ-seq and the high diversity of antibody repertoires results 
in a very low clonotype overlap between technical replicates (Figure 4-4 b). This shows that a different 
portion of the vast repertoire is captured within each technical replicate. Even samples made using 
high amounts of starting material share very few clonotypes (a 0.45% overlap between 5 µg and 2.5 
µg samples). This opens the possibility of performing multiple technical replicates as a way of recovery 
a large portion of the total repertoire.  
4.3.1 VDJ-seq outperforms other DNA based repertoire sequencing methods 
Besides VDJ-seq, there are two other repertoire sequencing methods that use DNA instead of RNA for 
the capture of recombination. The initial studies of repertoire were performed using a large set of V 
and J primer pairs. These methods were later adapted for use with next generation sequencers, 
allowing the examination of thousands of sequences at once (Georgiou et al., 2014). To compare VDJ-
seq with these earlier methods, I started off by examining the functional V gene usage quantified by 
VDJ-seq and a VJ primer based method (Kaplinsky et al., 2014). The comparison revealed a high 
number of differences (Figure 4-5 a and Figure 4-6 a). Several genes detected by VDJ-seq were absent 
from the VJ primer dataset, while other that were highly recombining according to VDJ-seq were only 
lowly detected using VJ primers. This is perhaps not surprising given the varied amplification efficiency 
of each primer pair and possible primer cross-reaction (Kaplinsky et al., 2014; Wardemann and Busse, 
2017). A more recent DNA-based technique that has adapted a genome-wide translocation 
sequencing assay (LAM-HTGTS) (Hu et al., 2016) for repertoire sequencing (HTGTS-Rep-seq, same 
principle of J gene primers with the addition of linear amplification and single stranded adaptor 
ligation) (Lin et al., 2016) shows high agreement in V gene usage with VDJ-seq (Figure 4-5 b and Figure 
4-6 b). However, the absence of UMIs or a deduplication step in the HTGTS-Rep-seq analysis pipeline 
resulted in a high number of identical sequences in the final dataset. I attributed these sequences to 
be PCR duplicates as naïve spleen B cells do not tend to have high clonality (Silva and Klein, 2015). 
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Because I could not definitively exclude the possibility that they represent clonal sequences, I chose 
to perform a clonotype comparison between VDJ-seq and HTGTS-Rep-seq. The number of clonotype 
groups obtained from comparable amounts of starting material was 2-5 times higher in VDJ-seq 
compared to HTGTS-Rep-seq, demonstrating that VDJ-seq has a greater capture efficiency than 
HTGTS-Rep-seq (Figure 4-6 c). In summary, these comparisons highlight some of the advantages of 
the unbiased repertoire capture produced with VDJ-seq, compared to other DNA-based repertoire 
sequencing methods.  
 
Figure 4-4: VDJ-seq produces highly reproducible libraries from different amounts of starting material.  
Data was generated using B cells enriched from two pooled 12-week-old C57BL/6 female mouse spleens. (a) The proportion 
of each V gene observed within VDJ-seq libraries is consistent between low and high starting material samples. (b) Venn 
diagrams depicting clonotype overlap between libraries prepared from different amounts of starting material. The clonotypes 





Figure 4-5: V gene usage of spleen B cells observed with VDJ-seq and two other DNA-based methods.  
The thicker bars highlight V genes missing in one of the samples. (a) Repertoire data generated from follicular B cells using a cocktail of VJ primers (Kaplinsky et al., 2014) compared to data 
generated with VDJ-seq from total spleen B cells. The VJ primers fail to capture several V genes across the mouse Igh locus. (b) Repertoire data generated from 2 µg of starting material extracted 
from spleen B cells using the HTGTS-Rep-seq method (Lin et al., 2016) compared with 5 µg startin material VDJ-seq library. The absence of the Ighv1-62-2 gene from the HTGTS-Rep-seq sample 





Figure 4-6: Further comparison of VDJ-seq to other DNA-based repertoire sequencing methods.  
(a) The proportions of V genes captured with the VJ primer cocktail method have a low agreement with VDJ-seq. (b) Unlike 
the VJ primer cocktail, VDJ-seq and HTGTS-Rep-seq have high agreement of V gene usage when comparing libraries made 
from similar starting material. (c) HTGTS-Rep-seq data contains many identical sequences, which I interpreted as PCR 
duplicates as naïve spleen B cells are not expected to have high clonality. As a result, I chose to compare the number of 
observed clonotypes captured with each assay. VDJ-seq with equivalent starting material captures a much higher number 
clonotypes compared to HTGTS-Rep-seq. 
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4.4 The BabrahamLinkON pipeline for the analysis of VDJ-seq data 
The herein described BabrahamLinkON pipeline (available on:    
https://github.com/peterch405/BabrahamLinkON) builds upon earlier work done by Felix Krueger 
(Bolland et al., 2016; Matheson et al., 2017) with contributions from Dan Bolland, Louise Matheson, 
Bryony Stubbs and Amanda Baizan-Edge. The initial pipeline was designed for mouse Igh and Igκ 
recombination. Mispriming correction was limited to the most frequent mispriming event between 
J2-J4 in the Igh, while for the Igκ a more extensive find and replace strategy was used. Subsequently, 
deduplication was performed based on the unique sequence 60bp downstream of the J primer and 
the V read start position for the Igh. Because of the lower diversity of the Igκ locus, an additional 6bp 
UMI with two anchor sequences were implemented (Matheson et al., 2017). The deduplication of Igκ 
reads uses the UMI with a single bp from the barcode, along with 20 bp from the J end read. The 
annotation of V segments was performed by bowtie (Langmead et al., 2009) alignment of V end reads 
to the mouse reference genome or with IMGT/HighV-QUEST (Alamyar et al., 2012). Despite the well-
suited nature of the pipeline for V gene quantification, the desire to perform more in-depth 
quantitative analysis, such as clone analysis and assembly of clones into clonotypes, raised the need 
for a new pipeline.  
The new pipeline divides the analysis of VDJ-seq data into three main stages: precleaning (orange), 
deduplication (green) and annotation with clone assembly (blue) (Figure 4-7). Aspects of each stage 
of the pipeline are described in more detail in the sections to follow. The precleaning stage of the 
pipeline first attempts to assemble the paired-end reads using the Paired-End reAd mergeR tool 
(PEAR) (Zhang et al., 2014). For reads obtained from 300bp paired-end sequencing runs, the assembly 
of reads tends to be above 95% (Figure 4-7). Germline sequence, sequences with low quality bases 
(Phred Q2; Phred is a measure of quality used in DNA sequencing; Q2, compared to other scores that 
predict an error rate, is an indicator that a certain portion of the read should not be used in further 
analysis) or sequences with UMIs containing bases with Phred quality scores of less than Q30 (a 1 in 
1000 probability that the base is incorrect; 99.9% accuracy) are all filtered out. The majority of a VDJ-
seq library will consists of germline reads (63.4%; Figure 4-7). Subsequently, J gene mispriming 
correction is performed and the J identity, along with the extracted UMI and anchor sequence are 
placed in the read name of each sequence in the output fastq file (Figure 4-8). The extracted UMI and 
anchor sequence is trimmed away as it is no longer needed within the read sequence (Figure 4-10 a). 
The anchor sequence is designed to secure the 3’ end of the P7 adaptor oligonucleotide, allowing the 
UMI random nucleotides to form a bubble between the two stretches of double-stranded DNA. This 
allows the P7 adaptors to be efficiently ligated to A-tailed DNA. A pair of anchors is used to ensure a 
signal is generated in both the red (A/C nucleotides) and the green (G/T nucleotides) laser channels of 
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the Illumina sequencers. Based on the pair of anchors, the sequences are split into two groups that 
are deduplicated separately of each other.  After precleaning, around 20% of the starting reads are 
left and ready for deduplication (Figure 4-7).  
 
Figure 4-7: BabrahamLinkON analysis pipeline overview.  
The pipeline is divided into three main stages. The first step involves assembly of paired-end reads into a single contiguous 
read, cleaning the data and correcting mispriming events (orange: precleaning). The UMI is also extracted from the reads at 
this stage and placed into the read name. Next, the reads are grouped according to their UMI sequence and a consensus 
sequence is derived. A set of criteria such as divergence of sequences in a UMI stack also filters incorrectly grouped 
sequences, chimeric reads or reads with substantial PCR and sequencing errors (green: deduplicate). Finally, the VDJ and DJ 
reads are annotated using IgBlast (blue: annotate and assemble). There are many tools that perform annotation and clone 
assembly and the output fasta/fastq from the deduplication stage can be used with any of them. The read percentages at 
each stage are based on a 5µg starting material sample from B cells enriched from the spleen of a female 12-week-old 
C57BL/6 mouse. The annotation was not performed for DJ recombination events, meaning most of the reads being removed 





Figure 4-8: Information deposited into the read name during different stages of the pipeline.  
The information required for deduplication is extracted at the precleaning stage and placed into the read name. This includes 
the anchor sequence and the UMI. In addition, the J gene identity from mispriming correction is included and can be used to 
verify J gene annotation in the last stage of the pipeline. For short reads the V gene identity based on Bowtie 2 alignment is 
also included. At the deduplication stage, the number of duplicates for each output read is written into the read name. This 
gives the user the flexibility to filter reads later based on their duplicate count. 
The majority of reads within a VDJ-seq library are duplicate sequences (86.7%) of the base (13.3%) 
reads that form the foundation of each unique UMI group (Figure 4-7). After bundling the reads with 
identical UMI sequences, a multiple sequence alignment (MSA) is performed using Kalign2 (Lassmann 
et al., 2009). The MSA allows a consensus sequence to be derived for each UMI group, forming the 
basis of the good-to-total ratio (gt-ratio) filter that was inspired by the MiGEC tool (Shugay et al., 
2014). The gt-ratio works by first determining the hamming distance of each sequence within the UMI 
group compared to the consensus sequence. The hamming distance represents the number of 
positions in which two strings of equal length differ (mismatches). Sequences with a hamming distance 
of less than 5 (default setting) are marked as good sequences and a ratio of good to total sequences 
(by default 1; all sequences need to be less than 5 from consensus) for each UMI group is used to filter 
out ones with divergent sequences (Figure 4-7). A minimum of three sequences within each UMI group 
is required to reach a consensus, with each additional sequence increasing the consensus confidence. 
For this reason, over-sequencing of VDJ-seq libraries is desired. UMI groups with low sequence counts 
may be the result of errors within the UMI sequence and therefore low count UMI groups are also 
filtered out into a separate file (Figure 4-7). The same strategy has been previously used in RNA based 
repertoire sequencing methods where early PCR errors and errors introduced during cDNA synthesis 
result in UMI groups that cannot be confirmed by another independent RNA, resulting in so-called 
clonotypes singletons (Shugay et al., 2014; Turchaninova et al., 2016; Yaari and Kleinstein, 2015). 
Depending on the sequencing depth and library diversity of a sample, an optimal sequencing depth 
may not always be achieved. The read count of each UMI group is written into the read name of each 
output consensus sequence (Figure 4-8). This allows more stringent downstream filtering, in cases of 
enough over-sequencing, or the inclusion of low count UMI groups in cases of insufficient over-
125 
 
sequencing. After deduplication, around 9% of error corrected and deduplicated reads are written out 
in either fasta or fastq format, ready for annotation and clonetype assembly (Figure 4-7).  
The final stage of the BabrahamLinkON pipeline is performed using IgBlast v1.7.0+ (Ye et al., 2013) 
with the IMGT (internation ImMunoGeneTics information system) database and the Change-O v0.3.7+ 
(Gupta et al., 2015) IgBlast output parser for annotation. However, the output of the deduplication 
stage can be used with any of the publicly available annotation tools (Alamyar et al., 2014; Bolotin et 
al., 2015; Gaëta et al., 2007; Munshaw and Kepler, 2010; Ralph and Matsen, 2016; Ye et al., 2013). In 
addition to the IMGT reference, a custom D gene germline reference has been constructed that allows 
annotation of DJ recombination events. The reference is based on the human DJ reference concept 
first introduced by Duncan K. Ralph for the Partis annotation tool (Ralph and Matsen, 2016). The idea 
is to use the D germline sequence as a pseudo V gene that allows its seamless use in tools solely 
designed for VDJ annotation. After the IgBlast results are parsed with Change-O, sequences without 
or with a low score V or J call are removed along with sequences without a CDR3. Each sequence is 
assumed to arise from an individual cell and the expansion of each cell during B cell development gives 
rise to a pool of clones that all contain the same recombined sequence. At this stage of the pipeline, 
the clones are assembled together into a clonotype using their V and J gene annotation along with 
their CDR3 length and nucleotide composition. A single nucleotide mismatch between the CDR3 of 
clones that will be grouped/assembled is allowed by default. The clone assembly assigns a unique tag 
to each clonotype group, preserving the IgBlast annotation of each sequence/clone. This contrasts 
with RNA based tools, which tend to output only clonotype groups, as assigning an individual sequence 
to a single clone cannot be made due to the multi-copy nature of RNA. After annotation and clonotype 
assembly, around 60% of sequences are annotated as VDJ and are returned in a tab-separated file 






Figure 4-9: The composition of a DNA fragment in a VDJ-seq library.  
(a) The final library contains DNA fragments with a P7 and P5 adaptors required for sequencing. In the P7 end, 50% of the 
library contains one of the two anchor sequences along with a 12N (random nucleotide) UMI. The P5 end contains the Illumina 
index for multiplexing samples. In samples prepared without an anchor-UMI it is possible to use the sonication variability in 
the V region along with the junctional diversity as a proxy UMI. (b) A mean coverage plot over the V region illustrates the 
variable V length produced by sonication.  
The BabrahamLinkON pipeline is designed to accommodate four different forms of input data, 
depending on library preparation and sequencing length used. The latest generated libraries use a 12N 
UMI and are sequenced using long 300 bp paired-end sequencing runs (Figure 4-9 a). The long reads 
allow a straightforward read assembly and deduplication that is solely based on the diverse UMI 
sequence (the umi pipeline; Figure 4-10 a). However, extensive datasets have been generated within 
the lab using several different iterations of the VDJ-seq method. To be able to make use of all this 
data, three additional pipeline options have been created (Figure 4-10). I designed the first of these 
options (short) to accommodate short reads that cannot be assembled and that do not contain an 
anchor-UMI sequence (Figure 4-9 b). These types of samples represent the initial datasets generated 
with VDJ-seq (Bolland et al., 2016). Due to the lack of overlapping sequence, the primary analysis 
focuses on the J end reads. The V end reads are primarily used for their sonication variability proxy 
UMI and the more confident V gene annotation that can be attained from them. My initial analysis of 
this data using the gt-ratio filter revealed that the sonication variability alone contained insufficient 
diversity. Much like the previous pipeline, I chose to include a stretch of basepairs that roughly 
overlapped one of the highly diverse junctions form the J end read (Figure 4-10 b). In later iterations 
of VDJ-seq, a 6 N UMI with anchor sequences was added (Matheson et al., 2017), which required a 
separate pipeline option (short_anchor) (Figure 4-10 c). Although 6 N alone was still not diverse 
enough for some samples, the additional inclusion of the sonication variability proved to create a 
sufficiently diverse UMI for many UMI groups to pass the gt-ratio filter. The final pipeline option 
(no_anchor) is to accommodate long reads without an anchor-UMI (Figure 4-10 d). This option is 
only available in the deduplication stage of the pipeline and is a cross between the long reads in the 
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umi pipeline option and the proxy UMIs from the short pipeline option. Altogether, the 
BabrahamLinkON pipeline can handle a diverse range of starting sequences and use cases depending 
on the experimental design. 
 
Figure 4-10: The four different use cases of the BabrahamLinkON pipeline.  
(a) The latest and recommended version of VDJ-seq, which always contains at least a 12 N UMI and sequenced using longer 
than 250bp paired-end sequencing, should always be used with the umi option of the BabrahamLinkON pipeline. This option 
exclusively uses the UMI for deduplication and error correction. In cases were the UMI is short (e.g. 6 bp), basepairs beyond 
the anchor sequence that contain variability arising from sonication can be added to the UMI. (b) Short reads that cannot be 
assembled and do not contain an anchor-UMI are processed with the short option of the BabrahamLinkON pipeline. A proxy 
UMI is constructed from the V end sonication variability and part of the junction in the J end read. The junction sequence by 
default is taken 50 bp into the J end reads. (c) In cases where short reads do contain an anchor-UMI, this can be used for 
deduplication much like in the umi option. These reads are processed using the short_anchor option of the pipeline. (d) 
For long reads that can be assembled, but do not contain an anchor-UMI, the no_anchor option can be used. Much like the 
short option, the no_anchor option uses the sonication variability and the junctional diversity to construct a proxy UMI. 
4.4.1 High homology of J genes results in primer mispriming 
Quantitative analysis of clonal counts and clonotype assemblies required a computational solution to 
several issues not addressed by the previous pipeline. Namely, the mispriming of J sequence results 
in the wrong annotation of the J genes. The J gene identity is subsequently used for clonotype 
assembly, which in the case of misprimed sequences leads to the creation of a new clonotype group 
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that incorrectly inflates the diversity observed. To better understand the extent of misprimng, I 
derived the true identity of germline reads by aligning them with Bowtie 2 (Langmead and Salzberg, 
2012) to a reference genome. Trimming off the primer sequence is desirable to get a higher quality 
alignment but is not essential. Subsequently, I aligned the start of each read to a custom reference 
composed of the J gene primers separated by a string of 6 N characters using the stripped Smith 
Waterman (SSW) algorithm implemented in the python scikit-bio package (scikit-bio.org) (Figure 
4-11). The true identity along with the primer identity allowed me to quantify the extent and 
characterise the nature of each mispriming event. Most reads fall onto the diagonal, which represent 
the correct primer amplifying its target J gene (Table 4-1). When I examined the J2 primers, I observed 
that they were priming the J4 gene (137895) at comparable levels to the target J2 gene (137249). This 
corresponded to the only mispriming event corrected by the previous pipeline. However, besides the 
J2-J4 event, other primers were frequently observed within germline sequences of genes they were 
not intended to amplify. A prominent example of this is the J3 primer amplifying the J4 gene at 
comparable levels to the J2-J4 mispriming event (Table 4-1). This analysis highlighted the need for a 
more comprehensive mispriming correction method.  
Table 4-1: The extent of mispriming of J genes estimated from germline reads.  
The true identity of a germline read is attained from its alignment to one of the four J genes in the mouse. By performing an 
alignment of the sequence corresponding to the length of the primers, the identity of the primer that amplified a read can be 
determined. By comparing the true identity with the primer identity, it is possible to quantify the level of mispriming.  
Before mispriming correction  
True identity   
J1 J2 J3 J4 
Misprimed 
J1 253633 3843 84 2030 
J2 1605 137249 50630 137895 
J3 23442 72114 465244 134353 
J4 480 44315 17280 558753 
 
Examining mispriming in germline reads revealed that in most cases the mispriming of each J gene 
happened in a consistent manner and leaves a portion of the true J gene behind. I chose to use a 
stretch of 5 bp of the unchanged J gene sequence to find the original J gene identity. The procedure I 
devised for mispriming correction starts by using the first 5-10 bps of each J end read to identify the J 
primer (Figure 4-12). The identification is performed using Levenshtein distance 
(https://github.com/ztane/python-Levenshtein/) which corresponds to the number of operations 
required to transform one string into another string of equal or different length. The initial identity is 
used to align the expected length of each J primer to the primer reference. I have found that limiting 
the length of the sequence being aligned limits false alignments.  
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Figure 4-11: Alignment of the mouse Igh J primer sequences from each read allows the correction of mispriming.  
The reference sequence contains along with the J gene primer sequence an additional 5 bp that can be used to identify the 
misprimed J gene. Each J primer sequence is separated by a string of 6 N characters. By aligning germline reads to the 
reference genome it is possible to determine the original J gene that was extended and captured. The alignment of the primer 
sequence within each read was performed using the stripped Smith Waterman algorithm. This allows the identification of 
sequences that contain insertions/deletions (indels) or mismatches as illustrated by the J1 primer in the J1 true reads. The 
sequence identifying the true J identity is highlighted in bold with vertical grey lines tracing it back to the reference.  
If the initial J identity matches the aligned reference J, a set of offsets are used to locate the position 
of the 5 bps that match the true J gene. The offsets are determined by the distance from the end of 
each J reference to the start of the 5 bp used for mispriming correction (Figure 4-11 and Table 4-2). 
For every sequence with an identifiable J primer, a 5 bp sequence is extracted for each J gene based 
on the expected location of the true J gene sequence, which is subsequently compared with a 5 bp 
reference for that J gene. The comparison is performed using Levenshtein distance and the gene with 
the 5 bp sequence of zero distance is used to correct the primer sequence. Primer sequences with 
indels and mismatches are also corrected (Figure 4-11) and the final identity of the J sequence is 
written into the sequence read name (Figure 4-8). 
During mispriming correction there is a small number of reads that escape correction and are 
incorrectly assigned a J gene sequence (Table 4-3). In rare cases where two or more J genes have a 
perfect match 5 bp sequence, the reads are marked as multi-hit sequences (Figure 4-12) and are 
filtered out by default at the beginning of deduplication. In addition, a certain proportion of sequences 
that do not have a perfect match to any of the 5bp J gene reference sequences are marked as unclear 
(Figure 4-12). The lack of a perfect match could be caused by several mechanisms such as PCR and 
sequencing error within the 5 bp sequence or chewback from the NHEJ machinery (discussed in the 
next section). Because these unclear sequences still represent legitimate recombination products they 
are by default retained in downstream analysis. The J gene mispriming takes place during the first 
round PCR (Figure 4-1), which means a single UMI group will contain a mixture of both correct and 
misprimed sequences. Because the misprimed sequences are typically less frequent than correctly 
primed sequences, especially after mispriming correction, it is expected that by collapsing a group of 
sequences within a UMI group into a consensus sequence the J misprimed sequence minority will be 
corrected. Indeed, the analysis of the true vs misprimed reads after deduplication and consensus 
sequence construction shows that only a small number of incorrect J identity reads remain (Table 4-3). 
The same is true for the germline unclear reads that contain mismatches in their 5 bp mispriming 
correction sequence (Table 4-4). Filtering UMI groups with low number of reads at the deduplication 
stage can also increase the rate at which the consensus sequence returns the correct J primer, but the 




Figure 4-12: Flowdiagram describing the process of mispriming correction.  
The correction of misprimed sequences is based on a 5bp sequence beyond the primer that can be unambiguously identify 
the true J gene. Based on how the sequence is misprimed, the 5bp is in different, but consistently reproducible positions along 
the read. By using a set of offsets, it is possible to find the location of the 5bp along the misprimed read. A reference sequence 
is created from the primer sequences (+5bp beyond primer), with each J sequence separated by 6 N bases from each other. 
The alignment to a reference sequence is performed using the striped Smith Waterman algorithm from the Scikit-bio package 
(http://scikit-bio.org). After the identification of the true J, the primer sequence is replaced with the correct J sequence.  
132 
 
Table 4-2: A set of offsets for each immunoglobulin locus is used for mispriming correction.  
For the mouse Igh locus the set of offsets is primarily linked to the J1 gene, which misprimed other J gene with a 2 bp offset 
while getting misprimed itself with an 8 bp offset (see Figure 4-11 for graphical explanation). For the mouse Igκ locus an 
additional primer identity sequence had to be introduced due to the J4 primer mispriming J5 with an alternative 5 bp 
identification sequence (see Figure 4-13 for a graphical explanation). The human IGH locus is by far the most complicated to 
correct due to the higher number of J genes and their multiple alleles. Numerous alternative 5 bp identification sequences 
had to be introduced and for J6 it was not possible to distinguish between the different alleles.    
Mouse Igh mispriming offsets 
    
  
Misprimed J offset 
    
  
J1 J2 J3 J4 
    
Primer 
identity 
J1 - 2 2 2 
    
J2 8 - - - 
    
J3 8 - - - 
    
J4 8 - - - 
    
          
  
Mouse Igκ mispriming offsets 
    
  
Misprimed J offset 
    
  
J1 J2 J4 J5 
    
Primer 
identity 
J1 10 - -2 9 
    
J2 - - - - 
    
J4 - - - - 
    
J5 - 1 3 - 
    
J5.c - - - - 
    
          
  
Human IGH mispriming offsets   
Misprimed J offset   
J1 J2 J3 J4.1 J4.3 J5.1 J5.2 J6.1 
Primer 
identity 
J1 - 4 6 1 - 7 7 - 
J2 - 4 6 1 - 7 7 -3 
J3 4 3 - 0 - 6 6 -4 
J4.1 0 -1, -2 1 - - 2 2 -8 
J4.3 0 -1, -2 1 - - 2 2 -8 
J4.1c 1 0, -1 1 1 - 3 3 -7 
J4.3c 1 0, -1 1 
 
- 3 3 -7 
J5.1 3 2 4 8 7 - - -5 
J5.2 3 2 4 8 7 - - -5 
J6.c 0 - - - - - - 0 
J6.c2 0 - - - - - - 0 
J6.3 - - - - - - - -  








Table 4-3: Success of mispriming correction judged from germline reads.  
The success of the correction can be seen by running the misprimed corrected reads through the germline alignment and 
primer identification script again. The few reads present off the diagonal show that the correction successfully replaced the J 
primer sequence with the true J sequence in most cases. Because mispriming takes place during the first PCR amplification, a 
sequence marked with a single UMI can have multiple different J primers mispriming it. Therefore, since most sequences are 
primed by the correct J primer, by collapsing a group of sequences, based on their UMI, into a consensus sequence it can be 
expected that this will correct the misprimed J minority of reads. Indeed, by analysing the true vs misprimed identity of reads 
after deduplication and consensus sequence construction it can be seen that only a small number of reads remain off the 
diagonal. 
After mispriming correction 
 
True identity   
J1 J2 J3 J4 
Misprimed 
J1 279129 3 5 10 
J2 8 257441 435 69 
J3 10 62 532775 17 
J4 13 15 23 832935       
After deduplication and consensus sequence  
True identity   
J1 J2 J3 J4 
Misprimed 
J1 4100 0 0 0 
J2 0 5878 10 0 
J3 0 0 8953 1 
J4 2 1 4 16478 
 
Table 4-4: Unclear mispriming events tend to have correct identity after deduplication. 
The lack of the 5 bps used for mispriming correction in some sequences results in the inability to confidently resolve the 
identity of these events, which are marked as unclear. However, the correct identity is still obtained in most cases after the 
generation of a consensus sequence. 
Unclear before deduplication  
True identity   
J1 J2 J3 J4 
Misprimed 
J1 9989 32 52 25 
J2 19 1571 331 1613 
J3 254 424 7324 1503 
J4 7 276 127 15908 
      
Unclear after deduplication and consensus sequence  
True identity   
J1 J2 J3 J4 
Misprimed 
J1 1 0 0 0 
J2 0 99 1 5 
J3 0 8 229 3 
J4 0 0 0 37 
 
For the mouse and human Igh loci clear majority of mispriming events can be successfully corrected. 
The exception being the J1 primer mispriming the J3 genes in the mouse Igh, where the short J1 primer 
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sequence is incorrectly aligned to the J3 reference and is discarded due to too many mismatches 
(Figure 4-11). The Igκ poses additional challenges, as several mispriming events cannot be corrected 
and result in false J gene identities. A prime example is the J1 gene being misprimed by J2-5 primers 
(Figure 4-13). The CCTCC sequence used to identify the J1 gene is overwritten by a stretch of C 
nucleotides present within the J2-5 primers, which in the case of J2 and J5 primers produces a 
sequence that is indistinguishable from a true J2 and J5 gene. In addition, there are several examples 
of J genes being primed in a way that somehow results in two or more sequence variants at the 
expected location of the 5 bp used for mispriming correction (Figure 4-13). In the case of the J4 primer 
mispriming the J5 gene, an additional reference sequence (J5c) was introduced for mispriming 
correction based on a large fraction of reads displaying this variant. Because of the inability to correct 
certain mispriming events, I introduced a metric based on the germline reads called the mispriming 
error (Table 4-5, Table 4-6, Table 4-7). The metric allows users to examine what the error of mispriming 
correction is for different species and loci and allows users to make informed decision regarding 
downstream analysis. The error for the mouse and human IGH is minimal (Table 4-5 and Table 4-7), 
while for the mouse Igκ the inability to correct certain mispriming events leads to a higher percentage 
error (Table 4-6). With increasing J gene and allele numbers the mispriming correction becomes even 
more complicated, as exemplified by the high number of additional reference sequences required for 
correction of human IGH sequences (Table 4-2). Because of the repetitiveness of the immunoglobulin 
loci, it is perhaps not surprising that the 5 bp sequence used for mispriming correction can be observed 
at multiple locations. The repetitiveness underscores the importance of looking in the correct location 
for the 5 bp sequence and in rare cases it can also lead to misidentification. A good example is the 5 
bp sequence beyond the J1 primer in the Igκ locus (ACCGA), which also appears in the J5 gene after a 
J1 primer has misprimed it (Figure 4-13). As a result, a sequence within the J1 primer had to be used 
(CCTCC), which prevented the correction of a proportion J1 gene sequence misprimed by the J2 
primer. In cases where the J identity percent error after mispriming correction is high, performing 





Figure 4-13: Alignment of the mouse Igκ J primer sequences reveals the inability to correct certain mispriming events.  
In the case of J1 gene mispriming by J2-5 primers, the CCTCC sequence used to identify the J1 read is not present as the single 
T is replaced by the stretch of Cs within the J2-5 primers. Unlike other J genes, the 5 bps beyond the J1 primer sequence cannot 
be used for mispriming correction as this sequence also appears in the J5 gene that is misprimed by J1. Another issue arises 
for the J4 and J5 genes, where mispriming with the J2 primer looks identical to a true J2 read. The mouse Igκ locus also 
contains examples were the 5 bp sequence is not conserved for all reads, as illustrated by J2 mispriming of J1 reads, J1 and J5 
mispriming of J4 reads and J2 mispriming of J5 reads. Because the 5 bp does not match any J genes, these sequences will be 







Table 4-5: The extent of J mispriming before and after mispriming correction for the mouse Igh.  
Percent error is the portion of incorrectly identified J genes after mispriming correction, based on germline sequence, over 
the total J gene reads. The mispriming error may vary from batch to batch, so it can useful to examine the mispriming error 
from the germline reads of each sample just as a quality control.  
Igh before mispriming error  
Total Misprimed Percent 
misprimed 
J1 4074 27 0.662739 
J2 6379 470 7.367926 
J3 10419 1465 14.06085 
J4 14587 1890 12.95674     
Igh after mispriming error  
Total Misprimed Percent error 
J1 4101 0 0 
J2 5919 10 0.168947 
J3 8955 1 0.011167 
J4 16484 7 0.042465 
 
Table 4-6: The extent of J mispriming before and after mispriming correction for the mouse Igκ.  
Percent error is the portion of incorrectly identified J genes after mispriming correction, based on germline sequence, over 
the total J gene reads. 
Igκ before mispriming correction  
Total Misprimed Percent 
misprimed 
J1 42435 11020 25.97 
J2 58363 1639 2.81 
J4 74006 1167 1.58 
J5 44053 4069 8.89     
Igκ after mispriming correction  
Total Misprimed Percent error 
J1 32935 1551 4.71 
J2 61868 1703 2.75 
J4 74870 211 0.28 










Table 4-7: The extent of J mispriming before and after mispriming correction for the human IGH.  
Percent error is the portion of incorrectly identified J genes after mispriming correction, based on germline sequence, over 
the total J gene reads.  
Human IGH before mispriming correction 
 Total Misprimed 
Percent 
misprimed 
J1 54645 47861 87.59 
J2 24101 13929 57.79 
J3 103284 87109 84.34 
J4 54324 32679 60.16 
J5 177456 40728 22.95 
J6 219413 24 0.01 
    
Human IGH after mispriming correction 
 Total Misprimed 
Percent 
error 
J1 11781 113 0.96 
J2 16984 19 0.11 
J3 30513 50 0.16 
J4 47846 116 0.24 
J5 331893 51 0.02 
J6 313242 45 0.01 
 
4.4.1.1 Endonuclease chew back in NHEJ DNA repairs can extend into the 5bp used for mispriming 
correction 
The non-homologous end joining (NHEJ) repair machinery poses an additional challenge to correcting 
J gene mispriming events. The nuclease activity of NHEJ, which is designed to expose short stretches 
of microhomology that can facilitate end joining, results in the nibbling (chew-back) of the J gene 
sequence (Chang et al., 2017; Malu et al., 2012). To determine the extent of chew-back within each J 
gene, I created sequence logos that display the information content at each position after the 5 bps 
that are used for mispriming correction. When the same base is always present at an observed 
position, the information content of this position would be the maximum value of 2 bits (this is 
because a single base at a position for DNA tells us two bits of information about itself, that is whether 
it is a pyrimidine or a purine and whether it is either A/G or C/T). If two bases are observed at equal 
frequency at a position than the information content of this position would be a total of 1 bit. In other 
words, the height of the bases can be interpreted as the degree of conservation of that residue at a 
position within a sequence. In the case of the 5 bps, which are required to be present in every 
sequence that can be misprimed corrected, the information content is 2 bits (Figure 4-14). With each 
subsequent position the information content decreases as the conserved germline sequence is 
replaced by other bases due to the nuclease activity of NHEJ. This is nicely observed for the J1 and J4 
sequences, where a gradual decrease in information content is observed when moving away from the 
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first 5 bases (Figure 4-14). The effect of chew-back is most prominent at the RSS heptamer where the 
double-stranded break is created (Figure 1-3 a). In the case of J2 and J3 the much sharper transition 
between the 5 bp mispriming correction sequence and the chew-back sequence is due the proximity 
of the cleavage site. This means that the 5 bps used for mispriming correction of J2 and J3 will be 
conserved less frequently than in J1 and J4.  
 
Figure 4-14: Seqlogo illustrates the impact of chew-back around the sequence used for J gene mispriming correction.  
The first five positions of the seqlogo correspond to the basepairs used to identify the true J gene and correct mispriming 
sequences. Below the seqlogo are the four mouse J gene sequences with the primers highlighted in red. The high degree of 
homology can be seen within the primer sequences. The sequence within the rectangle matches the position of the seqlogo, 
with the bold capital letters corresponding to the 5 basepairs used for mispriming correction. It is possible to use these 5 
basepairs because they are either located beyond the primer sequence, as in the case of J2 and J3, or remain after other J 
primer have misprimed, as in the case of J1 and J4. The nuclease chew-back from the non-homologous end joining machinery 
is most prominent at the RAG1/2 cleavage site and diminishes with increasing distance. The cleavage site is located at the 
start of the RSS heptamer sequence highlighted in blue. The seqlogos were created using the matplotlib python library 
(Hunter, 2007) with the approach described by Saket Choudhary and Markus Piotrowski (https://github.com/saketkc/motif-
logos-matplotlib/blob/master/Motif%20Logos%20using%20matplotlib.ipynb). 
4.4.2 Correcting errors within UMI sequences 
The presence of PCR and sequencing errors within UMI sequences can unintentionally lead to 
increased repertoire diversity. For this reason, I decided to explore methods for UMI correction and 
implement one into the deduplication pipeline. The presence of UMI errors has been previously 
documented and removing UMI groups with reads counts below a certain threshold was proposed as 
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a possible solution (Islam et al., 2014). A study conducted with iCLIP and single cell RNA-seq datasets 
compared five different method for the correction of errors within UMI sequences, including the read 
count threshold method (Smith et al., 2017). Three of the methods in the study were developed by 
the authors, who demonstrated that their directional-adjacency method outperformed all the other 
methods. The premise behind directional-adjacency is that errors within the UMI sequences arise 
during the library making process from correct UMI sequences that are present at much higher 
frequency. This bridges the idea of removing low count UMI groups that correlate with errors within 
the UMI sequence and the low divergence of related UMIs. By connecting UMI groups (nodes) that 
are different by a single nucleotide (adjacent nodes) and can be grouped into a structure where the 
head node has a read count that is more than 2n-1 of the adjacent node (directionality of the edges), 
a network of connected UMI sequence is created (Figure 4-15). Each network contains a head node 
that represents the highest count UMI group under which the UMIs with errors can be collapsed. This 
approach of sequence error correction has also been used in the immunoglobulin annotation tools 
MiXCR for correcting errors within CDR3 sequence and collapsing clonotypes (Bolotin et al., 2015). As 
a result, I chose to implement the directional-adjacency UMI error correction method into 
BabrahamLinkON. 
 
Figure 4-15: Constructing networks of UMI sequences for UMI error correction based on directional adjacency.  
(a) The network is constructed from a list of UMI and their counts using two rules. A UMI can only have 1 mismatch from an 
adjacent UMI and the head node UMI (one with the highest count) must have a count of more than 2n-1 compared to the 
adjacent UMI. This strategy for UMI error correction was devised by Tom Smith et. al. in UMI-tools (Smith et al., 2017). (b) 
Each node represents a UMI group with the UMI sequence shown in bold. In italic is the read sequence, which would be much 
longer in reality, with the number of reads within each UMI group displayed underneath. The size of the nodes is proportional 
to the UMI group sequence count. The directional networks all contain a head node (highlighted in red, blue or green) with 
adjacently connected components. The idea is to collapse UMI groups with lower read count under a higher count head node 





Figure 4-16: Resolving networks with multiple head nodes is done using the consensus sequence of each UMI group. 
 In this example there are three possible networks formed from each of the head nodes (red, green and blue). The connected 
component within each network are based on the directionality of the edges (2n-1) and adjacency of node (1 mismatch 
between UMIs) (each possible network is highlighted by coloured edges that match the head node colour of that network). 
Several adjacent nodes are present within multiple networks and need to be assigned to a singular head node. To resolve to 
which head node the adjacent nodes belong to, the consensus sequence of each adjacent node overlapping multiple networks 
is compared to the consensus sequence of each head node. The head node that best matches the adjacent node consensus 
sequence is assigned that adjacent node. At the end, a separate network containing only a single head node is obtained, 
under which all the adjacent node sequences can be collapsed.  
While implementing the directional-adjacency method from UMI-tools for VDJ-seq UMIs, I ran into 
the problem of a single network containing multiple head nodes (Figure 4-15). I decided to resolve the 
networks by comparing the consensus sequence of the head nodes with the consensus sequence of 
the shared adjacent node and assigning the adjacent nodes to the best head node match. In RNA-seq 
and iCLIP datasets the UMI groups are additionally split depending on their alignment across the 
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genome. Only UMIs of reads that align to the same region (gene) are considered for correction, 
meaning the number of encountered UMI is drastically reduced (Smith et al., 2017). This suggested to 
me that perhaps because in VDJ-seq the UMIs are only split into the two anchor groups, the diversity 
of the UMIs may be on the limit. I examined the UMI diversity within a 5 µg starting material dataset 
by placing each UMI onto the full diversity space created by a 12N UMI (over 16 million different 
combinations) (Figure 4-17). The analysis revealed that indeed there were biases in composition of 
observed UMIs, which I interpreted to be the result of the manufacturing process. By using a mixture 
of UMIs manufactured separately (CV 0.37 and CV 0.43), afforded by the two anchors, the random 
bias of the two batches was reduced (CV 0.25; Figure 4-17). This highlighted yet another unexpected 
role of the two separate anchor sequences. Overall, the observed spikes in very closely related 
sequences can explain the prevalence of multi-head node networks.  
The splitting of UMIs by only the anchor sequence, instead of by genomic locations like in RNA-seq, 
raised another issue with large datasets. Due to the non-linear increase in computational time with 
increasing UMI numbers, the UMI error correction of large samples takes a very long time despite my 
attempts at optimising several key algorithms. Even though this makes it impractical to routinely use 
UMI error correction, the procedure still holds value in evaluating the length of proxy UMI in 
downsampled datasets. Because the diversity of a proxy UMI is unknown, it is difficult to decide how 
long it should be. By testing a range of V end and J end UMI lengths using a 200,000 read downsampled 
file, with UMI correction either on or off, I was able to empirically determine an optimal length of the 
proxy UMI (Table 4-8). With short proxy UMI lengths (8-6 and 8-7) the number of output reads from 
the UMI correction is consistently lower compared to the non-corrected reads. This suggests that the 
UMI correction is correcting UMIs that should not be corrected, leading to their subsequent filtering 
with the gt-ratio filter. This points to a low diversity proxy UMI. Alternatively, with long proxy UMIs 
(8-9) the number of output sequences is now higher than the output without correction (Table 4-8). 
The longer the UMI, the higher the probability that it will contain a PCR or sequencing error. The higher 
output reads from the UMI correction suggest that in these long proxy UMIs there are now errors that 
are being successfully corrected. However, as the intention is not to use UMI correction for the full 
dataset the long proxy UMI are not ideal. The intermediate UMI length (8-8) shows a near identical 
read output from both corrected and not corrected UMIs, suggesting a balance between UMI diversity 
and UMI errors has been achieved. In addition to UMI length, I also tested two cut-offs for low UMI 
group read count. The cut-off of 1, which only removed UMI group with a single sequence, was 
insufficient as with increasing proxy UMI length the impact of PCR and sequencing errors was masked 




Figure 4-17: Distribution of UMI sequences displays biases towards certain type of composition.  
The plots represent the entire diversity space for a 12N UMI sequence (412 – over 16 million possibilities) divided into 166 
individual bins. Each bin is the mean distance between sampled UMIs. The distance is calculated by measuring the number of 
unsampled UMIs between two sampled UMIs. Each plot contains a different number of UMIs depending on the content within 
the 5 µg dataset used for the observed plots (blue). To maintain an equal scale between the plots, each plot was normalised 
by the distance between equally distributed UMIs. The expected distance between UMIs was calculated by randomly sampling 
an equal amount of UMIs as in the observed sample from the entire diversity space (expected green plots). The distance 
between perfectly distributed UMIs if shows as a grey dashed line, which also represents the mean of all the bins. The degree 
of the bias is shown by the distance away from the dashed line (the further away the greater the bias). The bias seen within 
the UMI distribution varied between the two anchors suggesting it varies for each manufactured oligo. The spikes above the 
dashed line highlight areas were very few UMI are sampled from, leading to an underrepresentation of these UMI within the 
sample. On the other hand, the spikes below the dashed line highlight areas of highly sampled UMIs, which leads to an 
overrepresentation with the sample. A coefficient of variation calculated for each plot shows that the joint use of both anchor 




Table 4-8: UMI correction procedure reveals the optimal length of proxy UMIs.  
For sequences without a UMI or a very short UMI the use of the sonication variability (V end length), along with the junctional diversity (J end length) can be used together as a proxy UMI. 
However, the difficulty with using a proxy UMI is in the choice of what length to use. A proxy UMI that is too short will not provide enough diversity and group incorrect sequences, while a proxy 
UMI that is too long will suffer from the increase chance of encountering PCR and sequencing errors, which will artificially inflate diversity. Values that are less important have been greyed out. 









V end length 8 8 8 8 8 8 8 8 
J end length 9 9 8 8 7 7 6 6 
Output reads 9625 9250 9576 9086 9501 8680 9404 8203 
Cluster discarded 1566 2746 1755 3125 1979 3802 2247 4565 
Low UMI count 44197 41109 44026 40532 43764 39451 43477 38042 
Directional-adjacency corrected 0 1947 0 2184 0 2688 0 3326 
Corrected clusters with low ratio 0 1422 0 1682 0 2259 0 2943 
         









V end length 8 8 8 8 8 8 8 8 
J end length 9 9 8 8 7 7 6 6 
Output reads 2392 2416 2390 2394 2393 2236 2383 2067 
Cluster discarded 1566 2746 1755 3125 1979 3802 2247 4565 
Low UMI count 51430 47943 51212 47224 50872 45895 50498 44178 
Directional-adjacency corrected 0 1947 0 2184 0 2688 0 3326 
Corrected clusters with low ratio 0 1422 0 1682 0 2259 0 2943 
 
Table 4-9: Number of output reads after deduplication of VDJ-seq libraries prepared with different number of primer extension cycles.  
With increasing number of primer extension cycles the number of output reads counterintuitively goes down. However, the number of low count UMI groups that are filtered out increases, 
suggesting that libraries with higher number of cycles were insufficiently sequenced.  
 2 cycles 1 2 cycles 2 4 cycles 1 4 cycles 2 8 cycles 1 8 cycles 2 10 cycles 1 10 cycles 2 12 cycles 1 12 cycles 2 
Input reads 431950 556415 474362 581471 777151 841914 842689 1047160 878002 1196872 
Output reads 35061 41403 43131 53028 26082 29485 7704 12312 1136 2464 
Low ratio discarded 10304 12668 13841 15654 26079 29489 31507 41916 35890 56917 
Low count groups 21773 25483 80731 89729 384375 405991 560108 659556 685058 886440 
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4.4.3 Increasing the number of primer extension cycles results in template switching 
During VDJ-seq optimisation we wanted try and increase the capture efficiency that is only around 7-
10%, depending on starting material. Because VDJ-seq was always performed with only a single cycle 
of primer extension, Dan Bolland tested the impact of increasing numbers of cycles on the final library 
diversity. The initial logs from the deduplication portion of the BabrahamLinkON pipeline revealed 
decreasing number of output reads with increasing numbers of cycles (Table 4-9). This counterintuitive 
result made sense considering the increasing numbers of filtered low count UMI groups with 
increasing cycles. Due to the higher diversity of reads within the higher cycle samples, the current 
sequencing depth was most likely insufficient despite devoting a larger portion of the sequencing lane 
to higher cycle samples (Table 4-9 Input reads). As a result, I decided to include the low count UMI 
groups in further downstream analysis. The increased primer extension cycles produce more UMI 
unique reads, but surprisingly after performing an additional deduplication using the entire length of 
the read, many sequences were removed (Figure 4-18). By examining one of the series of duplicated 
sequences I noticed that some contained two copies of the anchor sequence which should not be able 
to happen based on the adaptor design (Figure 4-19). The large number of duplicated sequences with 
different UMIs also prompted me to examine the number of clones within each clonotype. Given that 
all the sample are technical replicates from the same mouse naïve spleen (unstimulated by antigen), 
the size of clonotype groups is expected to be low and equal between all samples. Instead, an increase 
in the size of clonotype groups correlating with increasing cycle numbers is observed (Figure 4-20). 
Altogether, the double anchors and the unique UMIs in sequences that are expected to have the same 
UMI, points to template switching. This is additionally supported by the increasing number of 
sequences being filtered out by the gt-ratio filter (Table 4-8 Cluster discarded). Template switching 
has been previously documented as the cause of chimeric reads and could explain replacement of 
UMIs by those originating from free adaptors or other DNA molecules which could be exacerbated by 
the repetitive nature of the immunoglobulin loci (Patel et al., 1996). For this reason, it is recommended 





Figure 4-18: Increasing read output with increasing number of primer extension cycles.  
Each primer extension cycles contains two technical replicates. Libraries were prepared from the spleen of a 24-month-old 
C57BL/6 mouse by Dan Bolland. The output reads from the deduplication pipeline were merged with low UMI count reads 
and additionally deduplicated based on the entire read sequence (without anchor-UMI).  
 
 
Figure 4-19: Presence of two anchor sequences within a single read.  
The design of the anchor-UMI sequence does not allow a second anchor-UMI sequence to be ligated on. A template switching 
event could explain the appearance of these chimeric reads. All the read sequences shown here have identical sequences 
apart from the UMI. The J primer is highlighted in red with the 5 bp sequence used for mispriming correction shown in grey. 




Figure 4-20: The size of clonotype groups increases with increasing primer extension cycle numbers.  
Because the samples came from an unimmunised mouse, the number of clones is expected to be low. In addition, all samples 
represent technical replicates, which are expected to yield the same clonotype sizes. Plotted with the R package ggridges 
v0.5.0. 
 
4.4.4 Deduplication and annotation of short reads with Partis 
IgBlast annotation of recombined genes works by first searching for the V gene and subsequently 
masking the sequence that matched the top germline V gene (Ye et al., 2013). The masking is 
performed to avoid incorrect hits when searching for the D and J genes. After a V gene has been 
successfully found, the search for the J gene follows. The D gene is the last to be searched for and is 
assumed to be positioned between the V and J genes. The short reads inherently produce a low quality 
V gene match, which normally results in the removal of these reads. However, higher confidence calls 
can be independently obtained from the V end reads and because the aim is to only obtain the V gene 
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identity, a single V end sequence from a UMI group is sufficient. This meant that the V end reads never 
went through deduplication and consensus sequence construction. The current annotation of short 
reads is not ideal as IgBlast initially searches for the short V sequence within the J end reads, which 
could produce inaccurate junction boundaries and perhaps even impact the D and J genes calls. 
Previous iterations of the pipeline used a separate script to fill in the missing sequence between the J 
end and V end reads to allow the use of annotation tools such as IMGT/HighV-Quest. However, by 
joining the V and J reads together and reverse complementing th sequence so they are in the VDJ 
orientation I was able to use the annotation tool partis (Ralph and Matsen, 2016), which is capable of 
filling in potential deletion within sequences (Figure 4-21). As a result, the newest version of the 
pipeline deduplicated the V end reads in the same manner as the J end reads and creates high quality 
consensus sequences around which gaps can be filled. 
 
Figure 4-21: Partis asnnotation example output. 
Partis marks the missing sequence between the V and J reads as a deletion and fills it with germline sequence. The sequence 
between the red bases marking cytosine (TGT) and tryptophan (TGG) is the CDR3.  
4.5 Commands and additional output of BabrahamLinkON 
The following section contains documentation of the BabrahamLinkON commands and provides 
examples of additional plots optionally produce during processing, which can be used to verify 
everything has run as expected or can be helpful for troubleshooting. 
4.5.1 Preclean commands and output documentation 
All input fastq files are assumed to have been adaptor and quality trimmed. Adaptor and low-quality 
end sequence trimming can be performed using Trim Galore!   
(https://www.bioinformatics.babraham.ac.uk/projects/trim_galore/), which is wrapper script for the 
adapter-trimming tool Cutadapt (Martin, 2011). For Igκ, the low diversity of the first four nucleotides 
of the J end R2 (read 2) results in low quality bases that should be additionally trimmed. 
 
BabrahamLinkON preclean - choosing pipeline 
-h, --help            show the help message and exits 
--version show the program's version number and exit 




Four options are available depending on the reads. Reads that can be 
assembled and have an anchor-UMI are used with the umi option. 
Reads that are too short to assemble and do not have an anchor-UMI 
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mispriming_error are used with the short option. Reads that are too short to assemble 
but contain an anchor-UMI are used with the short_anchor option. 
Finally, a method to estimate the inaccuracy of mispriming correction 




Arguments available in precleaning 
Arguments shared by all: 
-h, --help show the help message and exits 
--species SPECIES Which species or locus:  mmu – Mus musculus; hsa - Homo sapiens; 
mmuk – Mus musculus kappa). So far, only these three options are 
available. [mmu] 
-t NTHREADS, --threads NTHREADS 
 Number of threads to use. [1] 
-v INPUT_V,--V_r1 INPUT_V 
 Input fastq file with V end sequences 
-j INPUT_J, --J_r2 INPUT_J 
 Input fastq file with J end sequences 
--fast Perform fast inaccurate J identification (additionally need to use  
--no_mispriming). Only recommended if mispriming correction 
is not desired. 
--no_mispriming Don't perform mispriming correction. (Not recommended) 
--prefix PREFIX Prefix of the output file. By default, the prefix is the basename of the 
V end fastq file. 
--out OUT_DIR         Output directory. By default a new folder is created with the V end 
fastq file basename in the same directory as the fastq files. In cases 
were users do not have write permission in the current directory, a 
custom output directory can be specified.  
--verbose Print detailed progress 
--plot Plot alignments of reads to the germline J genes. Useful as a quick 
check for the consistency of germline J gene levels observed between 
samples. 
-q Q_SCORE, --q_score Q_SCORE 
 Minimum Phred quality score allowed for bases in UMI. This is to 
guarantee that only high quality UMIs are used. [30] 
-ul UMI_LEN, --umi_len UMI_LEN 
 Length of the UMI [12] 
--j_len J_LEN Length of J end sequence, [50] bp into read (--in_len), to add to 
the UMI to further diversify the UMI. [0] 
--in_len IN_LEN How many bps to go into the J end sequence before taking –-j_len 
to increase diversity of the UMI. [50] 
--an1 AN1 Adaptor 1 anchor sequence. This is only used if custom anchor 
sequences were designed. [GACTCGT] 
--an2 AN2          Adaptor 2 anchor sequence. This is only used if custom anchor 
sequences were designed. [CTGCTCCT] 
--keep_germline       Skip germline removal step. Useful if the deduplication and analysis 
of germline sequences captures is desired. 
--keep_pear Do not delete output files from pear. Useful for troubleshooting 
assembly of paired-end reads. 
149 
 
Arguments unique to the UMI and short_anchor pipeline: 
-ba BEYOND_ANCHOR, --beyond_anchor BEYOND_ANCHOR 
 Length of V end to take beyond the anchor sequence. Useful if the 
UMI is short (e.g. 6 bp) and part of the V region that contains 
sonication variability is required to increase UMI diversity. 
Arguments unique to the short and short_anchor pipeline: 
--ref REF_PATH Igh reference files path 
 
 
Available command options for each pipeline 
BabrahamLinkON preclean UMI pipeline 
preclean.py umi  [-h][--species SPECIES][-t NTHREADS] 
[-v INPUT_V][-j INPUT_J][--fast] 
[--no_mispriming][--prefix PREFIX] 
[--out OUT_DIR][--verbose][--plot] 
[-q Q_SCORE][-ul UMI_LEN] [--j_len J_LEN] 
[--in_len IN_LEN][--an1 AN1][--an2 AN2] 
[--keep_germline][--keep_pear] 
[-ba BEYOND_ANCHOR] 
BabrahamLinkON preclean short pipeline 
preclean.py short  [-h][--species SPECIES][-t NTHREADS] 
[-v INPUT_V][-j INPUT_J][--fast] 
[--no_mispriming][--prefix PREFIX] 
[--out OUT_DIR][--verbose][--plot] 
[-q Q_SCORE][-ul UMI_LEN][--j_len J_LEN] 
[--in_len IN_LEN][--keep_germline] 
[--keep_pear][--ref REF_PATH] 
BabrahamLinkON preclean short_anchor pipeline 
preclean.py short_anchor 
 [-h][--species SPECIES][-t NTHREADS] 
[-v INPUT_V][-j INPUT_J][--fast] 
[--no_mispriming][--prefix PREFIX] 
[--out OUT_DIR][--verbose][--plot] 
[-q Q_SCORE][-ul UMI_LEN] [--j_len J_LEN] 




Precleaning of long reads with UMIs can be run with the following example command: 
preclean.py umi -v <R1.fastq.gz> -j <R2.fastq.gz> --species mmu 
–-threads 8 –-q_score 30 --umi_len 12 
where umi selects the long read with UMI option of the pipeline. The <R1.fastq.gz> is the 




Figure 4-22: Coverage plot of germline VDJ-seq reads over the mouse J genes.  
The plot is optionally produced from the germline reads that are removed during precleaning. The sigmoid curve on the 
right-hand side of each peak is characteristic of the variable sonication. 
The germline read coverage plots (Figure 4-22) are produced using the Gviz package v2.32.1+ (Hahne 
and Ivanek, 2016). Genomic intervals are extracted from a Samtools v1+ (Li et al., 2009) sorted and 
indexed BAM file using the GenomicsRanges package v1.28.6+ (Lawrence et al., 2013) and the track 
annotation is extracted from Ensembl using the biomaRt package v2.32.1+ (Durinck et al., 2009). All 
of the R packages are part of Bioconductor (Huber et al., 2015). The germline VDJ-seq read coverage 
plot can be used to qualitatively compare the germline reads captured between samples. The visible 
alignment of the reads beyond the J genes confirms their germline identity. The plot enables a quick 




BabrahamLinkON preclean mispriming_error tool 
preclean.py mispriming_error 
 [-h] [--species SPECIES] [-t NTHREADS]  
--input_dir IN_DIR 
Arguments:  
-h, --help show the help message and exits 
--species SPECIES Which species or locus:  mmu – Mus musculus; hsa - Homo sapiens; 
mmuk – Mus musculus kappa). So far, only these three options are 
available. [mmu] 
-t NTHREADS, --threads NTHREADS 
 Number of threads to use. [1] 
--input_dir IN_DIR 
 Input directory that was created by the preclean.py pipelines. This 
folder needs to contain the germline fastq files (not compatible 
with --keep_germline). 
 
4.5.2 Deduplication commands and output documentation 
 
BabrahamLinkON Deduplicate choosing pipeline 
-h, --help            show the help message and exits 
--version show the program's version number and exit 







There are six available options depending on the reads. Reads that 
have been assembled and have been split into two anchor fastq files 
with the UMI withing the read name are used with the umi option. 
Reads that were too short to assemble and do not have an anchor-
UMI are used with the short option. Reads that were too short to 
assemble but contain an anchor-UMI are used with the 
short_anchor option. For long reads that have been assembled 
but do not contain an anchor-UMI are used with the no_anchor 
option. For creating sequence logos of the UMI the umi_seq_logo 
option can be used. Finally, for reverse complementing the output 
sequences from the JDV to the VDJ orientation that is required for 
some annotation tools, the reverse_complement option can be 
used. 
 
The no_anchor option is a special use case as there are no explicit commands in the precleaning 
stage of the pipeline to prepare these sequences for deduplication. The umi precleaning pipeline can 
be used on these sequences as it is designed for long reads. However, because the sequences do not 
contain an anchor sequence it will fail to identify it, but it will still extract x amount of nucleotides 
from the V end that can be used as a UMI for deduplication. Unfortunately, in order to pass the 
sequences to the deduplication pipeline the file will need to be manually renamed from 
`_other_J` suffix to the `_all_jv` suffix. The deduplication pipeline looks for files with unique 
suffixes for each pipeline. This was implemented as a precaution to avoid using the wrong input files 
in downstream steps of the pipeline. 
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Arguments available in deduplicate 
Arguments shared by all:  
-h, --help Show the help message and exits 
--input_dir IN_DIR 
 Input directory that was created from precleaning. 
--out OUT_DIR Output directory. By default, a folder is created in main directory. 
-t NTHREADS, --threads NTHREADS 
 Number of threads to use for processes that can be performed in 
parallel. [1] 
--mismatch MISMATCH    
 Number of mismatches allowed between the consensus sequence 
and the sequences that were used to create the consensus. [5] 
--min_reads MINREADS   
 Minimum number of reads in UMI group, if less than or equal to [2] 
then these reads will be written into a separate file. 
--gt_ratio GTRATIO 
 Ratio of good to total reads within a UMI group/stack. A read is 
classified as good if it has less than the allowed number of 
mismatches (see --mismatch). This allows the identification of 
UMI group with too many sequence error or with incorrectly grouped 
reads. The accepted values range from 0 to 1. [1] 
--stats Output stats from UMI deduplication [False] 
--umi_correction Perform correction of errors that might be present within the UMI. 
Very slow for large samples, but can be used with downsampled files 
to identify optimal length of V end for UMI. 
--threshold THRESHOLD 
 Number of mismatches allowed in UMI when doing UMI correction. 
[1] 
--skip_unclear Do not process unclear J reads (see mispriming correction). [False] 
--keep_mh Keep multiple hit J reads (see mispriming correction). [False] 
--use_j Deduplicate using J identity from mispriming correction. 
--ignore_umi Deduplicate without using the UMI (for troubleshooting or QC). 
--no_consensus Do not output consensus sequence, but instead only return the first 
sequence in the UMI stack (for troubleshooting or QC). 
--j_trim Trim J primer when comparing sequences to the consensus sequence. 
This allows misprimed J sequences to be corrected by the more 
frequent true J sequence. The length of the sequence to be trimmed 
should be set to the longest J gene. [25] 
--no_msa Do not use multiple sequence alignment (KAlign2) to derive 
consensus sequence. Recommended only for troubleshooting and QC 
purposes. [False] 
--fq Output fastq instead of fasta. Some annotation tools accept fastq files 
instead of fasta. 
--cons_no_qual Make consensus sequence without using fastq quality scores. 
--with_N  Output consensus sequences with ambigious N bases. If the 
consensus sequence contains N bases (ambiguous with tied quality 
scores), normally the sequence that best matches the consensus is 
used to fill in the N bases. This is done to avoid problems with 
interpretation of N by annotation tools. 
Arguments unique to umi and short_anchor pipeline 
--an1 AN1 Default: GACTCGT 





Available command options for each pipeline 
BabrahamLinkON deduplicate UMI pipeline 
deduplicate.py umi 
 [-h] --input_dir IN_DIR [--out OUT_DIR] 
[--threads NTHREADS][--mismatch MISMATCH] 







BabrahamLinkON deduplicate short pipeline 
deduplicate.py short 
 [-h] --input_dir IN_DIR [--out OUT_DIR] 
[--threads NTHREADS][--mismatch MISMATCH] 






BabrahamLinkON deduplicate short_anchor pipeline  
deduplicate.py short_anchor 
 [-h] --input_dir IN_DIR [--out OUT_DIR] 
[--threads NTHREADS][--mismatch MISMATCH] 







BabrahamLinkON deduplicate no_anchor pipeline 
deduplicate.py no_anchor 
 [-h] --input_dir IN_DIR [--out OUT_DIR] 
[--threads NTHREADS][--mismatch MISMATCH] 







Deduplication of long reads with UMIs can be run with the following example command: 
deduplicate.py umi --input_dir <directory_path> --threads 8 -–stats 
-–min_reads 2 -–gt_ratio 1 –-mismatch 5 
154 
 
where umi selects the long read with UMI option of the pipeline. The <directory_path> 
specifies the path of the directory created during precleaning that contains a fastq file for each group 
of anchor sequences. 
 
Figure 4-23: Duplicate histograms are output as part of the deduplication pipeline.  
The dashed line corresponds to the low count UMI groups cut off point. Anything equal or less than the cut off will be placed 
into a separate file. This plot is useful to determine if the sample has sufficient over sequencing and if the cut-off point is 
reasonable. Histograms with only the left tail cut-off are indicative of sufficient over sequencing. In cases where only the right-
hand tail is visible, indicative of under sequencing, the choice of including the low count UMI groups in downstream analysis 







Table 4-10: Log of duplication level/count of each UMI pre and post deduplication.  
The duplication values can be found in the <sample_name>_umi_per_position.tsv file created by the deduplication pipeline. 
The lower counts post deduplication correspond to the reads not passing the good-to-total ratio filter. The duplication counts 
can be used to create an equivalent histogram to the one shown in Figure 4-23. Counts between 6 and 21 have been omitted 
here.  
Counts Instances_pre Instances_post 
1 5062 5062 
2 2332 2253 
3 1864 1798 
4 1747 1679 
5 1650 1584 
6 1487 1433 
… … … 
21 31 30 
22 12 11 
23 9 8 
24 6 6 
25 4 4 
26 1 1 
27 1 1 
28 2 2 





Table 4-11: Log of each UMI group/stack pre and post deduplication. 
The information of each UMI stack can be found in the <sample_name>_per_umi_per_position.tsv file created by the deduplication pipeline. The log contains information on the total number 
of reads observed for each UMI (total counts). It also shows the number of mismatches/differences each sequence contains when compared to the consensus sequence, and provide the MSA 
output for unique sequences in a comma delimited fasta format. The alignment output is very useful in troubleshooting cases were high number of sequences are removed with the good-to-
total ratio filter. The number of times each UMI was observed is also shown, but this metric is only useful when performing UMI correction where observations higher than one indicate merging 




















AAAAACCATAGA 1 1 1 1 >0_AAAAACCATAGA_1, 
AGTG…GTTG 
0 
AAAAACCCATCT 1 1 1 1 >0_AAAAACCCATCT_1, 
CCCT…CCCA 
0 
AAAAAGCGTGCT 5 1 5 1 >0_AAAAAGCGTGCT_5, 
AGTG…TGAG 
0,0,0,0,0 





AAAAAGTTAGAG 5 1 5 1 >0_AAAAAGTTAGAG_5, 
CCCT…CATT 
0,0,0,0,0 




High number of sequences being filtered out by the good-to-total ratio filter is usually a sign that either 
something has gone wrong with the library preparation or the sequences are not being correctly 
grouped. A very useful output of the deduplication pipeline for the troubleshooting of such cases is 
the per UMI log. A portion of the log is shown in Table 4-11, which shows the number of 
differences/mismatches of each sequence from the consensus and provides the MSA output for each 
unique sequence. The consensus difference highlights outlier sequences that may contain PCR and 
sequencing errors or have been incorrectly grouped. Incorrect grouping can arise from low diversity 
UMIs, template switching during primer extension or during UMI error correction where lower count 
UMI groups are merged with higher count UMI groups that differ in their UMI sequence by only 1 
hamming distance. If higher numbers of mismatches are present within the UMI group sequences, the 
number of allowed differences between a UMI stack sequence and the UMI stack consensus sequence 
can be changed from the default 5.  
 
BabrahamLinkON deduplicate umi_seq_logo tool 
deduplicate.py umi_seq_logo 
 [-h] --input_dir IN_DIR [--out OUT_DIR] 
[--an1 AN1][--an2 AN2] 
Arguments:  
-h, --help show the help message and exits 
--input_dir IN_DIR 
 Input directory that was created from precleaning. 
--out OUT_DIR Output directory. By default, a deduplicated folder is created in main 
directory, or if the folder already exist the output is written into the 
folder. 
--an1 AN1 Anchor 1 sequence [GACTCGT] 
--an2 AN2 Anchor 2 sequence [CTGCTCCT] 
 
The weblogo package v3.5.0 was used as the backend for the generation of sequence logo plots of the 
UMI (Crooks et al., 2004). An example sequence plot is shown in Figure 4-24. Such plots can be used 
as a troubleshooting tool to ensure an equal representation of all the bases within the UMI. This can 
be especially useful is cases were a proxy UMI, such as the V end sonication variability or a portion of 





Figure 4-24: An example sequence logo plot of the UMI sequence.  
A separate plot is generated for each of the anchor sequences. These plots are useful for troubleshooting overrepresentation 
of bases at certain positions of the UMI. This is especially useful when using V end or J end sequences as a proxy for a true 
UMI, where an equal distribution may not be present.  
 
BabrahamLinkON deduplicate reverse_complement tool 
deduplicate.py reverse_complement 
 [-h] [--an1 AN1] [--an2 AN2] --input INPUT [--
fq] 
Arguments:  
-h, --help show the help message and exits 
--an1 AN1 Anchor 1 sequence [GACTCGT] 
--an2 AN2 Anchor 2 sequence [CTGCTCCT] 
--input INPUT   Input file or directory with files. By default, a fasta file is expected. 
--fq Instead of a fasta, the input and the output files are fastq. 
 
4.5.3 Annotation and assembly command documentation 
 
BabrahamLinkON annotation and assembly - choosing pipeline 
-h, --help            show the help message and exits 
--version Show the program's version number and exit 




Two options are available depending on the reads. At this stage only 
the state of the reads, whether they are assembled into a single read 
or still split into J end and V end reads matters. Assembled reads are 
used with the umi option. For short reads, the short option needs to 
be used. Short read annotation is performed separately for each read 
end, as the J end may not contain enough V sequence to obtain a high 
confidence call. The end with the highest score is used for the final 
gene call. As an additional control, the V gene identified in the 
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precleaning stage with Bowtie2 alignment can be manually compared 
with calls obtained from IgBlast.  
The third assemble_only option is used if annotation has already 
been performed and only the clone assembly is required. Clone 
assembly can take a long time on very large sample, and therefore in 
some cases were only the annotation of the V(D)J genes is desired then 
assembly is often skipped. In addition, if the clonal overlap between 
multiple samples is desired, the tsv files of all the samples can be 
supplied and a single merged output tsv will be produced. 
 
 
Arguments available in annotation and assembly 
Arguments shared by all: 
-h, --help Show the help message and exits 
--threshold THRES     Number of differences allowed between CDR3 sequences [1] 
--only_v Use only V identity and CDR3 for clone assembly 
--out OUT_DIR         Output directory. By default, the files are written into the directory 
created during deduplication. 
Arguments unique to the umi and short pipeline 
-fa FASTA, --fasta FASTA 
 Input fasta file from deduplication. 
--plot Plot V and J scores with cutoff. 
--full_name           Retain full name of first V and J genes, otherwise the allele 
information is removed. 
--minimal             Work with and output only a minimal table 
--threads NTHREADS 
 Number of threads to use [1] 
--species SPECIES     Which species (mmu hsa mmuk) [mmu] 
--aux AUX             Custom aux file required by Igblast. The default aux files have been 
included with the pipeline installation. 
--custom_ref Use AEC custom reference for Igblast. 
--v_cutoff V_CUTOFF 
 IgBlast V_SCORE cutoff [>50] 
--j_cutoff J_CUTOFF 
 IgBlast J_SCORE cutoff [>35] 
--skip_assembly       Do not assemble clones into clonotypes 
--call_dj             Call DJ recombination alongside VDJ. 
Arguments unique to the short pipeline: 
-fq V_FASTQ, --v_fastq V_FASTQ 
 V end R1 fastq file 
Arguments unique to the assemble_only pipeline: 
-tsv TSV_FILES, --tsv_files TSV_FILES 
 Input tsv files from previous runs of assemble_clones 
 
Annotation and clone assemble of long reads with UMIs can be run with the following example 
command: 
assemble_clones.py umi –fa <input_fasta> --threads 8 species 
mmu --full_name –-plot 
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where umi selects the long read with UMI option of the pipeline. The <input_fasta> specifies 
the path of the fasta file produced by the deduplication.  
 
 
Figure 4-25: Histograms of V and J scores from IgBlast.  
The vertical dashed line marks the score filter cut-off. The majority of reads have a high score.  
The histogram of V and J scores can be optionally produced during the annotation stage of the pipeline 
(Figure 4-25). It can be used to verify that most sequences contain high quality scores and that the 






The development of a comprehensive analysis pipeline for VDJ-seq, along with a desire to profile low 
cell number samples, led to the optimisations and improvement of the VDJ-seq protocol. The 
systematic correction of mispriming events along with the incorporation of a high diversity UMI 
allowed the profiling of antigen receptor repertoires at the level of individual clones. Using multiple 
reads harbouring identical UMIs enabled the correction of PCR and sequencing errors and the filtering 
of aberrant reads. This opens up VDJ-seq for potential clinical applications such as studies of clonal 
expansion in leukaemia, along with basic research of repertoires in mouse models and in human 
health and disease (Galson et al., 2014; Hou et al., 2016b; Robinson, 2015). VDJ-seq is also able to 
capture substantially higher numbers of clonotypes compared to other gDNA-based methods and 
produce an unbiased quantification of all V genes (Chovanec et al., 2018). By additionally creating an 
annotation reference for recombined D genes, it is now possible to quantify the full range of VDJ, DJ 
and unrecombined sequences captured with VDJ-seq, which will enable more quantitative studies of 
the earliest recombination events in cells such as CLPs.  
The field of antigen receptor (AgR) repertoire studies has seen immense progress since the first 
adaptations of techniques for next generation sequencing in 2009 (Weinstein et al., 2009). The 
challenges of developing high-throughput wet lab methodologies that can capture the AgR repertoire 
without bias face an equally great challenge in the analysis of the data (Chaudhary and Wesemann, 
2018; Greiff et al., 2015; Yaari and Kleinstein, 2015). Some of the future developments to improve 
VDJ-seq should address the large proportion of germline fragments that soak up the sequencing 
depth. The depletion of abundant sequences by hybridisation (DASH) method utilises CRISPR 
(clustered regularly interspaced short palindromic repeats) with the associated Cas9 nuclease and 
guide RNAs to specifically cleave undesired sequences within an Illumina library just before PCR 
amplification (Gu et al., 2016). The cleavage prevents the amplification of these sequences, effectively 
depleting them from the final library. Using guide RNAs for the germline reads within a VDJ-seq library 
should make it possible to efficiently eliminate them. The advantage of DASH is that it can be used 
with small amounts of starting material and without losing substantial amounts of non-targeted 
sequences. The elimination of germline fragments would substantially reduce sequencing costs and 
perhaps permit the sequencing of multiple technical replicates that would lead to the capture of a 
greater portion of the repertoire. 
The theoretical diversity of AgR repertoires makes the probability of individuals sharing clones (public 
clones) unlikely. However, several studies have observed the presence of public clones and pointed to 
genetic background and antigen driven convergence of BCRs as the mechanisms of public clone 
emergence (DeKosky et al., 2016; Greiff et al., 2017a; Jackson et al., 2013). Interestingly, public clones 
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can be predicted with high accuracy based on features of the CDR3 region (Greiff et al., 2017b). The 
ability to capture both the heavy and light chains from the same cell has additionally revealed that Igl 
public sequences are more common than Igh public sequences, while the knowledge of the 
recombination status of both loci can additionally provide invaluable insight into basic mechanisms 
such as allelic inclusion and to a more broader understanding of diseases (DeKosky et al., 2013, 2016). 
In addition, the ability to produce and screen mAbs with native pairing, as opposed to random pairing 
of current antibody screening libraries, provides a massive resource for future therapeutics 
development (Jayaram et al., 2012; Wang et al., 2018). As a future direction, merging the low cost of 
VDJ-seq with the ability to examine Igh:Igl pairing is foreseeable with the recent advance in split-pool 
barcoding techniques (Cao et al., 2017; Rosenberg et al., 2018; Svensson et al., 2018). A split-pool 
barcoding adaptation for AgR-seq could soon enable the analysis of millions of paired recombination 




5 Promoter interaction dynamics in a model system of human 
embryonic development 
My interests lie in understanding how genome conformation regulates B cell development. Our group 
has recently published a highly collaborative study in which we have performed promoter capture 
Hi-C (PCHiC) on mouse pre-B cells (Koohy et al., 2018). The ultimate aim of developing techniques for 
the visualisation of entire PCHiC datasets is to be able to investigate genome organisation changes 
taking place during the transition from pro-B to pre-B cells. Unfortunately, current requirements for 
large quantities of starting cells prohibit the generation of datasets from pro-B cells. A complementary 
project in progress in the lab aims to overcome this limitation by refining PCHiC for use with 
substantially smaller numbers of cells. My contribution to this project has been to develop more 
informative ways of analysing these complex datasets. For this study, we availed of a collaborative 
opportunity to develop this platform in collaboration with Peter Rugg-Gunn’s group, who have 
developed the important and tractable human naïve and primed hPSCs system from which we were 
able to study high quality PCHiC and related datasets. 
5.1 Background 
Pluripotent stem cells have the capacity to from all cell lineages of the adult body. The derivation of 
mouse embryonic stem cells (mESCs) from the entire mouse blastocyst, or inner cell mass (ICM), led 
to the stabilisation of their in vivo transient state of pluripotency and was instrumental in expanding 
our understanding of cell fate decisions and the ability of these cells to differentiate into numerous 
cell types under specific growth conditions. These studies were later followed by the derivation of 
human pluripotent stem cells (hPSCs) from blastocyst stage embryos acquired by in vitro fertilisation 
(IVF) techniques (Thomson et al., 1998), many of which are still commonly used today (Guhr et al., 
2018). Being able to maintain hPSCs in culture indefinitely, while retaining their capacity to 
differentiate, provides an indispensable tool for expanding our knowledge of human embryonic 
development and disease modelling with the ultimate goal of harnessing the plasticity of these cells 
for regenerative medicine. However, in vitro hPSCs of early studies displayed molecular and 
morphological differences to their mouse counterparts, despite the derivation being performed from 
an equivalent preimplantation embryonic developmental stage (Collier and Rugg-Gunn, 2018). It was 
later discovered that the culture conditions, used for deriving and maintaining human preimplantation 
epiblast cells, were incapable of retaining them in a preimplantation-like state, and instead stabilised 
them in a later developmental stage characteristic of postimplantation epiblast cells (Nakamura et al., 
2016).  
The maintenance of mESC in different culture media formulations leads to morphological, gene 
expression and epigenetic differences between the cells, while still allowing them to retain their 
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pluripotent characteristics. mESCs grown in the presence of leukaemia inhibitory factor (LIF) and 2i 
(two inhibitors of MEK and GSK3) gave rise to a homogeneous population of cells referred to being in 
a ‘naïve’ state of pluripotency, representative of preimplantation epiblast cells (Ying et al., 2008). 
Alternatively, culturing mouse ESC in the presence of FGF and Activin A generates a cell type that is 
representative of postimplantation epiblast cells (mEpiSCs), which are classified as being in a ‘primed’ 
state of pluripotency (Brons et al., 2007; Tesar et al., 2007). Molecular and phenotypic analysis of naïve 
mESC and primed mEpiSCs reveals that hPSCs more closely resemble primed mEpiSCs. In the past few 
years, considerable progress has been made towards formulating culture conditions and 
reprogramming methods for deriving naive hPSCs from primed hPSCs and maintaining them in culture. 
One of two most prominent methods for reprogramming and maintaining primed hPSCs in a naïve 
state is using the 5i/L/A media formulation, which utilises five inhibitors along with LIF and Activin A 
(Theunissen et al., 2014). The second method employs the transient induction of pluripotency 
transcription factors to reprogram primed cells to a naïve state, in the presence of the t2iL+PKCi media 
formulation; t2iL+PKCi uses a titrated low dose 2i with LIF and a PKC inhibitor (Takashima et al., 2014). 
The t2iL+PKCi method has also been used to directly isolate preimplantation human naïve cells from 
the blastocyst ICM (Guo et al., 2016). The newly established culture conditions provide for the very 
first time an in-vitro model that enables us to expand our understanding of the earliest stages of 
human embryonic development.  
Studies of human and mouse embryos have revealed that a global remodelling of the epigenome takes 
place during the transition between preimplantation and postimplantation development. Single and 
low cell number studies have mapped the transcriptional output of cells within the developing embryo 
and provide a trajectory upon which in-vitro states of pluripotency can be overlaid (Petropoulos et al., 
2016; Stirparo et al., 2018). Human state specific expression of transcription factors such as KLF17 and 
DPPA5 in the naïve state and OTX2 and DUSP6 in the primed state are one of the hallmarks separating 
these two states of pluripotency (Collier and Rugg-Gunn, 2018). A prominent feature of 
preimplantation embryos is the global hypomethylated state, which is recapitulated upon 
reprogramming of primed hPSCs to the naïve state (Guo et al., 2014; Pastor et al., 2016). Conversely, 
primed hPSCs are globally hypermethylation, making methylation status an additional hallmark of 
naïve pluripotency (Collier and Rugg-Gunn, 2018). Further differences between naïve and primed hPSC 
have been noted in their metabolism, their X-chromosome status in female cells, and the distribution 
of H3K27me3 modification levels (Takashima et al., 2014; Theunissen et al., 2014, 2016; Vallot et al., 
2017). Numerous studies have described the profound changes in transcription, protein expression, 
and the epigenetic landscape that take place during the short stage of development that is captured 
in-vitro using naïve and primed hPSCs as a model system. However, very little is known about the 3D 
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genome organisation of naïve human pluripotent cells and how cis-regulatory regions govern gene 
expression profiles with implications on human embryonic developmental progression.  
5.1.1 Genome architecture and its role in cellular function 
The enormous stretches of DNA within each cell’s nucleus are not compacted in a random spaghetti 
fashion. Rather, early studies performed with electron microscopy revealed intricate structural 
organisation of DNA in metaphase chromosomes (Paulson and Laemmli, 1977). Subsequent research 
focusing on the interphase nucleus, with the use of fluorescent in-situ hybridisation, revealed that 
individual chromosomes occupy distinct nuclear territories and rarely intermingle (Cremer and 
Cremer, 2001; Cremer et al., 2006). Suggestions of the importance of genome architecture for function 
and transcriptional regulation came from early observations of the inactive X-chromosome and the 
formation of the Barr body (Barr and Bertram, 1977; Eils et al., 1996). However, the breakthrough that 
accelerated the study of genome architecture came with the development of the chromosome 
conformation capture (3C, one-to-one) technique (Dekker et al., 2002) (Figure 5-1). With 
formaldehyde fixation, restriction enzyme digestion and subsequent ligation of proximal fragments it 
became possible to investigate the interaction of linearly distant genomic loci at high resolution. 
Subsequent techniques derived from the principles of 3C expanded the ability of the technique to 
examine interactions of a specific viewpoint (4C, one-to-all) (Simonis et al., 2006; Zhao et al., 2006), a 
genomic region (5C, many-to-many) (Dostie et al., 2006) and ultimately of the entire genome (Hi-C, 
all-to-all) (Lieberman-Aiden et al., 2009) (Figure 5-1). The techniques, often complemented with single 
cell 3D FISH studies, allow the high-throughput discovery and quantification of interaction 
probabilities on a population and single cell level (Nagano et al., 2013).  
 
 
Figure 5-1: Chromosome conformation methods for the study of DNA interactions. 
Black arrow designate the transcriptional start site. Arc arrows indicate the type and number of interaction each method 
can detect. The colour of the arrows matches the colour of the viewpoint rectangle. Taken from (Wijchers and de Laat, 
2011). 
The first genome wide conformation capture studies using Hi-C were also able to detect the distinct 
chromosomal territories that were previously described using chromosome paints (Lieberman-Aiden 
et al., 2009). In addition to chromosome territories, Hi-C was also able to detect two sets of genomic 
compartments within chromosomes at the 1-10 Mb scale, termed compartment A and B. The 
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underlying feature of these compartments was their preferential interaction with other regions of the 
same type, giving rise to a checkerboard pattern within interaction matrices. The compartments 
correlated with features such as DHS accessibility, gene density and histone marks, which led to the 
designation of the A compartment as the active, gene-rich euchromatin compartment, while the B 
compartment was an exact opposite with regions of inactive, gene-poor heterochromatin (Lieberman-
Aiden et al., 2009). As large-scale structural features with a distinct chromatin status, the A/B 
compartments reflect the previously established tendencies of euchromatin and heterochromatin to 
segregate. These tendencies were first observed as late stage replication domains and more simply as 
the banding patterns of metaphase chromosomes (Allshire and Madhani, 2018). This perhaps suggests 
that the A/B compartments represent stable structural components of the genome. However, the 
capture of the dynamic genome reorganisation during hPSC differentiation revealed extensive 
compartment switching that was attributed to changes observed within topologically associated 
domains (TADs) (Dixon et al., 2015). With the increasing resolution and coverage of Hi-C studies, TADs 
were uncovered as yet another genome architectural feature at the lower sub-megabase level (Dixon 
et al., 2012; Hou et al., 2012; Nora et al., 2012; Sexton et al., 2012). The higher interaction frequency 
within a domain, with few interactions between domains is what defines TADs. The boundaries of 
TADs are enriched with cohesin, the protein complex that regulates the separation of sister 
chromatids during cell division, and the insulator protein CTCF (Dixon et al., 2012; Rao et al., 2014; 
Symmons et al., 2014), whose binding motif orientation was shown to determine its ability to form 
domains (Guo et al., 2015; Wit et al., 2015). The CTCF and cohesin dependent domain formation has 
been proposed to be the result of a loop extrusion mechanism, which is supported by perturbation 
experiments (Haarhuis et al., 2017; Wutz et al., 2017) and an in-silico model (Barrington et al., 2017; 
Fudenberg et al., 2016; Goloborodko et al., 2016). The large-scale principles of genome structure have 
provided us with enourmous insight into how DNA is folded within the nucleus and the implications 
thereof on the smaller scale contacts involved in transcriptional regulation.  
The intricacy of transcriptional regulation is exemplified by the involvement of distal regulatory 
elements (enhancers, silencers, insulators) that have been shown to loop and contact non-adjacent 
promoters and ultimately impact their expression levels (Bulger and Groudine, 2011; Laat and 
Duboule, 2013; Spitz, 2016). Some of the most dramatic phenotypes include the sonic hedgehog (Shh) 
gene involved in limb development and the Sox9 gene involved in sex determination. The Shh gene 
has a distal enhancer located 1 Mb away, in the intronic region of another gene. Point mutation or 
deletion of the Shh enhancer leads to the loss of Shh expression and results in limb deformation, which 
is similar in phenotype to the deletion of the Shh gene itself (Lettice et al., 2003; Sagai et al., 2005). In 
the Sox9 example, the identification of a new enhancer Enh13 and its deletion substantially reduced 
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the levels of Sox9 expression in XY males below the required levels for testes development, leading to 
a sex reversal phenotype (Gonen et al., 2018). Additional studies with artificial tethering of enhancers 
and looping factors provided direct evidence of the importance of looping in the regulation of 
transcription (Deng et al., 2012; Müeller-Storm et al., 1989).  
One of the limitations of Hi-C is the enormous diversity of pairwise interaction that it generates, 
requiring vast amount of sequencing to achieve enough coverage for the identification of interactions 
such as enhancers and promoters (Belton et al., 2012). To gain higher resolution information on the 
scale of promoter-enhancer interactions, a protein enrichment method based on Chromatin 
ImmunoPrecipitation (ChIP) was developed called Chromatin Interaction Analysis with Paired-End-Tag 
sequencing (ChIA-PET) (Fullwood et al., 2009). The method was successfully used to examine the 
interactome of active promoters bound with RNA polymerase II (Li et al., 2012). However, the inability 
to examine inactive promoters and regions of differential protein occupancy lead to the development 
of capture Hi-C (CHiC) and HiCap (Mifsud et al., 2015; Sahlén et al., 2015; Schoenfelder et al., 2015). 
The CHiC relies on a pool of capture probes consisting of 120 bp biotinylated oligos that enables a 
substantial enrichment of promoter interaction from a Hi-C library. The capture of promoter 
interactions allows the discovery of their distal regulatory elements and is revealing the structural 
organisation that leads to the coregulation of genes, such as through colocalization within 
transcription factories or repressive Polycomb bodies. Generation of extensive CHiC datasets in cells 
of the hematopoietic lineage additionally revealed that cell specific interactions can distinguish cell 
types, and can link non-coding disease associated variants with possible target genes (Javierre et al., 
2016). Altogether, the studies of the 3D genomic architecture have revealed multiscale principles of 
DNA folding and its functional roles in controlling transcription.  
5.2 Hypothesis 
During the short developmental time between pre- and postimplantation development, cells within 
the human embryo undergo enormous epigenetic and chromatin remodelling. Some of these changes 
include the removal and reestablishment of DNA methylation marks, promoter histone modifications 
and the expression of a state specific transcriptome along with the translation of unique transcription 
factors. Based on these changes and other lower resolution studies performed in mESC (Joshi et al., 
2015), it can be expected that there will be extensive promoter-enhancer rewiring.  
5.3 Aims 
Our current understanding of the 3D genome organisation of the human naïve and primed states of 
pluripotency is very limited. To better understand the coordination of developmental gene control, 
we have used promoter capture Hi-C to enrich over 22,000 promoters from naïve and primed hPSCs. 
My aims for this collaborative project are: 
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1. To examine new ways of visualising entire PCHiC datasets that would aid with an unbiased 
examination of interaction features.  
2. To investigate the changes in promoter interactions between naïve and primed hPSCs. 
 
5.4 A novel way of visualising and analysing promoter capture Hi-C (PCHiC) data 
The enriched nature of PCHiC creates regions of locally enriched interactions that overall produce a 
relatively sparse significant interaction matrix. For this reason, PCHiC data is most commonly viewed 
and presented in the form of arc diagrams or circular plots, instead of classical HiC heatmaps. This 
limits the examination of the data to a select region of interest. For the general aim of uncovering 
interaction between a promoter and its distal regulatory elements such as enhancers, these methods 
are sufficient. However, a comprehensive way of examining entire networks of interacting promoters 
and other ends that could reveal co-regulatory mechanisms and elucidate the dynamic changes that 
separate different cell states has been lacking. Therefore, for the comparison of naïve and primed 
hPSCs promoter interactions I chose to combine both cell types into a single network, where the 
positions of HindIII fragments (nodes) would act as anchors around which the cell type specific 
interactions could be changed (Figure 5-2 a). Significant interactions only present within the naïve 
hPSCs are coloured blue, primed specific interactions are coloured red, while interactions present in 
both cell types (shared) are coloured black/grey. Using a force directed network layout, where nodes 
that interact more frequently are pulled closer together while less interacting nodes are pulled further 
apart, allowed me to visualise clusters of highly interacting HindIII fragments which tend to contain 
gene families such as protocadherin and the histone H1 genes (Figure 5-2 b). Importantly, it also 
allowed me to pick out clusters that preferentially interacted in naïve or in primed hPSCs. By examining 
the interaction frequency of each gene on a HindIII fragment, it became clear that the protocadherin 
genes have substantially more interactions in primed cells compared to naïve, while the opposite is 
true for the histone H1 genes (Figure 5-2 c). The increase in interactions for each family of genes also 
corresponded to an increased in the level of expression when compared to the other cell type (DESeq 
padj >= 0.05) (Figure 5-2 c and d). One of the powerful features of the network approach is that is 
allows me to overlay a range of different data onto the nodes (HindIII fragments) and edges 
(interactions between fragments). Asides from the origin (naïve or primed) of each interaction/HindIII 
fragment, shown in Figure 5-2 b, I have also overlaid categories of gene expression that again 
highlights the protocadherin and histone H1 clusters as predominantly expressed in naïve or in primed 
(Figure 5-2 d). The expression overlay also allows quick identification of other biologically relevant 
clusters and eliminate perhaps less functionally important clusters such as the keratin and olfactory 
receptor clusters, which despite having differences in interaction frequencies have no differential 
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gene expression. An overlay of A/B compartment switching reveals clusters of genes that undergo 
activation (B to A) or silencing (A to B) (Figure 5-3). One prominent example is the TET2 gene that 
encodes the enzyme responsible for converting DNA 5-methylcytosine (5mC) into 
5-hydroxymethylcytosine (5hmC), which form part of the active DNA demethylation cycle (Wu and 
Zhang, 2017). TET2 is within the active A compartment in naïve cells and switches to the inactive B 
compartment in primed cells. The expression of the TET2 enzyme could partly explain the DNA 
hypomethylation observed in naïve hPSCs (Collier and Rugg-Gunn, 2018). Altogether, the ability to 
visualise entire PCHiC datasets and examine clusters of interactions provides substantial advantages 
over previous methods and has allowed us to examine previously unappreciated clusters of promoter 
interactions.  
The PCHiC datasets also reveal previously undocumented interactions with regulatory regions in the 
naïve state that correlate with higher expression of state-specific genes. Two examples include the 
TET2 and DPPA5 genes. The HindIII fragment containing the TET2 promoter in naïve hPSCs forms 
several interactions with downstream enhancer regions that are enriched in H3K27ac (Figure 5-4 – 
highlighted in grey). These interactions correlate with higher TET2 gene expression naïve compared 
to primed hPSCs. Moreover, the slight increase of repressive H3K27me3 over the TET2 promoter 
region in primed hPSCs may contribute to the lower levels of transcription in primed cells. The DPPA5 
gene is one of the highest differentially expressed genes between naïve and primed hPSCs (Collier et 
al., 2017; Stirparo et al., 2018). In naïve hPSCs, the HindIII fragment containing the DPPA5 promoter 
establishes naïve-specific interactions with several downstream naïve-specific enhancer regions 
enriched with H3K27ac (Figure 5-5 – highlighted in grey). Besides these, the entire region surrounding 
DPPA5 in naïve hPSCs is in an active state with an increased number of interactions. These examples 
demonstrate the value of the PCHiC data as a resource for better understanding the naïve state of 
pluripotency. Further exploration of this data will help to reveal the cis-regulatory regions that 





Figure 5-2: Network visualisation of PCHiC data reveals large-scale interaction changes between two samples.  
(a) Arc diagrams are the typical PCHiC visualisation method, which however, only allow the examination of a limited region 
of the genome. By constructing networks, where each node represents a HindIII fragment and each edge represents a 
significant interaction called by CHiCAGO (see Methods, section 2.16.2), it is possible to get an overview of entire PCHiC 
datasets. A singular network is created from both datasets where interactions unique to naïve hPSC are drawn in blue, primed 
hPSC are drawn in red, and interactions shared by both are drawn in black/grey. The same colour scheme is also applied to 
HindIII fragments. (b) A force directed layout (Jacomy et al., 2014) of the network containing both the naïve and primed 
samples. Some of the interaction clusters containing gene clusters have been labelled. (c) The number of interaction that each 
gene establishes with other HindIII fragments highlights some of the most highly interacting genes. (d) Differential gene 




Figure 5-3: Switching from active to inactive compartments happens in several interaction hubs that include the TET2 gene.  
Approximately 11% of HindIII fragments switch compartments between the naïve and the primed cell states. 5% of 
compartment B (inactive) fragments in naïve cells switch to compartment A (active) in primed cells (green), while 6% of 
compartment A fragments in naïve cells switch to compartment B in primed cells (orange). 
5.4.1 Force directed layout captures general features of genome folding 
Significant PCHiC interactions are centred on baited fragments that produce island of enrichment. Due 
to these local cis interactions the PCHiC network is not fully connected and instead contains numerous 
independent subnetworks. These subnetworks in turn contain clusters of highly interacting bait and 
other ends that can be subdivided into what is known in network science as communities (Figure 5-6). 
The communities form interactions within themselves more frequently then with other communities. 
This is essentially the definition of topologically associated domains (TADs) (Dixon et al., 2012), which 
led me to compare TAD calls from our HiC data with the communities detected in the PCHiC network. 
Overlaying TAD information, determined from naïve and primed HiC, onto the network nodes reveals 
a striking concordance with subnetwork and community clusters (data not shown). I subsequently 
examined the overlap of HindIII fragments within communities and TADs. The TAD-community overlap 
was significantly higher than compared to random regions of equal TAD size (Figure 5-7). Altogether, 
the comparison of TADs and communities demonstrates that the clusters created with the force-




Figure 5-4: TET2 establishes unique interactions to distal regulatory elements in the naïve state. 
Grey rectangle highlights naïve specific interaction to distal regulatory elements. Tracks were visualised using the WashU 
epigenome browser. The values of RNA- and ChIP-seq represent normalised reads counts (see Methods, section 2.16.6). 
Chromatin states identified by ChromHMM are coloured as follows: active – green; bivalent – orange; heterochromatin – 





Figure 5-5: DPPA5 establishes unique interactions to distal regulatory elements in the naïve state. 
Grey rectangle highlights naïve specific interaction to distal regulatory elements. Tracks were visualised using the WashU 
epigenome browser. The values of RNA-seq and ChIP-seq represent normalised reads counts (see Methods, section 2.16.6). 
Chromatin states identified by ChromHMM are coloured as follows: active – green; bivalent – orange; heterochromatin – 





Figure 5-6: The PCHiC network can be divided into subnetworks and individual communities.  
Each subnetwork is highlighted with a unique colour. Large subnetworks can be further broken down into communities. The multiple levels of the PCHiC network can be leveraged to perform 





Figure 5-7: Network communities overlap with TADs to a significantly greater extent than expected by chance.  
The percentage overlap between HindIII fragments within communities and the HindIII fragments within TADs was compared 
to the overlap with randomly shuffled regions matching the size of each TAD. Unpaired two-sample Mann-Whitney/Wilcoxon 
rank sum test with continuity correction was used to test the significance of the overlap difference.  
5.5 Examination of subnetwork dynamics reveals long range interactions as a major 
contributor to the differences between naïve and primed hPSCs 
One of my main aims in merging the naïve and primed PCHiC data into a single network was to examine 
interaction differences. Initially, I was more interested in large interaction changes in groups of genes 
that would suggest co-regulation, rather than subtle rewiring of enhancer regions that may influence 
transcription of individual genes. I chose to gauge the dynamics between naïve and primed hPSCs at 
the subnetwork level and decided to use the difference in the number of cell type specific interactions 
and HindIII fragments within each subnetwork as a measure of change (Figure 5-8 a); the greater the 
distance from the origin, the greater the change between the two cell states. Reassuringly, the 
protocadherin and the histone H1 subnetworks once again stood out. Interestingly, the size of 
numerous primed subnetworks was greater compared to their counterparts in naïve hPSCs, as 
highlighted by the skew of subnetworks in the lower-left quadrant of Figure 5-8 a. The skew suggests 
that primed cells establish interactions that bring together multiple communities that are self-
contained in naïve cells. To investigate the cause of the community merging into a larger subnetwork 
in primed hPSCs, I first examined the most changing subnetwork (Figure 5-8 a). Linear genomic plots 
and a multidimensional scaling network layout revealed that primed cells establish long-range 
interactions (> 1 mb) that are absent in naïve cells (Figure 5-8 b). I next wanted to determine whether 
the establishment of long-range interactions was unique to the examined subnetwork, or if it was a 
more widespread feature. Examining the mid-range and shortest 1000 interactions in each dataset 
revealed no appreciable differences between naïve and primed. However, the top 1000 longest 
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interactions were considerably longer in primed cells compared to naïve, suggesting this is a general 
feature (Figure 5-8 c). 
 
Figure 5-8: Large-scale changes between naïve and primed hPSCs result from the gain of long-range interaction in primed 
hPSCs.  
(a) Difference in the number of interactions and interacting HindIII fragments between naïve and primed hPSC reveals the 
most changing subnetworks. The lower-left quadrant contains subnetworks with more interactions and interacting HindIII 
fragments in primed hPSC, while the top-right quadrant contains larger naïve hPSC subnetworks. The protocadherin (PCDH) 
and histone H1 (HISTH1) subnetworks are highlighted in red along with the most changing subnetwork. (b) The most changing 
network plotted on a linear genomic arc plot (top) with interaction longer than 220 (> 1 mb) highlighted in red in primed and 
blue in naïve (no blue interactions are present). By using multi-dimensional scaling (MDS) with the genomic distance as the 
edge weights, the distance between nodes can be interpreted as linear genomic distance. The stress score denotes the 
reliability or degree of correspondence of the genomic distances and the distances between the nodes determined by MDS 
(score of 0-1). Values below 0.1 represent a good fit, whereas values above 0.15-0.2 are generally too far from the original 
distances to make meaningful conclusions (Kruskal and Wish, 1978). (c) Comparison of 1000 longest, shortest and mid-range 
interaction distances between naïve and primed hPSC (long - > 1mb; mid – around 15 kb; short – around 6 kb). 
177 
 
To establish what the long-range interactions are doing and whether they are biologically relevant, I 
used ChromHMM (Ernst and Kellis, 2012, 2017) to determine the chromatin state of HindIII fragments 
with the top 1000 longest interactions in naïve and in primed hPSCs (Figure 5-9 a). In naïve cells, most 
long-range interactions were between active state (H3K4me3, H3K27ac, H3K4me1) fragments. 
Conversely, in primed cells the longest interactions formed between bivalent state (H3K27me3, 
H3K4me3, H3K4me1) fragments. With the dominance of the bivalent state in primed cells, it is possible 
that the Polycomb group (PcG) proteins, namely the Polycomb repressive complex 2 (PRC2) 
responsible for depositing H3K27me3 marks via the EZH1/2 methyltransferase subunit 
(Schuettengruber et al., 2017), could be driving the establishment of the observed long-range 
interactions. To further examine the regions of PRC2 occupancy, I overlaid the bivalent and Polycomb 
chromatin states onto separate naïve or primed interaction networks (Figure 5-9 b). In primed hPSCs, 
the two chromatin states overlap with several HindIII fragment clusters that contain numerous 
interactions within and between each other. Reassuringly, these interaction hubs contain homeobox 
genes, including the HOXA-D gene clusters, which encode a set of transcription factors responsible for 
specifying segment identity within the embryo; in other words, specifying which part of the embryo 
will give rise to which body part (Pearson et al., 2005). Homeobox genes have been previously shown 
to be regulated by PcG and Trithorax group proteins (Schuettengruber et al., 2017). Based on the large 
concentration of co-regulated HindIII fragments, it is tempting to speculate that the hubs correspond 
to Polycomb bodies, which have been described by microscopy as nuclear foci with high 
concentrations of PcG proteins (Matheson and Elderkin, 2018). However, further work will need to be 
performed to confirm this hypothesis. Examining the same regions in naïve cells reveals a stark 
contrast to primed cells, with most of the hub and inter-hub interactions being absent (Figure 5-9 b). 
This is perhaps not surprising given the absence of the H3K27me3 mark from the promoters of naïve 
cells, which has been established in a number of studies in both human and mouse (Marks et al., 2012; 
Reddington et al., 2013; Theunissen et al., 2014). Altogether, the absence of H3K27me3 repressive 
hubs in naïve cells contrasts with the widespread, long-range, highly interacting hubs observed in 




Figure 5-9: Comparison of chromatin states of top 1000 longest interactions reveals dominance of the bivalent state in 
primed hPSCs.  
Chromatin states were determined using ChromHMM. (a) The chromatin states of the nodes connected by the top 1000 
longest interactions in naïve and the top 1000 in primed. Each heatmap is divided by the chromatin state of the promoter 
HindIII fragment. (b) Visualising bivalent and Polycomb-only interactions on the network highlights several clusters in primed 
hPSC (top) that all contain homeobox genes. The clusters, together with the interactions are virtually absent in naïve hPSC 
(bottom). (c) Circos plots of the 6 chromosomes containing HOX genes. Interactions with and between HOX genes are 
highlighted in red. Other long range (220) and trans interactions are shown in blue. Track on the outside shows H3K27me3 
peaks. HOXA – chr7; HOXB – chr17; HOXC – chr12; HOXD – chr2. 
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5.6 Intra-HOX gene interaction are absent from naïve hPSCs 
The stark contrast of interactions between naïve and primed hPSCs in the HOX clusters led me to 
examine them in more detail. Circos plots reveal, in more detail, the almost complete absence of 
interactions in naïve cells, except for directly above the HOX clusters, while primed cells display 
numerous long-range and trans interactions (Figure 5-9 c). Similar observations were also made in the 
equivalent naïve and primed mouse system (Joshi et al., 2015). However, my closer examination of 
the HOXA cluster revealed a surprising absence of intra-HOXA interactions in naïve hPSCs, which were 
a prominent feature in primed hPSCs (Figure 5-10). The change in intra-HOXA interactions was 
accompanied by a decrease of the H3K27me3 mark, while the H3K4me3 remained equivalent in both 
cell types. The decrease in H3K27me3 resulted in active chromatin state annotation of small gene 
overlapping regions, along with an observable leaky transcription of HOXA genes. I further examined 
the HOXC cluster, where I observed a similar absence of intra-HOXC interactions (Figure 5-11 a). 
However, the inter-HOXC interactions appear to be more prominent in naïve compared to primed 
cells. Quantification of the inter-HOX and intra-HOX interactions revealed that HOXA and HOXD have 
more inter-HOX interactions in primed cells, while HOXB and HOXC have more inter-HOX interactions 
in naïve cells (Figure 5-11 b). Overall, intra-HOX interactions are a dominant feature of primed hPSCs, 
while inter-HOX interactions are observed more equally between the two cell types, indicating that 






Figure 5-10: Visualisation of HOXA interactions and histone modifications reveals differences between naïve and primed 
hPSCs. 
Interactions with (inter) and between (intra) HOXA genes reveals a dominance of intra cluster interactions in primed hPSCs. 
Tracks were visualised using the WashU epigenome browser. The values of RNA- and ChIP-seq represent normalised reads 
counts (see Methods, section 2.16.6). Chromatin states identified by ChromHMM are coloured as follows: active – green; 






Figure 5-11: Intra-HOX interactions dominate in primed hPSCs.  
(a) Comparison of interactions between naïve (blue) and primed (red) hPSCs in the HOXC gene cluster. Bottom track shows 
RefSeq genes. (b) Quantification of the number of interactions that HOX genes make with other non-HOX containing (inter) 





The examination of promoter interactions in naïve and primed hPSCs using a network approach 
revealed numerous, large connected hubs with cell state-specific interaction frequency. The use of a 
force directed network layout (Jacomy et al., 2014) revealed features of genome organisation, such as 
TADs. This is perhaps not surprising given that several network-based approaches have been recently 
proposed as an accurate means for calling TADs (Norton et al., 2018; Yan et al., 2017). Nonetheless, 
the ability to view entire PCHiC datasets with meaningful organisational features on multiple scales 
provides an enormously powerful discovery tool. Indeed, by quantifying the differences in interacting 
HindIII fragments and total interactions on the scale of sub-networks, it was possible to identify several 
sub-networks between naïve and primed hPSCs that underwent substantial remodelling. Additionally, 
analysis of the changes in connectivity between individual communities within sub-networks also 
revealed a higher propensity of small communities to come together and form much larger interacting 
units in primed hPSCs. By overlaying histone-modification datasets onto HindIII fragments, it was 
apparent that long-range cis-interactions marked with H3K27me3 are associated with the aggregation 
of large interaction hubs. Together with future planned immuno-FISH experiments, these findings 
could establish a link with Polycomb body formation in the establishment of these large interacting 
units. Overall, the network-based approach to visualising and analysing PCHiC datasets has provided 
us with a multi-scale overview, ranging from global interaction dynamics to local communities that 
recapitulate TADs, and all the way down to individual promoter-enhancer interactions.  
Some of the sub-networks that underwent substantial remodelling include the histone H1 and the 
protocadherin gene families. Variants of the histone H1 family have previously been shown to be 
important in the maintenance of pluripotency, the ability to differentiate and in the repression of 
satellite repeats in mESCs and human induced pluripotent stem cells (iPSCs) (Turinetto and Giachino, 
2015). The hypomethylated state of naïve hPSCs would be expected to lead to de-repression of 
repeats, suggesting that higher expression of the histone H1 genes in naïve hPSCs, possibly resulting 
from their increased interactivity, could be a compensatory repression mechanism for satellite 
repeats. On the other hand, the protocadherin gene family encodes cell adhesion molecules that are 
predominantly expressed in the neural lineage (Chen and Maniatis, 2013; Sano et al., 1993).  Based on 
DamID studies, the protocadherin cluster is associated with the nuclear lamina (a protein mesh 
structure on the inner nuclear membrane) (Kind et al., 2015), which could account for the relatively 
low expression and interaction in naïve hPSCs. In primed hPSCs, the increased expression of several 
protocadherin genes could entail their selective looping out of the repressive lamina environment, 
which based on their increased flexibility would increase their interactivity with other genes within 
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the protocadherin cluster. Altogether, the interaction dynamics of sub-networks reveal new 
associations with the switching of pluripotent states. 
In addition to some of the large-scale interaction differences observed between naïve and primed 
hPSC, the PCHiC datasets have also revealed numerous examples of enhancer switching. In mouse 
naïve and primed ESCs the switching of enhancers has been previously documented and used as 
marker for distinguishing the two cell states (Collier and Rugg-Gunn, 2018). The OCT4 gene in naïve 
mESCs uses the distal enhancer, while in primed mEpiSCs the proximal enhancer is utilised instead. 
The use of a 6-cutter such as HindIII leads to lower resolution compared to a 4-cutter such as MboI 
(Sahlén et al., 2015). Because of this, proximal enhancer interaction in our datasets will likely not be 
detected. Nonetheless, the advantage of the less frequent cutter is its ability to capture longer-range 
interactions. Some of the genes that changed their distal enhancers between naïve and primed hPSCs 
includes TET2 and the naïve specific gene DPPA5. The current analysis of PCHiC with the CHiCAGO 
pipeline is based on pairwise comparisons of all the fragments (Cairns et al., 2016), which in some 
cases can produce stretches of significant interaction fragments, from which it can be challenging to 
infer the most important interactions. To address this complication, a method was developed that 
uses fine mapping, typically employed in genome-wide association studies (GWAS), to identify the 
primary interacting fragment (Eijsbouts et al., 2018). The method was shown to improve the resolution 
of existing datasets. The data presented here provide the opportunity for follow-up enhancer 
knockout studies to functionally interrogate the role of altered enhancer interactions, and fine-
mapping could potentially increase the success of such follow-up studies. Altogether, our PCHiC 
datasets and analysis provide a useful resource for understanding how cells are primed into lineage 
commitment and make one of their first developmental decisions. 
The observed emergence of intra-HOX interactions in primed hPSCs correlates with PRC2 H3K27me3 
modification, which together with H3K4me3 establishes a poised environment in which HOX genes 
are silent until ready for expression in a temporally controlled manner. The highly self-interacting HOX 
domains are one of the best examples of TAD regulated gene expression (Andrey et al., 2013), and 
their compaction into large hubs has been shown to involve interactions beyond simply pairwise that 
are detected by classical 3C methods (Olivares-Chauvet et al., 2016). These previous observations 
appear to be captured with our network approach, where the expected regulation by repression 
results in highly interacting hubs that include the HOX loci. The expression of Polycomb group proteins 
and the respective demethylases are similar between the two states, while the global H3K27me3 
levels remain the same (Marks et al., 2012). This observation has also been made in human naïve and 
primed pluripotent stem cells (Theunissen et al., 2014). However, the absence of H3K27me3 at 
promoters of key developmental genes in naïve hPSCs raises the question of what is keeping them 
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silent and preventing cells from improperly differentiating. Other studies have shown the involvement 
of PRC1 in the formation of long-range interaction involving the HOX genes (Schoenfelder et al., 2015). 
This requirement for PRC1 in long-range interactions, the loss of H3K27me3 at promoters of naïve 
hPSC and the absence of promoter long-range interactions in our PCHiC data, suggests that an 
interplay between both Polycomb repressive complexes may be required to establish highly 
interacting repressive hubs. A previous study in naïve and primed mESCs has also demonstrated the 
importance of PRC2 in the establishment of long range interactions and as the driver of genome 
organisational differences between the two cell states (Joshi et al., 2015). Further experiments 
examining the site of PRC1 occupancy and potentially other repressive complexes, such as REST, could 
potentially reveal the mechanism by which these important developmental loci are silenced in naïve 
hPSCs and which factors are directly involved in the formation of long-range interactions. A more 
recent study, using CRISPR-Cas9, demonstrated a PRC2 dependence in the establishment of poised 
enhancer interaction with their target genes (Cruz-Molina et al., 2017). The absence of PRC2 was 
shown to compromise the induction of genes in the differentiated cell types, suggesting a function of 
PRC2 beyond just repression that includes genome organisation and proper activation of genes 
required in differentiation.  
Summary of finding: 
 Network visualisation of PCHiC data revealed large-scale changes in interaction hubs between 
naïve and primed hPSCs. 
 Rewiring of promoter-enhancer interactions of cell specific genes takes place and correlates 
with transcriptional changes, with TET2 and DPPA5 as examples.  
 Large-scale changes between naïve and primed hPSCs stem from the gain of long-range 
interactions in primed hPSCs, which are dominantly established between HindIII fragments 
with the bivalent and Polycomb chromatin states. 
 Large interacting hubs formed by long range interactions in primed hPSCs overlap with 
homeobox genes, including the four HOX clusters that display intra-HOX interactions in 
primed hPSCs, which are absent in naïve hPSCs. 
Large amounts of starting material have been a limiting factor for examining the genome 
architecture of rare populations such as pro-B cells. Recent improvements in the Hi-C protocol are 
now enabling the study of chromatin conformation in thousands of cells instead of the previously 
required tens of millions of cells (Blanco et al., 2018; Oudelaar et al., 2017). We have recently 
published PCHiC datasets from pre-B cells, which examined the changed in genome architecture that 
take place during ageing (Koohy et al., 2018). A number of differences were observed that included 
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the A to B compartment switching of the genomic region encompassed the Irs1 gene. Future efforts 
are now focused on performing an equivalent capture in pro-B cells. The network approach of 
visualising the entire PCHiC dataset will provide a valuable tool for data exploration and analysis, 
comparing pro-B and pre-B datasets. The global overview of combined datasets could enable the 
identification of differences at individual loci, which may have been missed otherwise. The future 
use of dynamic networks could additionally provide a new insightful way of visualising the changes in 
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